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Abstract 
Background 
Low back pain (LBP) is one of the most common musculoskeletal conditions 
encountered in clinical practice. Physiotherapists as well as other professionals in 
healthcare use manual spinal mobilisations to treat patients with LBP with the aim of 
reducing pain or/and stiffness and improving the range of motion. Although spinal 
mobilisations are widely used in the clinical sitting, the underlying mechanisms 
regarding its effectiveness remain largely unknown. The purpose of the current study 
was to examine the physiological responses of spinal mobilisations in terms of the 
hypoalgesic and SNS responses in those with and without LBP.  
Methods 
Phase 1 examined the test-re-test reliability of sympathetic and hypoalgesic 
measurements (n = 15). Phase 2 was a pre-clinical study (single arm trial, n = 14) 
that investigated the hypoalgesic and sympathetic effects of thoracic mobilisation 
treatment in asymptomatic participants over a course of three sessions of 
mobilisation. Phase 3 investigated the hypoalgesic and sympathetic effects of 
thoracic mobilisation treatment in patients with nonspecific chronic low back pain 
(NSCLBP) (n = 36) over a course of three sessions of mobilisation. 
Results  
Phase 1 demonstrated that the within-day test-retest reliability of skin conductance, 
skin temperature, heart rate, respiratory rate, systolic blood pressure and PPT 
measurements were excellent (ICCs of 0.77 to 0.99). On the other hand, the 
reliability of diastolic blood pressure and salivary alpha-amylase measurements 
were demonstrated to be fair to good (ICCs of 0.55 and 0.7, respectively). Phase 2 
revealed significant sympathoexitatory effects in terms of diastolic blood pressure 
(p=0.026), heart rate (p=0.005) and respiratory rate (p= 0.001) where there were 
insignificant results with regard to peripheral sympathetic measures (skin 
conductance and skin temperature). Significant hypoalgesic effects were evident in 
some locations, including distal areas, but not at all visits. Phase 3 showed 
significant peripheral detectable sympathoexcitatory effects in the lower limbs in 
terms of increased skin conductance (p= 0.001) and decreased skin temperature 
(p= 0.001) following thoracic mobilisation that were not detected in asymptomatic 
participants. 
Conclusion  
This study demonstrated that patients with nonspecific low back pain are more 
peripheral sympathetic responsive to thoracic mobilisations than asymptomatic 
population suggesting that adaptive neuroplasticity, as well as dorsal horn and 
central processing, in the LBP patients, may be a feasible explanation of the results. 
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NPRS       = Numerical Pain Rating Scale 
NRM         = Nucleus raphe magnus  
NSCLBP   = Nonspecific chronic low back pain 
NSLBP      = Nonspecific low back pain 
PA             = Posteroanterior  
PAG          = The periaqueductal grey  
PNS          = Parasympathetic nervous system 
PPT          = Pressure pain threshold 
PRISMA   = The Preferred Reporting Items for Systematic Reviews  
RCT          = Randomized controlled trial 
Q-Q plot    = quantile-quantile plot 
RR            = Respiratory rate 
RT            = Right 
S               = Seconds 
S2             = Second sacral vertebra 
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S3             = Third sacral vertebra 
S4             = Fourth sacral vertebra 
sAA           = Salivary alpha-amylase 
SBP          = Systolic blood pressure 
SC            = Skin conductance 
SD            = Standard deviation  
SEM         = Standard error of measurement 
SMT         = Spinal manual therapy 
SNAG      = Mulligan sustained apophyseal glide 
SNS         = Sympathetic nervous system 
SPSS       = The Statistical Package for Social Scientists 
SR            = Skin resistance  
SRD          = Smallest real difference 
ST             = Skin temperature 
T1             = First thoracic vertebra 
T12           = 12th thoracic vertebrae 
T2             = Second thoracic vertebra  
T3             = 3rd thoracic vertebrae 
T4             = 4th thoracic vertebrae 
T6             = Sixth thoracic vertebrae 
TPT          = Thermal pain threshold  
U/m          = Unite per minute 
U/ml         = Unit per millilitre 
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Ul             = Microliter 
V              = Voltage 
VAS         = Visual Analogue Scale 
vlPAG      = Ventrolateral periaqueductal grey  
vPAG       = Ventral periaqueductal grey 
WRC        = White rami communicantes 
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Chapter one 
Introduction  
Low back pain (LBP) is one of the most common musculoskeletal conditions that 
has a relatively high incidence both in the United Kingdom and worldwide (Lidgren, 
2003; Dunn and Croft, 2006). Between 49% and 70% of people suffer from LBP at 
some point in their lifetime (Koes et al., 2001; Koes and Van Tulder, 2006). 
Maxfarlane et al. (2006) reported that more than one-third of the UK population is 
affected each year. During the first 46 weeks of LBP, 58% of the patients report 
rapid improvement; however, recovery is often incomplete (Pengel et al., 2003). For 
most sufferers, persistent pain and associated disability may last for months, and a 
small proportion of patients may even become severely disabled (Koes et al., 2006). 
Moreover, recurrence is common over the next 12 months in those with completely 
resolved pain (Henschke et al., 2009). Maniadakis and Gray (2000) reported that in 
1998, out of the total cost of LBP healthcare, approximately £600 million was spent 
on physiotherapy and other allied fields. LBP is one of the most common 
musculoskeletal conditions encountered in clinical practice (Krismer and Van Tulder, 
2007). Multiple systematic reviews have indicated the beneficial effects of manual 
therapy in treating spinal pain conditions (Koes et al., 2001; Gross et al., 2002; 
Assendelft et al., 2003; Assendelft et al., 2004; Bronfort et al., 2004; Cleland et al., 
2005; Chou and Huffman, 2007). Physiotherapists as well as other professionals in 
healthcare use manual therapy to treat patients with LBP with the aim of reducing 
pain or/and stiffness and improving the range of motion (Bronfort et al., 2004). 
Manual therapy includes physical techniques that are applied to patients by the 
therapist in the form of either manipulation or mobilisation. Manual therapy has been 
shown to have hypoalgesic and sympathetic effects in asymptomatic populations 
and patients with cervical pain (Vicenzino et al., 1998; Sterling et al., 2001; Perry 
and Green, 2008; Jowsey and Perry, 2010; Krouwel et al., 2010).  
Spinal manual therapy (SMT) is widely applied in the clinical setting to treat 
musculoskeletal pain (Krouwel et al., 2010). However, the mechanisms underlying 
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its effectiveness remain largely unknown (Sterling et al., 2001; Hegedus et al., 2011). 
Over the last two decades there has been increasing interest in the 
neurophysiological responses of the sympathetic nervous system (SNS) to SMT. 
Several studies have measured sympathetic nervous system responses but 
research on the lumbar area of the spine is very limited. To date there are no 
reported studies on any patient population (Perry and Green, 2008; Jowsey and 
Perry, 2010; Krouwel et al., 2010). In contrast, the neurophysiological effects of 
spinal manipulation have undergone intense scrutiny (Thomson et al., 2009). 
The overall aim of this thesis was therefore to explore the hypoalgesic and 
sympathetic effects of spinal mobilisation in asymptomatic and symptomatic 
populations with nonspecific chronic low back pain (NSCLBP). In addition, this thesis 
aimed to inform future research by providing evidence of SNS and pain responses 
to specific mobilisation treatment techniques.  
The following outlines the topics covered in this thesis: In Chapter 2, the literature 
related to neurophysiological responses to spinal mobilisation is critically reviewed. 
Chapter 3 represents a systematic review of randomised controlled trials that assess 
the effectiveness of spinal mobilisation in terms of the hypoalgesic and SNS 
responses in healthy populations or in patients with spinal pain. Chapter 4 outlines 
the methods used for sympathetic and hypoalgesic measurements in the studies 
conducted in this thesis; with Chapter 5 reporting the test-re-test reliability of these 
measurements in asymptomatic participants (n = 15). Subsequently I investigated 
the effects of mobilisation treatment on these variables in asymptomatic populations 
and patients with NSCLBP. Chapter 6 reports a pre-clinical study (single arm trial, n 
= 14) that investigated the hypoalgesic and sympathetic effects of thoracic 
mobilisation treatment in asymptomatic participants over a course of three sessions 
of mobilisation. Chapter 7 outlines a clinical study (single arm trial, n = 36) that 
investigated the hypoalgesic and sympathetic effects of thoracic mobilisation 
treatment in patients with NSCLBP over a course of three sessions of mobilisation. 
Finally, Chapter 8 discusses the results of all three studies, highlights their original 
contribution to the available knowledge, and identifies areas for further research. 
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Chapter Two  
Review of literature related to low back pain and spinal mobilisation 
2.1. Definition and classification of low back pain 
Dionne et al.’s (2008) definition of LBP is internationally accepted:   
Pain between the inferior margin of the 12th rib and the inferior gluteal folds that is 
bad enough to limit usual activities or change the daily routine for more than one 
day. This pain can be with or without pain going down to the leg. This pain does not 
include pain from feverish illness or menstruation. 
Over the last two decades, a number of attempts have been made to classify LBP 
with the aim of assisting heterogenic patient populations and easing the decision-
making process (O’Sullivan, 2005). The literature in the area of LBP physiotherapy 
mostly uses the Quebec task force classifications system that provides a logical 
classification approach of LBP disorders within a biopsychosocial framework 
(Abenhaim et al., 2000; Waddell, 2004).  Both red and yellow flags (psychological 
and/or social factors) are considered under this framework. This system classifies 
LBP disorders as ‘specific LBP’ with a determined patho-anatomical causative factor 
(e.g. systemic inflammatory disorders, ankylosing spondylitis, disc prolapse, 
fracture, malignancy, and infection) and ‘non-specific low back pain’ (NSLBP) 
(defined as soreness, tension or/and stiffness over the lower area of the back without 
a specific possible cause [NICE, 2009]). Further delineation of acute (up to 6 weeks 
of symptoms), sub-acute (412 weeks of symptoms) and chronic low back pain 
(CLBP) (>12 weeks) has also been provided by this classification system (Koes et 
al., 2010). 
Eighty-five per cent of CLBP disorders (where back pain lasts for longer than 12 
weeks) are classified as nonspecific with no known diagnosis (O’Sullivan, 2005). A 
further classification has been made for these disorders based on the area of the 
pain and defined as radicular in nature or somatic referred (Abenhaim et al., 2000). 
However, this classification does not consider the underlying mechanism of the pain 
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disorder; this means that the selection of an appropriate intervention is difficult, which 
limits the value of this classification system in a clinical sitting (Padfield and Butler, 
2002). 
2.2. Physiotherapy treatment of nonspecific chronic low back pain 
There is ongoing debate about the best intervention for NSCLBP that is perhaps the 
result of diagnostic imprecision (Savigny et al., 2009). The National Institute of 
Clinical Excellence (2016) recommended that manual therapy be offered to patients 
with nonspecific low back pain but only as part of multi-modal treatment packages.   
A complete examination by a physiotherapist is essential to make a decision about 
whether physiotherapy is appropriate for the patient or not. In the first meeting 
between a LBP patient and a physiotherapist, a study of the patient’s subjective 
history is made, with a focus on the localisation of symptoms, the aggravating and 
ameliorating factors, past medical history, general health and history of past and 
present episodes of symptoms (Petty, 2011). Specific questions to rule out any 
serious pathological conditions are also asked, based on which the patient may be 
referred to other health professionals (Greenhalgh and Selfe, 2006). Furthermore, 
an insight into some factors that may affect recovery is important when taking the 
subjective history of the patient, such as the perception of the problem, functional 
limitations, and physical or psychological factors (Petty, 2011). 
Following the subjective examination, a physical (objective) examination is 
performed based on the information gained. Normally, objective examination of the 
spine involves: 
-Manual palpation of the lumbar and sacral areas to assess inflammation, 
tenderness and segmental hypomobility and dysfunction.  
-Physiological movement assessment to determine which movements can be 
performed by patients, 
-Accessory movement assessment to examine gliding movements of the 
joints during physiological movements that require external force and cannot 
be performed by the patient alone (Maitland et al., 2005), 
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-Other tests for assessment of nerves or muscles that may reproduce the 
patients’ symptoms.   
Based on the results of complete examination by a physiotherapist, a decision is 
made about whether manual therapy is appropriate for the patient or alternative 
treatment or further investigation is required. However, little research has been 
conducted to assess which CLBP patients would benefit from spinal manual therapy 
(Bronfort et al., 2004). It has been suggested that manual therapy can be 
recommended for CLBP patients who are free from any contraindications for this 
intervention (e.g. history of cancer, direct trauma, pain at rest, loss of bladder or 
bowel control and progressive neurological deficit). Spinal manual therapy may not 
be the best choice for CLBP patients with psychosocial factors or patients who are 
physically deconditioned and cannot increase their activity (ICSI, 2006). 
2.3. Spinal manual therapy 
Spinal manual therapy (SMT) is a frequently used treatment for NSLBP by 
healthcare professionals such as physiotherapists, chiropractors and osteopaths 
(Bronfort et al., 2004). A number of systematic reviews of the literature have 
indicated the efficacy of SMT in the treatment of spinal pain (Gross et al., 2002; 
Bronfort et al., 2004; Cleland et al., 2005; Miller et al., 2010). Several reviews 
examined the role of manual therapy as a management of CLBP. Most of these 
reviews reported that manual therapy is effective for NSCLBP in terms of pain and 
functional measures (Koes et al., 2001; Assendelft et al., 1995). A Cochrane review 
found that spinal manual therapy is moderately superior to sham manual therapy for 
CLBP (Chou and Huffman, 2007). Recent international guidelines for the 
management of chronic low back pain recommended spinal manual therapy as a 
beneficial management for NSLBP patients (Savigny et al., 2009). However, Flynn 
et al. (2002) recognised that manual therapy should not be expected to be 
efficacious intervention for all LBP patients. 
Manual therapy includes physical techniques that are applied to patients by the 
therapist in the form of either manipulation or mobilisation. Manipulations are high-
velocity thrust (HVT) techniques used to treat spinal pain. HVT techniques are 
usually applied at the end of the joint range and sometimes accompanied by a 
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‘popping’ sound. On the other hand, mobilisation is defined as a low-velocity, non-
thrust passive movement, which is applied to a joint within or at the limit of the joint 
range (Maitland et al., 2005; Clinical Guidelines for the Physiotherapy Management 
of Persistent Low Back Pain, 2006). Moreover, mobilisation may be accompanied by 
active movements, such as mobilisation with movement techniques that was devised 
by Mulligan (1999). However, although the effects of spinal manipulation have 
undergone intense scrutiny, spinal mobilisation has received relatively little attention 
in comparison (Thomson et al., 2009). Furthermore, a large proportion of those 
investigations on spinal mobilisation have not looked at the neurophysiological effect 
of the mobilisation as a single treatment (Koes et al., 1992; Dishman and Bulbulian, 
2001).  
2.3.1 Passive mobilisation techniques 
In 1965, Geoffrey Maitland was among the first physiotherapists to educate 
practitioners of mobilisation techniques that were applied to a joint in the form of 
graded oscillatory forces (Banks, 2010). These techniques are commonly used in 
clinical practice with the aim of reducing pain or/and stiffness and improving the 
range of motion. For example, Gracey et al. (2002) reported that Maitland 
mobilisations are used by 42% of physiotherapists to treat LBP. However, the 
underlying mechanisms regarding its clinical effectiveness are unknown (Vicenzino 
et al., 1998 and 1996; Sterling et al., 2001; Coronado et al., 2012). 
The posteroanterior (PA) spinal mobilisation technique is one of the most commonly 
used passive manual techniques in clinical practice (Jull, 2000; Magarey et al., 
2004). It is described as the application of pressure to the spinous process (central 
PA) or transverse process (unilateral PA) of the spinal vertebrae by the therapist by 
either the thumbs (thumb grip) or the heel of the hand (pisiform grip) (Maitland, 2005; 
Snodgrass et al., 2006). It is a low-velocity force directed from the posterior to 
anterior area of a single vertebra (Maitland, 2014).  
The aim of mobilisation techniques applied by physiotherapists is to decrease pain 
or stiffness and/or increase the range of motion. The treatment dose depends on the 
aim of the treatment. Physiotherapists take into account a number of factors when 
selecting a specific technique such as the stage of the symptoms (acute or chronic), 
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the nature of the problem, the irritability and severity of the symptoms, the 
association between pain and stiffness based on the physical examination, pain 
mechanism, patient’s expectations and biopsychosocial factors (Maitland, 2005).  
The amplitude and number of courses of mobilisation depend on multiple 
parameters, and the treatment course is designed such that the optimal level of 
efficacy can be achieved (Table 2.1).  
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Table 2.1. Parameters for determining the mobilisation treatment dose  
Position  The patient can be in the prone position with the spine in extension, 
flexion, rotation, or lateral flexion, or a combination of positions 
(McCarthy, 2010). 
Level of 
treatment  
Maitland et al. (2014) recommended mobilising according to the 
symptomatic level (the most comparable level) as identified by the 
physical assessment.  
Grade Maitland et al. (2014) described four grades of mobilisation (I, II, III and 
IV):  
-Grade I: movement of small amplitude within the initial range (soft 
resistance) 
-Grade II: movement of large amplitude within the available range (soft 
resistance) 
-Grade III: movement of large amplitude associated with firm 
resistance 
-Grade IV: movement of small amplitude associated with firm 
resistance.  
Direction of 
mobilisation 
force  
This refers to the inclination of the mobilisation force, such as medial, 
lateral, cephalad or caudal (McCarthy, 2010). 
Rhythm  The rhythm can be either staccato or slow and smooth (Petty, 2011). 
Rate  Typically, a frequency of 1 Hz (one oscillation/second) to 2 Hz (two 
oscillations/second) (Souvlis et al., 2004) is used. The frequency can 
also be quasi-static (0 oscillations) (Petty, 2011). 
Duration  This refers to the length of time of the applied mobilisation. Normally, 
three sets of 30 seconds to 1 minute are applied (Maitland, 2005). 
Reproduction 
of symptoms  
Mobilisation may be performed at the point before that where the 
symptoms are reproduced or at the point where the symptoms are 
partially or fully reproduced (based on the desired effect) (Petty, 2011). 
 
However, there are not enough studies on the optimum mobilisation parameters and 
the efficacy of treatment (Pentelka et al., 2012).  
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2.4. Understanding the mechanism of action of spinal mobilisation  
Even though there is sufficient evidence to support the effective use of spinal 
mobilisations in the treatment of musculoskeletal conditions such as NSCLBP, the 
mechanisms behind it remain largely unknown (Vicenzino et al., 1998 and 1996; 
Khalsa et al., 2006; Coronado et al., 2012). A comprehensive understanding of these 
mechanisms is crucial for multiple reasons. The successful outcomes reported in 
recent studies are dependent on the identification of likely respondents rather than 
identification of a specific lesion (Flynn et al., 2002). Responders to mobilisations 
may be identified by the clustering of signs and symptoms (Flynn et al., 2002; 
Cleland et al., 2007). Although this proposed direction would be helpful in clinical 
practice, clinical outcomes cannot be predicted based on the signs and symptoms 
alone (Bialosky et al., 2009). On the other hand, if the mechanisms behind the 
mobilisations are understood, it would be possible to identify the predictive factors, 
based on which future clinical decisions to identify responders could be made (Flynn 
et al., 2002). Furthermore, establishing the mechanisms of mobilisation could 
increase its acceptance in clinical practice. Therefore, healthcare providers might be 
able to use these techniques more appropriately if they are aware of their 
mechanisms of action (Bialosky et al., 2009). 
The therapeutic effects of mobilisation, especially decrease in pain after spinal 
mobilisation, are explained by theories, such as the gate-control mechanism 
(stimulation by non-noxious input is able to close the gate to painful input) along with 
other biomechanical effects (Melzack and Wall, 1965; Evans, 2002). Recently, there 
has been an increase in the number of studies supporting the neurophysiological 
mechanism, and the spinal and supraspinal mechanisms are the most commonly 
accepted (Schmid et al., 2008; Hegedus et al., 2011; Kingston et al., 2014; Voogt et 
al., 2014). Based on the findings of various investigations, it was proposed that a 
multi-system, centrally coordinated response is the mechanism underlying the 
therapeutic effects of mobilisation (Vicenzino et al., 1998; Evans, 2002). Several 
studies have identified other changes associated with spinal mobilisation, such as 
alterations in certain vasomotor, sudomotor and cutaneous measures; these findings 
indicate that spinal mobilisations may initiate SNS responses (Wright and Vicenzino, 
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1995; McGuiness et al., 1997; Vicenzino et al., 1999; Souvlis et al., 2000; Sterling et 
al., 2001; Cleland et al., 2004; Jowsey and Perry, 2010). These responses of the 
SNS have been demonstrated in parallel with pain modulation responses following 
mobilisation in animal and human studies (Sterling et al., 2001; Grayson et al., 2012). 
However, these findings have not been confirmed in patients with LBP. Therefore, 
this thesis focuses on pain modulation (hypoalgesic effect) and SNS responses to 
passive spinal mobilisation in individuals with and without LBP. In order to explain 
these neurophysiological responses to spinal mobilisation, the subsequent literature 
review will focus on somatosensory innervation of the spine, explaining how spinal 
mobilisation is understood to act as a physiological stimulus.  
2.5. Somatosensory input from the spine  
2.5.1. Cervical spine 
Ligaments, capsules, paraspinal musculature, intervertebral discs and other 
structures of the cervical spine are innervated with afferent nerves, which project 
either directly or indirectly to different levels of the neural axis (Bolying and Jull, 
2004). The vestibular, optic and sympathetic systems are related to the cervical 
spine, and these systems play a role in the production of a multifaceted 
neurophysiological response to the afferent input that occurs during spinal 
mobilisations. Touch and movement stimulate both cutaneous receptors and deeper 
tissue receptors such as the muscle spindle, during the application of spinal 
mobilisation (Bolton, 1998). Furthermore, paciniform corpuscles are common in the 
joint capsule on the external surface of the vertebrae, while Golgi tendon organs are 
located at the musculotendinous junction (Bolton and Tracey, 1992). The afferents 
from the receptors terminate in the spinal cord: cutaneous afferents synapse in 
laminae IIV, afferents from the zygapophysial joint synapse in laminae I and II, and 
low-threshold afferents from the muscles terminate in the ventral horn as well as 
laminae IVVI (Bolton, 1998). The primary afferent from the cervical spine projects 
higher through the dorsal column–medial lemniscal, spinothalamic and 
somatosensory pathways to the medulla nuclei, including the vestibular nuclei and 
ipsilateral cuneate nucleus, which provides afferent information, both nociceptive 
and proprioceptive, to the contralateral thalamus, cerebellum and sensorimotor 
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cortex (Bolton, 1998; Bolton and Tracey, 1992). Therefore, the stimulation of this 
multifaceted afferent input of the cervical spine is usually associated with a number 
of postural reflexes, such as opticokinetic, vestibulocollic and cervicocollic reflexes, 
which are responsible for eye movements, head movements and head on body 
movements, as well as the appropriate physiological responses to these movements 
(Bolying and Jull, 2004). 
2.5.2. Thoracic and lumbar spine 
Similar types of receptors as found in the zygapophysial joints are located in the 
thoracic and lumbar spines as well as in the cervical spine (McLain and Pickar, 
1998). Although both type I and II fibres are found, as well as free nerve endings, 
their numbers are lower than those in the cervical spine and large receptive fields 
(McLain and Pickar, 1998). However, the connections for afferents from the lumbar 
spine in the spinal cord differ from those of the cervical spine, particularly afferents 
from muscle spindles (Bolying and Jull, 2004). Keirstead and Rose (1988) found that 
unlike certain supraspinally projected cervical afferents, lumbar connections are 
monosynaptic with motoneurons. As a result, the neurophysiological effects on the 
activation of lumbar spine afferents might be different.  
In summary, the previous section indicates that movement of the vertebral column 
and its surrounding structures during spinal mobilisation can lead to activation of 
multiple receptors and the generation of afferent input that projects either to the 
spinal cord or beyond the spinal cord to reach supraspinal neurons (Pickar, 2002). 
The following section will describe the anatomy of the sympathetic and 
parasympathetic divisions of the ANS and their location with respect to the spine. 
2.6. The autonomic nervous system 
2.6.1. Anatomical divisions of the autonomic nervous system 
It has been shown over the last two decades that elements of the ANS could be used 
to objectively measure physiological changes that occur during therapeutic 
treatments. The following section will describe the anatomy of the ANS and how 
changes in this system can be captured; moreover, these changes will be explained 
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in relation to known theories regarding the mechanism of action of spinal 
mobilisation.  
Although parasympathetic nervous system (PNS) and the SNS interact with each 
other in the nervous system, they function as one unit (Benarroch, 2006). The 
internal environment of the body is controlled by the ANS, which supplies cardiac 
muscles, smooth muscles, glands and the viscera (Benarroch, 2006). The SNS and 
the PNS represent the two anatomical and topographical divisions of the ANS 
(Figure 2.1). The SNS is the larger part that plays a catabolic role in regulating the 
internal state of the body by increasing heart rate, expending energy and directing 
circulation from the peripheral regions of the body toward the centre (Goldberg, 
2010). On the other hand, the PNS has an anabolic role that involves slowing down 
the heart rate, absorbing nutrition and conserving energy (Goldberg, 2010). The SNS 
and PNS exit the CNS at various sites to reach structures that they supply with their 
endings. These two complementary systems usually have opposite functions in each 
part of the body, as their terminals are either cholinergic or adrenergic.    
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Figure 2.1. Anatomical divisions of the autonomic nervous system (Thomas, 
2007). 
Neurons of the ANS are classified into afferent, connector and efferent neurons. The 
receptors of the viscera are the origin of afferent impulses to the CNS. The efferent 
pathway consists of the ganglia that lie outside the CNS and is composed of the pre- 
and post-ganglionic neurons. These ganglia are located along the spine from the T2 
to L4 anterolateral to vertebral bodies (Goldberg, 2010).  
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There are differences in the points at which the SNS and PNS connect with the CNS. 
The PNS nerves that protrude from the spinal nerves include cranial nerves III, VII, 
IX and X and sacral nerves S2, S3 and S4. Therefore, nerves of the PNS are 
described as having ‘craniosacral outflow’. On the other hand, sympathetic nerves 
are described as having ‘thoracolumbar outflow’, as they are represented by spinal 
nerves T1 to L2 (Benarroch, 2006). 
The SNS, being larger than the PNS, is distributed widely throughout the body and 
innervates the muscular walls of many blood vessels, piloerection muscles and 
cutaneous sweat glands. The SNS is activated in emergencies and causes 
redistribution of blood to the heart and the brain from the periphery, which results in 
sweating and arrest of digestion (Snell, 2010). As the activity of sweat glands is 
sympathetically controlled, Fowles (1974 and 1986) suggested that the activity of 
sweat glands was an ideal measure of SNS activity. The SNS consists of efferent 
nerve pathways from the spinal cord, two ganglionated sympathetic trunks, 
branches, plexuses and regional ganglia (Benarroch, 2006).  
Motor pathways of the ANS have synapses within autonomic ganglia. The axons 
traveling from the CNS to such ganglia are called preganglionic axons, while the 
neurons forming the ganglia and the axons connecting them to the target organ are 
called postganglionic axons. Anatomically, the parasympathetic ganglia are located 
close to the target peripheral organ, so their postganglionic fibres are short. On the 
other hand, the sympathetic ganglia lie some distance away from the target organ 
(close to the spinal cord), so their postganglionic fibres are relatively long (Snell, 
2010).  
The lateral horn of the grey matter in the spinal cord (T1 to L2 segments) contains 
the cells bodies of preganglionic sympathetic neurons (Figure 2.2). At the level of 
the spinal cord where the cell bodies exist, the preganglionic sympathetic axons exit 
through the ventral roots of the spinal nerve. Following this, the preganglionic 
sympathetic axons enter the ventral ramus of the spinal nerve that leaves the ventral 
ramus just beyond the intervertebral foramen and forms a branch called the white 
rami communicantes (WRC) that enters the adjacent sympathetic trunk. Then, 
preganglionic sympathetic neurons either end or travel within the trunk upward or 
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downward. Preganglionic neurons that travel from the WRC at the lower thoracic 
and lumbar levels within the sympathetic trunk tend to assume a downward course 
toward the lower lumbar and sacral levels prior to their ending. Next, preganglionic 
neurons synapse in the sympathetic ganglia where the postganglionic cell bodies 
exist. After synapsing, the postganglionic neuronal axons exit the trunk; alternatively, 
before synapsing, they may assume a downward or upward course through the trunk 
(Palastanga et al., 1994). There are three paths via which postganglionic 
sympathetic neurons exit the sympathetic trunk. Most of them join a ventral ramus, 
while others follow arteries or form branches that travel directly to the viscera or the 
plexus. Postganglionic neurons leave the sympathetic trunk by joining a ventral 
ramus to form a branch called the grey rami communicantes (GRC). This branch 
leaves the trunk at every spinal level where the WRC leaves the spine, that is, from 
T1 to L2. Therefore, only ventral rami at the level of T1L2 are connected to the 
sympathetic trunk by WRC and GRC.  
After the postganglionic neurons join the ventral ramus, most of them assume a 
distal course within the ramus. Through the course of the ventral and dorsal rami, 
the postganglionic neurons reach their targets, including blood vessels of the joints 
or muscles, blood vessels in the skin (where cutaneous branches are related), and 
muscles related to piloerection or sweat glands in the skin (some of these neurons 
pass along the course of cutaneous branches of the somatic nerves).  
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Figure 2.2. Anatomy of the preganglionic and postganglionic sympathetic 
nerve fibers and synapses (Boron and Boulpaep, 2005). 
In summary, this section presented the anatomy of the sympathetic and 
parasympathetic divisions of the ANS and their location with respect to the spine. 
The following section will discuss the proposed neurophysiological mechanisms of 
action of spinal mobilisation and their potential relevance to the decrease in pain that 
is observed after spinal mobilisation. 
2.7. Proposed neurophysiological mechanism of action of spinal mobilisation 
Pain is one of the main indicators for spinal mobilisation. Although the clinical 
outcomes of spinal mobilisation are widely known, the underlying mechanisms are 
unclear (Vicenzino et al., 1998 and 1996; Sterling et al., 2001; Coronado et al., 
2012). An increasing number of studies have demonstrated that the effect of 
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mobilisation goes beyond biomechanical changes, and these studies have proposed 
various neurophysiological theories to explain the clinical benefits of mobilisation 
(Krouwel et al., 2010; Willett et al., 2010; Pentelka et al., 2012). These theories 
suggest that spinal mobilisation has the ability to activate a number of 
neurophysiological responses in the central and peripheral nervous system 
(Bialosky et al., 2009).   
Pain processing can be influenced by the peripheral healing process that occurs as 
a result of inflammation in cases of musculoskeletal injuries (Bialosky et al., 2009). 
Joint mobilisation may directly influence the interaction between peripheral 
nociceptors and inflammatory mediators. In fact, some authors have reported 
changes in the blood levels of endogenous cannabinoids, serotonin, anandamide 
and B-endorphine following joint mobilisation (McPartland et al., 2005; Degenhardt 
et al., 2007). Moreover, a study by Teodorczyk-Injeyan et al. (2006) showed that 
there was a significant decrease in the level of blood and serum cytokines in the 
mobilisation group in comparison with the control and sham group. The reduction of 
these inflammatory mediators following mobilisation may affect their interaction with 
peripheral nociceptors and influence pain processing (Bialosky et al., 2009).  
Pain is transmitted to the substantia gelatinosa in the dorsal horn of the spinal cord 
by slow-conducting fibres (unmyelinated C and myelinated A delta fibres). Then, the 
nociceptive afferents are modulated via the midbrain and thalamus to the cortical 
level (Bolying and Jull, 2004). Melzack and Wall (1965) were some of the first 
researchers to appreciate that pain gating (stimulation by non-noxious input is able 
to close the gate to painful input) could be affected by the descending control 
systems projected from the supraspinal centres to the spinal cord. They described 
how the nociceptive information toward the brain can be reduced by the mechanism 
of pain gating that occurs when A beta fibres (large-diameter, fast-conducting fibres) 
inhibit A delta and C-fibres (small-diameter, slow-conducting fibres) in the substantia 
gelatinosa. It has been suggested that mobilisation may stimulate the pain gate 
mechanism (Wyke and Polacek, 1975; Souvlis et al., 2004). Sensory inputs such as 
touch and non-threatening inputs often trigger the gate control mechanism (Melzack 
and Wall, 1965). Multiple structures are moved by mobilisation, such as joints, 
nerves, muscles and skin. Therefore, the related afferents are stimulated, including 
39 
 
articular, muscular, cutaneous and neurovascular afferents (Souvlis et al., 2004). As 
a result, mechanoreceptors elicit discharges that are transmitted by A beta fibres 
(large diameter) to the spinal cord, resulting in a decrease in pain awareness by 
decreasing the input from nociceptors (Wyke and Polacek, 1975). However, this 
preferential ability of the spinal mobilisation toward stimulation of the low threshold 
mechanoreceptors apart from high threshold neurons has been questioned 
(Zusman, 1986). Zusman (1986) argued that the proposed hypoalgesic responses 
of spinal mobilisation might be the result of the suggested ability of the repetitive 
movement during the application of mobilisation to decrease activity of joint 
afferents. 
George et al. (2006) and Bialosky et al. (2009) tried to explore whether there is a link 
between the hypoalgesic effects of SMT and the pain gate mechanism. These 
researchers measured the effect of spinal manipulation (HVT) on the activity of A 
and C fibres by sensory quantitative testing. Following SMT, they observed a 
reduction in dorsal horn excitability that was represented by reduction of C nerve 
fibre-mediated temporal summation. However, this was present only in areas that 
were supplied by the lumbar nerves and not the upper levels of the spine. These 
findings indicate that the dorsal horn of the spinal cord mediates local hypoalgesia. 
Another study by Malisza et al. (2003) used functional MRI to examine the effect of 
knee mobilisation in rats. Their results indicate that the hypoalgesia observed after 
mobilisation may be mediated at the spinal cord level, as the pain-associated areas 
of the spinal cord showed reduced activity. However, mobilisation is thought to 
produce an input that may extend beyond the spinal cord to the supraspinal levels 
of the CNS and modulate nociceptive information from the efferents (McGuiness et 
al., 1997; Vicenzino et al., 1999; Souvlis et al., 2000; Sterling et al., 2001; Cleland et 
al., 2004; Souvlis et al., 2004; Jowsey and Perry, 2010) 
The presence of descending modulatory circuits is another proposed mechanism of 
induced hypoalgesia. Through this mechanism, numerous neurotransmitters have 
been observed to function in areas of the CNS, including the anterior cingular cortex, 
the amygdala, the periaqueductal grey (PAG) and the rostral ventromedial medulla, 
and result in modulation of pain output (Peyron et al., 2000; Moulton et al., 2005; 
Sawynok, 2015). These neurotransmitters include endogenous opioids, 
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vasopressin, endocannabinoids, adenosine, oxytocin and serotonin (Sawynok, 
2015). It has also been shown that endocannabinoids and endogenous opioids are 
involved in mediating the hypoalgesia resulting from human touch and a placebo 
stimulus (Zubieta et al., 2005; Benedetti et al., 2011).   
Much work has focused on the PAG area and the nucleus raphe magnus (NRM). 
Both animal and human studies have demonstrated that the PAG area of the 
midbrain is the key to the descending control system and endogenous hypoalgesic 
mechanisms (Hosobuchi et al., 1977; Cannon et al., 1982). Reynold (1969) first 
began research into this theory and conducted a study which demonstrated that 
electrical stimulation in the midbrain PAG area of rats could produce profound 
hypoalgesia. He found that this hypoalgesic effect was sufficient to compensate the 
effect of anaesthesia in the surgery. Further animal studies showed that the PAG 
area has a columnar structure, which includes ventrolateral (vlPAG), lateral (lPAG), 
dorsomedial (dmPAG) and dorsolateral (dlPAG) subdivisions (Bolying and Jull, 
2004). Research has found that stimulation of the vPAG area in rats produces 
multiple effects, including hypoalgesia that is opioid in nature, freezing of movement 
and inhibition of the SNS (Farkas et al., 1998; Jansen et al., 1998). This state of 
hypoalgesia exhibits tolerance with repeated stimulation, and before it becomes 
apparent, it requires a significant period of peripheral stimulation (Cannon et al., 
1982; Morgan and Leibeskind, 1987; Takeshige et al., 1992). On the other hand, 
stimulation of the dPAG area in rats produces a non-opioid form of hypoalgesia, 
movement facilitation and sympatho-excitation effects (Farkas et al., 1998; Jansen 
et al., 1998). The onset of this type of hypoalgesia is generally more rapid than that 
of vPAG-stimulated hypoalgesia (Wright, 1995). Based on all these findings, it has 
been suggested that the dPAG area coordinates responses to nociceptive stimuli, 
whereas the vPAG area activates the opioid system. Therefore, the descending pain 
inhibitory systems, and most importantly, the PAG area, are crucial for coordinating 
the responses of different systems, including the SNS, the nociceptive system and 
the motor system, in order to integrate the behavioural responses to stimuli such as 
pain and stress (Fanselow, 1991; Lovick, 1991). 
In conjunction with these findings, Field and Basbaum (1989) reported that two 
individual projection systems exist from the PAG area to the spinal cord, which 
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primarily use different neurotransmitters. Projections from the vPAG area via the 
NRM use serotonin as a serotonergic neurotransmitter, whereas projections from 
the dPAG area via the nucleus gigantocellularis, paragigantocellularis and 
paragigantocellularislateralis use noradrenaline, which is described as being 
noradrenergic (Fields and Basbaum, 1989). Moreover, Kuraishi et al. (1983 and 
1990) demonstrated that the serotonergic system is important with regard to 
morphine-induced hypoalgesia against thermal nociceptive stimuli, whereas the 
noradrenergic system is more important in stimulating morphine-induced 
hypoalgesia related to stimuli of a mechanical nociceptive nature. 
Kuraishi (1990) found that nociceptive transmission in the spinal dorsal horn can be 
inhibited by the descending noradrenergic system, which also inhibits the release of 
substance P that is evoked by peripheral mechanical stimulation. This has led Wright 
(1995) to the assumption that activation of the descending pathways from the dPAG 
area is responsible for the immediate hypoalgesic effects of SMT, which are 
mediated by the SNS pathways. Therefore, it is hypothesised that if spinal 
mobilisation stimulates the dPAG area, the resultant hypoalgesia is accompanied by 
SNS responses (Jowsey and Perry, 2010).  
On the other hand, from an anatomical perspective, the paravertebral ganglia and 
sympathetic trunk are believed to account for the SNS response following spinal 
mobilisation (Peterson et al., 1993; Kingston et al., 2014). The sympathetic chain 
and associated ganglia expand along the spine, starting at the upper cervical level 
and moving downward toward the coccyx (Palastanga et al., 2006). Thus, 
mobilisation at any spinal level may stimulate local sympathetic fibres (Jowsey and 
Perry, 2010). This theory forms the basis of the regional bias theory, according to 
which various spine levels produce various sympathetic responses. Harris and 
Wagnon (1987) reported sympathetic excitation in the form of decreased skin 
temperature (ST) following thoracic manipulation versus sympathetic inhibition in the 
form of increased ST following lumbar and cervical manipulation.   
In summary, according to the neurophysiological mechanisms proposed so far, 
spinal mobilisation has the potential to initiate neurophysiological responses in the 
central and peripheral nervous system (Bialosky et al., 2009). The 
42 
 
neurophysiological mechanism is brought about via interaction between the 
autonomic nervous system and the pain system at several levels in the body, 
including the peripheral regions, the dorsal horn of the spinal cord, the brain stem 
and the fore brain (Benarroch, 2001). Such a multi-centre centrally coordinated 
response following spinal mobilisation has been reported in multiple studies (Willett 
et al., 2010; Pentelka et al., 2012). The following section will present a literature 
review of the studies that have reported hypoalgesic and SNS responses to spinal 
mobilisations. 
2.8. Hypoalgesic changes following spinal mobilisation 
Several studies have examined the immediate effects of a single mobilisation 
treatment on pain at various spinal levels in those with and without spinal pain 
conditions (Table 2.2). However, to date, no study has investigated the immediate 
hypoalgesic (pain relieving) effects of mobilisation treatment in LBP patients. As 
most of the studies so far have been conducted on asymptomatic participants, an 
experimental pain measure, such as the pressure pain threshold (PPT), has been 
used to determine whether or not hypoalgesia has occurred. PPT is defined as the 
minimal amount of pressure that a person perceives as painful (Chesterton et al., 
2007). PPT is a valid, reliable and widely used measure of the pain modulating 
system following different interventions in the research and clinical setting (Persson 
et al., 2004; Walton et al., 2014). There are reports on hypoalgesia following cervical 
mobilisation (Vicenzino, 1995; Vicenzino et al., 1996 and 1998; Sterling et al., 2001; 
La Touche et al., 2013), thoracic mobilisation (Fryer et al., 2004), and lumbar 
mobilisation (Krouwel et al., 2010; Willett et al., 2010; Pentelka et al., 2012). 
However, conflicting results have been reported by four studies (Soon et al., 2010; 
Sterling et al., 2010; Salom-Moreno et al., 2014; Snodgrass et al., 2014): one study 
included symptomatic participants who had whiplash for at least three months 
(Sterling et al., 2010); two studies included patients with chronic neck pain (Salom-
Moreno et al., 2014; Snodgrass et al., 2014); and the fourth study included 
asymptomatic participants (Soon et al., 2010). Sterling et al. (2010) suggested that 
these contradictory results might be related to the different musculoskeletal 
conditions that were studied. Another possible reason is the variation in the duration 
of symptoms between study participants. Moreover, the degree of chronicity of the 
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symptoms may also affect the hypoalgesic response. However, no studies have 
investigated the lasting effects of a single mobilisation treatment on PPT.  
A number of studies have measured PPT at specific locations in order to determine 
the extent of the hypoalgesic effects (local, segmental or systemic), to gain insight 
into the potential hypoalgesic mechanisms of mobilisation (Krouwel et al., 2010; 
Willett et al., 2010; Pentelka et al., 2012).  A study by Willett et al. (2010) used a 
repeated-measures design to examine the immediate effects of different mobilisation 
rates on the 5th lumbar vertebrae (2 Hz, 1 Hz and 0 Hz). The results did not show 
any significant difference in PPT measures between the different treatments (Table 
2.2). However, the PPT values increased following mobilisation at each site of 
measurement: L5 paravertebral muscles, L5 dermatome, L2 dermatome, and 1st 
interossei. There are some methodological limitations to this study: the subjects were 
not blinded to the intervention conditions, and a carry-over effect is possible as the 
difference in the duration between the three conditions was not clear. However, the 
widespread changes reported in this study in addition to the local changes may 
indicate the involvement of both spinal and central modulation of pain after 
mobilisation.  
Another study by Krouwel et al. (2010) compared the hypoalgesic effects of quasi-
static-, small- and large-amplitude lumbar mobilisation (posterior-anterior L3 
mobilisation at a rate of 1.5 Hz for three sets of sixty seconds) with a repeated-
measures design (Table 2.2). The findings failed to report any significant difference 
in PPT values between the three amplitudes (p = 0.864); this could mean that the 
hypoalgesic effect is not influenced by the amplitude of mobilisation. However, there 
were widespread changes in PPT values over the sites of the measurements (the 
L3 paravertebral muscles, the L3 dermatome, the S1 dermatome and the deltoid)  
that were significantly improved compared to the baseline measurements regardless 
of amplitude (p = 0.013). However, it was not mentioned whether the mobilisation 
was applied into the level of joint resistance or outside the level. Furthermore, no 
power calculation was used to justify the number of participants, which may have led 
to a type-II error. These results were contradictory to a proposed theory of Maitland 
et al. (2001) and Zusman (1986), who claimed that larger amplitude mobilisation is 
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superior to smaller amplitude mobilisation with regard to reducing pain. As a result 
of these contradictory findings, researchers are of the opinion that a greater 
difference might be observed between mobilisation amplitudes if a symptomatic 
population is used.   
45 
 
Table 2.2. The effect of passive spinal mobilisations on PPT 
 
 
Reference  
 
Design  
 
Subjects  
 
Technique  
 
Reliability of 
the PPT device 
 
PPT  
Vicenzino et 
al., 1995 
Within-subjects 
placebo 
controlled 
crossover trail 
 
 
24 asymptomatic 
Mean age 19.8 
Grade III Lateral glide to C5/6 
(3x30s) 
None reported Significant main effect of 
condition (p<.005) 
No effect size reported  
Sterling et al., 
2001 
Within-subjects 
placebo controlled 
crossover trail 
30 subjects (16 
female and 14 
male) with a 
mean age of 
35.77 years, with 
mid or lower 
cervical pain 
lasting longer 
than 3 months 
and a dysfunction 
at C5/6 
 
Grade III unilateral PA to C5/6 
on symptomatic side (3x30s) 
PPT left C5/6  
ICC 0.91. SEM 
1.62 
PPT right C5/6  
ICC 0.92. SEM 
1.41  
Sig main effect of condition 
(p<0.01) 
Mean increase in mobilisation 
group 22.5 (SD 2.4)% 
Fryer et al., 
2004 
RCT 96 asymptomatic 
volunteers, aged 
19-34 years 
1. Treatment (group 1): thoracic 
HVLA either for upper, mid or 
lower levels based on tender 
vertebra.  
 
PPT T4 ICC 
0.93 
PPT T6 ICC 
0.90 
A significant improvement in 
PPT measurement for 
mobilisation (P<0.01) and 
manipulation group (P=0.04), 
and a non-significant 
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2. Treatment (group 2): seated 
extension mobilisation of either 
upper, middle or lower thoracic 
spine based on identification of 
the most tender thoracic 
vertebra. 
 
3. Placebo: laser acupuncture 
with a laser pointer. 
improvement shown in the 
sham group (P=0.88). PPT in 
the mobilisation group 
increased by 28.42 kPa 
(d=0.72) compared to 11.88 
kPa (d=0.32) for the 
manipulation group. 
Furthermore, a statistical 
difference was found between 
the mobilisation and laser 
group (P=0.01), whereas no 
significant difference was 
found between mobilisation 
and manipulation (P=0.20) or 
between laser and 
manipulation groups (P=0.67). 
Thomson et 
al., 2009 
RCT 50 asymptomatic 
subjects with a 
mean age of 27  
years 
1. Treatment (group 1): a single 
HVLA thrust to the identified 
lumbar segment. 
 
2. Treatment (group 2): lumbar 
mobilisation into right rotation 
x30s 
 
3. Placebo: laser acupuncture 
with a laser pointer. 
 
ICC 0.78 Neither lumbar HVLA nor 
mobilisation had a significant 
effect on PPT (P=0.584). Only 
lumbar mobilisation appeared 
to have a greater mean 
increase in PPT and effect 
size (d=0.78) than the control 
group (d=0.36). 
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Willett et al., 
2010 
Within same-
subjects repeated 
measures  
30 asymptomatic  
Mean age 30 
years 
Large amplitude (200N), grade 
III, central PA mobilisations 
performed to L5 (3x60s), the rate 
of the mobilisations varied at 
each experimental session 
(quasi-static pressure,1 Hz, or 2 
Hz). 
 
PPT (L5, L2, 
1stinterossei) 
ICC 0.89-0.96 
SEM 0.17-0.25 
Significant main effect of 
mobilisation regardless of the 
rate of mobilisation (P<0.01), 
average percentage change:  
L5 paravertebral muscles 
19.15% 
L5 dermatome 17.33% 
L2 dermatome 14.96% 
1stinterossei 10.89% 
 
Krouwel et 
al., 2010 
Within same-
subject repeated 
measures 
30 asymptomatic  
Mean age 26 
years 
All subjects completed three 
experimental conditions on three 
separate occasions.  
1- quasi-static (maintained at 
200 N).  
2-small amplitude of oscillations 
(150N-200N)  
3- large amplitude of oscillations 
(forces between 50 and 200 N) 
Each condition involved a central 
PA L3 (3x60sx1.5 Hz)  
 
PPT (L3, S1, 
mid deltoid) 
ICC 0.84-0.94 
SEM 0.16-0.18 
Significant main effect of 
mobilisation regardless of the 
amplitude (P<0.05), average 
percentage change (SD): 
L3 paravertebral muscles 
16.26(1.78)%  
L3 dermatome 12.84(4.60)% 
S1 dermatome 11.46(6.37)% 
Deltoid 16.45(4.22)% 
 
Sterling et al., 
2010 
Parallel group: 
mobilisations or 
control (manual 
contact) 
39 whiplash 
associated 
disorder (grade 
II) 
18-65 years 
Lateral glide C5/6 (3x60s) None reported  No significant difference 
between mobilisation and 
control group (p=0.49) 
Percentage change: 
C6 24.1% (7.3) 
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Duration of 
symptoms 
greater than 3 
months 
Median nerve 11.3 %(4.7) 
Tibialis anterior 7.8 %(4.8) 
Soon et al., 
2010 
Within-subjects 
placebo controlled 
crossover trail 
24 asymptomatic 
Mean age 37 
years 
Grade III unilateral PA left C5/6 
(3x60s) 
PPT (left C5/6) 
ICC 0.96 
No significant effect (p=0.846) 
Pentelka et 
al., 2012 
Within subjects 
repeated measures  
19 asymptomatic  
Mean age 31.9 
years 
1. Treatment (group 1): (5x 30s) 
PA mobilisations to L4. 
 
2. Treatment (gtoup 2): (5x 60s) 
PA mobilisations to L4. 
PPT (L4, S1, 
deltoid) 
ICC 0.78-0.86 
Significant main effect of 
mobilisation regardless of the 
duration (p<0.01). Mean 
percentage change (60 
seconds) (actual change 
Kg/cm2) 
L4 paravertebral muscles 
56% (2.8), L4 dermatome 
41% (1.4), S1 dermatome 
41% (1.5), Deltoid 46%(1.6)   
La Touche et 
al., 2012 
RCT 32 patients with 
cervico-
craniofacial pain 
of myofascial 
origin 
1. Treatment: AP upper cervical 
mobilisation (3x120sx0.5Hz). 
2. Sham group: manual contact 
None  Significant difference in the 
percentage changes in PPT in 
the left and right cervical 
points for the treatment group 
(p<0.001). 
Salom-
Moreno et al., 
2014 
RCT 52 patients with 
bilateral chronic 
mechanical neck 
pain 
1.  Treatment (group 1):T3-T6 
HVLA thrust manipulation 
 
None  No statistically significant 
interaction for PPT at any 
location. Both groups 
experienced similar PPT 
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2. Treatment (group 2): grade III 
to IV central PA T3-T6 
mobilisation  
increases after the 
intervention at all locations 
(p<0.01) 
Snodgrass et 
al., 2014 
RCT 64 patients with 
chronic, 
nonspecific neck 
pain (aged 18-
55years) 
1. Treatment (group 1): a single 
cervical PA mobilisation with a 
30-N mean peak force (3x30s) 
 
2. Treatment (group 2): a single 
cervical PA mobilisation with a 
90-N mean peak force (3x30s) 
 
3. Placebo: received detuned-
laser treatment.   
ICC 0.93-0.96 The time-by-group interaction 
for summed PPT was not 
significant for all groups 
(F=1.41, P=0.242). 
Abbreviations: RCT: randomized controlled trial; kPa: kilopascals; ICC: intraclass correlation coefficient; SD: standard deviation; SEM: standard 
error of measurement; s: seconds;  C6: the 6th cervical vertebrae; C5/6: facet joint between the fifth and the sixth cervical vertebrae; L4: 4th lumbar 
vertebrae; L5: 5th lumbar vertebrae;T3: 3rd thoracic vertebrae; T6: sixth thoracic vertebrae; T4: 4th thoracic vertebrae; III: grade three; IV: grade four; 
AP: anterior-to-posterior pressure; PA: posteroanterior accessory mobilisation; PPT: pressure pain threshold; HVLA: high velocity low amplitude. 
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2.9. Changes in sympathetic measures following spinal mobilisation 
Based on the hypothesis of Wright and Vicenzino (1995) that SMT affects multiple 
systems, several studies have examined the effect of spinal mobilisation on the SNS. 
A number of studies have investigated the effect of different forms of spinal 
mobilisation by measuring outcomes related to the SNS such as vasomotor, 
cutaneous and sudomotor responses (McGuiness et al., 1997; Vicenzino et al., 
1999; Souvlis et al., 2000). Most of these studies have examined the immediate 
effects of a single mobilisation treatment on SNS at various spinal levels in 
participants with and without mechanical spinal pain conditions (Table 2.3). 
However, to date, no study has investigated the SNS responses to spinal 
mobilisation in patients with LBP. Skin conductance (SC) (which is also known as 
sweat response, skin resistance [SR], electrodermal activity [EDA], and galvanic skin 
response [GSR]) has been utilised as a measure of sympathetic activity over the last 
25 years in spinal mobilisation research (Balconi, 2010). It represents a 
measurement of spontaneous change in the electrical resistance of the toes and 
fingers, where the glabrous area of the skin is present (Balconi, 2010). A 
sympathoexcitatory effect results in the activation of synapses in the smooth 
muscles of vessels via adrenaline release, which leads to vasoconstriction (Storm et 
al., 2000). Furthermore, other sympathetic measures have been reported in related 
studies, including heart rate (HR), respiratory rate (RR), blood pressure (BP), 
thermal pain threshold (TPT) and skin temperature (ST). 
A number of studies have reported significant measures of sympathoexcitation, 
primarily SC, following cervical mobilisation (Peterson et al., 1993; Chiu and Wright 
et al., 1996; McGuiness et al., 1997; Vicenzino et al., 1998; Sterling et al., 2001; La 
Touche et al., 2012), thoracic mobilisation (Cleland et al., 2004; Jowsey and Perry, 
2010) and lumbar mobilisation (Perry and Green, 2008; Piekarz and Perry, 2016). 
However, contradictory results have been reported by Chiu and Wright (1998), who 
found no significant sympathetic change in skin conductance or skin temperature 
following cervical mobilisation. The authors attributed this to the slow rate of 
mobilisation and the small sample size of the study (n = 16). On the other hand, a 
RCT study conducted by Yung et al. (2014) showed significant sympathoinhibitory 
responses in terms of HR and systolic BP in a mobilisation group (AP pressure to 
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the right C6 costal process) that was not reported in a placebo group; however, this 
difference was not found to be significant. The authors reported several limitations: 
an important limitation was that they mobilised the right side of the costal vertebra 
C6, and thus, collateral circulation to the left may have affected any true 
cardiovascular response. Moreover, this study utilised asymptomatic young 
individuals (aged 24.7 ± 1.9), and therefore, the findings may not be generalisable 
to older populations with neck pain.    
One of the first studies in this field (neurophysiological mechanisms related to 
manual therapy) was by Peterson et al. (1993), who utilised a within-subjects 
crossover controlled trial to investigate the influence of cervical mobilisation on SNS 
activity while recording SC and ST of the upper limbs in asymptomatic participants. 
In the treatment group, a 50%60% increase in SC was recorded, in comparison to 
a 30% increase recorded in the placebo condition (manual contact without any 
movement). They suggested that the oscillatory component of the mobilisation 
technique was the reason behind the neurophysiological effect. However, 
measurement error related to the equipment (the Biopac System) was not reported, 
and no attempt was made to validate the placebo condition. Thus, it is difficult to 
ascertain the true effect of the mobilisation, considering the variations in the 
equipment measurements. 
In 1996, Chiu and Wright, by measuring SC of the upper limb, compared the effects 
of two different frequencies (2 Hz and 0.5 Hz) of cervical mobilisation techniques in 
asymptomatic participants utilizing a repeated measures design. Their results 
showed a 50%60% increase in SC from the baseline and a significant difference in 
favour of the 2-Hz frequency (two oscillations per second). They suggested that the 
movement component of mobilisation is important with regard to the 
neurophysiological effects, as mobilising at a faster oscillatory rate increased the 
SNS effects. However, a placebo condition was not used in the study, which made 
it difficult to determine the effect of factors other than mobilisation factors, including 
psychological factors (such as expectation, anxiety belief and depression), on SC. 
Moreover, only male volunteers were included, which affected the generalisability of 
the study findings. Furthermore, no power calculation was used to justify the number 
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of participants, and the process of randomisation between experimental conditions 
(2 Hz, 0.5 Hz and control) and allocation was not explained. All these shortcomings 
limit the applicability of the study findings.  
Recently a number of randomised control trials (RCTs) have been conducted on the 
SNS effects of spinal mobilisations (Perry and Green, 2008; Jowsey and Perry, 
2010; La Touche et al., 2012; Yung et al., 2014; Piekarz and Perry, 2016), of which 
only two studies measured the peripheral sympathetic responses of the lower limbs 
(Perry and Green, 2008; Piekarz and Perry, 2016). In one such RCT, Perry and 
Green (2008) reported that spinal mobilisation may influence the nervous system 
both at the spinal and supraspinal level. This study investigated the effects of 
unilaterally applied oscillatory lumbar mobilisation (grade III PA to left L4/5 for three 
sets of sixty seconds) compared to placebo mobilisations and a no treatment control 
group, on SC measured at both the left and right toes (Table 2.3). Although the 
researchers performed a power calculation and used a proper randomisation and 
allocation protocol and a double-blinded design, only male participants were 
included, which limits the generalisability of the findings to a larger clinical 
population. The results showed a statistically significant side-specific difference in 
SC (p = 0.005) in the mobilisation group with a percentage change in the order of 
13.47% compared to the placebo group (-1.93%) and control group (-0.87%). 
However, the reliability of the instruments at measuring SC (the Biopac System) was 
not assessed, which limits the findings. 
2.9.1. Salivary measures   
There has been rapid progression towards the scientific understanding of different 
salivary parameters (Nater and Rohleder, 2009). For example, a number of salivary 
components have been taken into account as meaningful physiological markers 
apart from hormonal analysis such as cortisol. Saliva is a diagnostic medium that 
has many advantages over blood and urine, including its non-invasive, safe and 
pain-free collection method that requires minimal training to undertake (Henderson 
et al., 2010). Thus, salivary biomarkers might be considered ideal for research 
studies related to psychology and science (Henderson et al., 2010).  
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Recently, interest has been growing in salivary alpha-amylase (sAA) as a non-
invasive marker for SNS activity, as opposed to cortisol, which is used as a measure 
of the hypothalamic–pituitary–adrenal (HPA) axis (Bosch et al., 2003). Research on 
rats showed an increase in sAA secretion after direct sympathetic stimulation 
(Sayardoust and Ekström, 2003; Proctor and Carpenter, 2007), whereas research 
on humans showed that sAA is a correlate of SNS activity in human subjects under 
different stressful conditions, including physical conditions (i.e. exercise, cold and 
heat) and psychological conditions (Chatterton et al., 1996; Nater et al., 2005; van 
Stegeren et al., 2006). Research reveals that a concentration of sAA is correlated 
with the release of norepinephrine into the blood stream (in response to stress), as 
propranolol (a beta-adrenergic blocker) has the ability to inhibit the response of sAA 
(Rohleder et al., 2006; van Stegeren et al., 2006). However, only one study has been 
found that examined the effect of a mobilisation treatment—in the form of a rib raising 
mobilisation technique—on sAA activity as a measure of sympathetic response 
(Henderson et al., 2010). This study reported a significant decrease in sAA activity 
in the treatment group when compared to the placebo. However, since the saliva 
samples were collected immediately after and 10 minutes after the treatment, an 
initial proposed sympathoexcitation might have occurred during the procedure.  
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Table 2.3. Changes in sympathetic measures following spinal mobilisation treatment 
Reference  Design  Subjects  Technique  SNS 
measures 
Reliability  Findings    
Peterson et al., 
1993 
Within-subjects 
Placebo (sham 
mob), control (no 
contact). 
Crossover 
16 asymptomatic 
Aged 18-35 years  
Grade III central PA 
to C5 (3x60s) 
SC 
ST 
None 
reported 
SC: significant increase in 
intervention procedure 
compared to placebo and 
control procedures. An 
increase in the order of 50-
60% during intervention 
steadily decreasing to that of 
placebo after. 
Placebo consistently increases 
in the order of 30% during the 
intervention and 15-20% after 
the intervention. 
 
ST: significant decrease in 
intervention procedure 
compared to control. No 
significant difference between 
placebo and intervention 
procedure. 
Chiu and Wright, 
1996 
Within subjects 
repeated 
measures 
16 asymptomatic 
(male volunteers) 
Mean age 18.5 
years 
1. Grade III central 
PA mobilisation to 
C5 (3x60sx2Hz). 
SC 
ST 
None 
reported 
SC: significant increase in 2 Hz 
group compared to control and 
0.5 Hz group. 2 Hz group 
increased in order of 50-60%. 
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2. Grade III central 
PA mobilisation to 
C5 (3x60sx0.5Hz). 
3. Control (no 
manual contact). 
0.5 Hz group increased in 
order of 15-20% and control 
condition increased in order of 
14-18%. 
ST: no significant difference in 
ST between 3 groups. 
McGuiness et al., 
1997 
Within-subjects 
Placebo (sham 
mob), control (no 
contact) 
Crossover 
23 asymptomatic 
Aged between 18-
29 years  
Grade III central PA 
C5 (3x60s) 
BP 
RR 
HR 
None 
reported  
BP, RR, and HR: significant 
increase in all outcomes in 
intervention group compared to 
control and placebo 
procedures. RR increased in 
the intervention group during 
treatment by 44%, diastolic BP 
increased by 12.5% and 
systolic BP increased by 4.5%. 
HR increased in the order of 
10.5%. 
Chiu and Wright, 
1998 
Within-subjects 
Placebo (4 
experimental 
procedures) 
Crossover 
17 asymptomatic 
Mean age 20.71 
years 
Grade III PA 
mobilisation to the 
right articular pillar 
of C5/6 
 
Grade III transverse 
mobilisation to the 
left side of C5  
SC 
ST 
None 
reported 
SC and ST: no significant 
difference among the 4 
experimental procedures. 
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Vicenzino et al., 
1998 
Within-subjects 
Placebo (sham 
mob), control (no 
contact) 
Crossover 
24 asymptomatic 
Mean age 21 years 
Grade III left lateral 
glide C5 (3x30s) 
BP 
RR 
HR 
None 
reported 
BP, RR and HR: significant 
increase in all outcomes in 
intervention group compared to 
control and placebo 
procedures. RR increased by 
36% during treatment, diastolic 
and systolic BP increased by 
14% and HR increased by 
13%. 
Sterling et al., 
2001 
Within-subjects 
Placebo (sham 
mob), control (no 
contact) 
Crossover 
30 subjects (16 
female and 14 
male) with a mean 
age of 35.77 years, 
with mid or lower 
cervical pain lasting 
longer than 3 
months and a 
dysfunction at C5/6 
 
Grade III unilateral 
PA to C5/6 on 
symptomatic side 
(3x30s) 
SC 
ST 
None 
reported 
SC and ST: significant change 
in both outcomes in 
intervention group compared to 
control and placebo 
procedures. SC increased  by 
16%-114% on different 
measures , 
ST decrease by 1%-3% on 
different measures. 
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Cleland et al., 
2004 
Within-subjects 
Placebo (2 
experiments) 
Crossover 
15 asymptomatic 
subjects. 
Mean age of 29.2 
years 
Group 1: grade III 
central PA 
mobilisation to T12 
for 30s by an expert 
clinician. Group 2: 
grade III central PA 
mobilisation to T12 
for 30s by a novice 
clinician. 
SC None 
reported 
SC: by the novice, SC 
increased by 17.75%, by the 
expert SC increased by 
36.25% during intervention. 
There was a significant greater 
change in the mean of SC after 
mobilisation by the expert 
clinician (P < 0.025) compared 
to the mean increase in SC 
after treatment by the novice 
clinician. 
Perry and Green, 
2008 
RCT 45 asymptomatic 
males  
Mean age of 21.5 
years 
Grade III unilateral 
PA to left L4/5 facet 
(3X60s) 
SC None 
reported 
SC: Significant change in SC 
of the ipsilateral limb during the 
treatment with unilateral PA 
oscillatory mobilisation 
compared with placebo and 
control (P=0.005) groups, this 
change lasted 5 minutes. SC 
increased by 13.5 % during 
intervention (for the 
mobilisation group) that was 
greater to the placebo (-1.93%) 
and control (-0.87%) groups. 
 
58 
 
Jowsey and Perry, 
2010 
RCT 36 asymptomatic 
Mean age of 22.7 
years 
Treatment: right T4 
'screw' mobilisation. 
SC None 
reported 
SC: Significant change in SC 
from baseline to 5 minutes post 
intervention in the right hand 
after a right sided T4 
mobilisation compared to 
placebo intervention (P=0.034).  
SC in the right hand increased 
by 16.85% greater than 
placebo during post 
intervention period. 
La Touche et al., 
2012 
RCT 32 patients with 
cervico-craniofacial 
pain  
Mean age of 33.19 
years 
AP upper cervical 
mobilisation 
(0.5Hzx3x2minutes)  
SC 
ST 
RR 
HR 
None 
reported 
SC: significant within session 
increase by 84%. 
RR: significant increase within 
session increase by 10%. 
HR: significant within session 
increase by 6%. 
ST: no change. 
Yung et al., 2014 RCT 39 asymptomatic 
Mean age of 24.7 
years 
Treatment: AP 
pressure to the right 
C6 costal process 
(1.5Hzx5x10s). 
BP 
HR 
None 
reported 
BP and HR: Within-group 
comparisons indicated 
statistically significant 
decrease between baseline 
and post-AP pressure in HR 
(AP group) and systolic BP 
(both groups). There was no 
statistically significant 
difference between groups for 
mean HR, mean systolic BP 
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and mean diastolic BP for all 
time points. 
Piekarz and Perry, 
2016 
RCT 60 asymptomatic 
male 
Mean age of 21.53 
years 
Treatment 1: PA L4 
mobilisation 
(3Hzx3x60s) 
Treatment 2: PA L4 
mobilisation 
(2Hzx3x60s) 
SC None 
reported 
SC with 3 Hz increased by 
20.1%, 12.4% with 2 Hz, -1.3% 
for placebo and 3.2% for 
control condition from baseline 
to intervention period. Only the 
3 Hz technique showed a 
significant increase in SC 
compared to placebo and 
control condition.  
Abbreviations: RCT: randomised controlled trial;  Mob: mobilisation; s: seconds;  Hz: hertz; C6: the 6th cervical vertebrae; C5/6: facet joint between 
the 5th and the 6th cervical vertebrae; L4: 4th lumbar vertebrae; L4/5: facet joint between the 4th and 5th lumbar vertebrae; T3: 3rd thoracic vertebrae; 
T6: sixth thoracic vertebrae; T4: 4th thoracic vertebrae;T12: 12th thoracic vertebrae; III: grade three; IV: grade four; AP: anterior-to-posterior pressure; 
PA: posteroanterior accessory mobilisation; SC: skin conductance; ST: skin temperature; BP: blood pressure; HR: heart rate; RR: respiratory rate; 
HVLA: high velocity low amplitude. 
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2.10. Concurrent changes in hypoalgesia and SNS responses following spinal 
mobilisation 
Lovick (1991) and Morgan (1991) have suggested that the concurrent hypoalgesic 
and sympathoexcitation might be produced by stimulation of dorsal (dPAG) in 
animals. Only two studies have investigated the concurrent effects of spinal 
mobilisation on hypoalgesia and SNS responses (Sterling et al., 2001; La Touche et 
al., 2012). Sterling et al. (2001) utilised a repeated-measures design and included 
patients with chronic cervical pain. Following unilateral cervical mobilisation, there 
were significant differences in the responses on outcome measures PPT, TPT, SC 
and ST. Based on their findings, Sterling et al. (2001) concluded that there is some 
indirect evidence that the dPAG area partially mediates the hypoalgesia resulting 
from mobilisation, as the concurrent hypoalgesia and sympathoexcitation effects 
following mobilisation appear to be produced in a parallel manner by this area. La 
Touche et al. (2012) applied anterior-posterior upper cervical mobilisation in patients 
with temporomandibular disorders. Their results demonstrated hypoalgesic and 
sympathoexcitatory effects, which indicated the influence of mobilisation on the 
CNS. However, PPT was measured only at the cervical and craniofacial levels but 
not distally to the mobilised level. Moreover, although the anterior-posterior 
technique was applied, sympathetic measures (SC and ST) were assessed at the 
right upper limb only. Previous studies that applied the anterior-posterior technique 
measured SC and ST bilaterally to account for any side differences (Cleland et al., 
2004; Piekarz and Perry, 2016). 
In summary, there is no evidence to indicate that the immediate hypoalgesic 
response or SNS effects occur alone or concurrently following passive mobilisation 
treatment in LBP patients. Furthermore, to date, the dose-dependent effect of 
mobilisation is unknown, as studies have investigated the hypoalgesic effects and/or 
SNS responses only after a single session of mobilisation. The overall aim of this 
thesis was, therefore, to investigate the hypoalgesic and sympathetic effects of 
passive mobilisation treatment in participants with and without LBP over a course of 
three sessions of mobilisation. Although the optimal number of sessions of many 
conservative treatments is unknown, a short course of mobilisation has been 
recommended for the management of CNSLBP (Airaksinen et al., 2006). 
61 
 
The next chapter will systematically review and evaluate the published RCTs on the 
hypoalgesic and SNS responses to passive spinal mobilisation along different 
regions of the spine. 
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Chapter 3 
The sympathetic and hypoalgesic effects of spinal mobilisations: a 
systematic review 
3.1. Introduction 
The discovery of the neurophysiological effects of spinal mobilisations is important 
for clinicians to help them understand the benefits of the spinal mobilisations with 
making substantial and categorical changes to their perspective (Hegedus et al., 
2011). The neurophysiological effectiveness of spinal mobilisation has not been 
clearly established. Although few systematic reviews regarding this issue have been 
published (Schmid et al., 2008; Hegedus et al., 2011; Kingston et al., 2014; Voogt et 
al., 2014), the results of the studies concerning changes in related outcome 
measures to neurophysiological effects of spinal mobilisation techniques are 
conflicting. The review by Schmid et al. (2008) comprised of 15 randomised 
controlled trials (RCTs), investigating the immediate neurophysiological effects of 
passive accessory cervical joint mobilisation techniques either in asymptomatic 
subjects or patients with neck pain or upper extremity symptoms. The result 
suggested that the midbrain is involved in mediating the pain control and autonomic 
responses of passive cervical mobilisation. Although the overall quality was high, 
most of the involved trials were conducted by the same group of authors, which 
potentially affects the evidence. Five of the studies included a symptomatic 
population, two of which included patients with neurogenic pain and the other two 
included patients with epicondylalgia, whereas only one of the included studies 
involved patients with musculoskeletal cervical pain, thus influencing the 
generalisability of the results to this group of patient.  
Hegedus et al. (2011) summarised the results of 10 studies examining the temporal 
nature of the neurophysiological effects of a single session of spinal mobilisations. 
Six of the studies were pertinent to the cervical spine, one to the lumbar spine and 
three to the thoracic spine. The result of this review reported that five minutes or less 
is the average time of the neurophysiological effects with regard to SNS measures 
of a single session of spinal mobilisations. Thus, this may cause uncertainty about 
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any meaningful, lasting effect of a single session of spinal mobilisation. However, 
the majority of the studies reviewed were rated as having unimportant clinical 
outcomes and a moderate strength of evidence. Studies were not specific to a 
population with spinal pain as a population of patients with upper limb symptoms 
were included; and other forms rather than passive mobilisation were involved. 
Furthermore, there was an overrepresentation of healthy subjects and an 
underrepresentation of the lumbar spine as a spinal region.  
Voogt et al. (2014) found moderate evidence to suggest that manual therapy 
increased local pressure pain thresholds in patients with musculoskeletal pain. 
However, only two of the studies reviewed included mechanical neck pain patients 
who were treated with manipulation rather than passive mobilisations. 
None of the available systematic reviews reviewed the effect of passive spinal 
mobilisations along the three different regions of the spine with regard to 
hypoalgesic, and SNS effects (Schmid et al., 2008; Hegedus et al., 2011; Kingston 
et al., 2014; Voogt et al., 2014). A useful contribution to the literature can therefore 
be achieved by an updated review that incorporates recent studies. Furthermore, 
this review will attempt to determine if these neurophysiological effects are 
influenced by rate, amplitude or duration of mobilisation or if the spinal mobilisation 
is superior to other forms of therapy regarding the previously mentioned effects. 
The aim of this review was to systematically review randomised controlled trials 
which assess the effectiveness of spinal mobilisations with regard to hypoalgesic 
and SNS responses in healthy populations or in patients with cervical, thoracic or 
lumbar pain. 
3.2. Methods 
Recommendations for conducting reviews from the Centre for Reviews and 
Dissemination were followed for the methods used to undertake this systematic 
review (Tacconelli, 2009). In order to ensure a comprehensive and standardised 
framework for reporting, the Preferred Reporting Items for Systematic Reviews 
(PRISMA) were followed to report this review (Moher et al., 2009).  
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3.2.1. Literature search 
Electronic databases were searched to identify the maximum number of relevant 
articles and to minimise selection and publication bias (from database inception to 
December  2016): Academic OneFile, BioMed Central Journals, CINAHL, 
SPORTDiscus, MEDLINE (EBSCO), PEDro, Web of Knowledge, SCOPUS, AMED, 
ScienceDirect, The Cochrane Controlled Trial Register (CENTRAL), Health 
Technology Assessment, NHS Economic Evaluation, ZETOC, TRIP, Health 
Services/Technology Assessment Text, National Research Register, Current 
Controlled Trials website, Science Citation Index and Social Science Citation Index, 
and OpenGrey. 
An adjacency search was also carried out in systematic reviews on SMT using The 
Cochrane database. A reference list search of all full text articles available online 
was carried out to identify any supporting literature.  
3.2.1.1. Search strategy   
Combined with spinal mobilisation/spinal mobilization or manual therapy, the 
following free text words were used: “neurophysiology”, “neurophysiological effect”, 
“pain threshold”, “sympathetic effect”, “sympathetic nervous system”. 
Table 3.1. Example of a search strategy (ScienceDirect). 
ScienceDirect N of results 
Spinal mobilization + sympathetic nervous 
system 
34 
Spinal mobilisation + sympathetic nervous 
system 
34 
Manual therapy + sympathetic nervous 
system 
178 
Spinal mobilization + neurophysiology 22 
Spinal mobilisation + neurophysiology 22 
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Manual therapy + neurophysiology 185 
Spinal mobilization + sympathetic effect 0 
Spinal mobilisation + sympathetic effect 0 
Manual therapy + sympathetic effect 3 
Spinal mobilization + pain threshold 49 
Spinal mobilisation + pain threshold 49 
Manual therapy + pain threshold 120 
 
3.2.2. Eligibility criteria 
3.2.2.1. Inclusion 
1. Design: Any RCT. 
2. Population:  
a) Studies with participants aged 18 years or older as more people experience 
spinal pain as they grow older (UK BEAM, 2004), including either one or both 
genders. 
b) Included either healthy participants or patients with non-specific back  pain 
at either cervical, thoracic or lumbar parts of the spine that are not caused by 
a recognisable known specific pathology (e.g. structural deformity, fracture, 
osteoporosis, tumor, and infection), inflammatory disorder (e.g. ankylosing 
spondylitis), cauda equina syndrome or radicular syndrome (UK BEAM, 
2004). 
3. Intervention:  
a) Studies examined the neurophysiological effects of spinal mobilisation as 
the main or control treatments were included. All studies must have offered 
the spinal mobilisation in isolation (without combining it with any other type of 
physical therapy such as exercises) in at least one group of participants in 
order to have comparable results post-intervention. However, studies that 
offered any form of physical therapy interventions other than spinal 
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mobilisation to some groups of participants (to create a control group) were 
still included providing that the true intervention group was given spinal 
mobilisation in isolation. This would minimise bias and make the findings more 
credible by ensuring that any favourable or unfavourable outcomes, from 
spinal mobilisation, were attributable to this treatment and could be compared 
with other treatments. 
b) Studies that compared the neurophysiological effects of different rates, 
sets, duration or amplitudes of spinal mobilisations were also included.  
4. Outcome: Studies were included if at least one physiologic outcome measure 
had been used such as the hypoalgesic effect or/and SNS effects of spinal 
mobilisation. Some or all of the following outcome measures are expected to 
be available in the studies included: PPT, TPT, SC, ST, HR, RR, and BP. 
3.2.2.2. Exclusion 
1. Studies that used spinal mobilisation in combination with other forms of 
treatment or exercises. 
2. Studies that examined mobilisation with movements forms of manual therapy 
[e.g. the Mulligan sustained apophyseal glide (SNAG) as the focus of this 
review is the passive spinal mobilisation]. 
3. Studies with a study population consisting of patients with cervical, thoracic 
or lumbar pain, which is not mechanical in origin.  
4. To ensure accurate and complete interpretation, studies published in 
languages other than English were excluded.  
3.2.3. Selection of studies 
All titles were screened by the author to assess for relevance and duplication. The 
abstracts of relevant titles were evaluated for eligibility. The reviewer retrieved full 
text articles of every study that met the inclusion criteria. The titles and abstracts of 
the identified studies were reviewed in order to identify the potential relevance of the 
studies for the review. Furthermore, the reference lists of all studies retrieved were 
assessed and a search of relevant studies was performed.  
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3.2.4. Approach to Methodological Quality Assessment 
The eligible articles were evaluated for methodological quality using a criteria list 
based on the updated method guidelines for systematic reviews in the Cochrane 
Back Review Group (Appendix 1) (van Tulder et al., 2003). The maximal achievable 
quality score is 11 and papers that score six or more are considered to have low risk 
of bias whereas papers that score less than 6 are considered to have a high risk of 
bias (Verhagen et al., 2001). A second and third reviewer were included in 
assessment of the quality of the literature. 
3.2.5. Data extraction  
Data were extracted and summarised (Table 3.2). The following data were extracted 
from the studies: author, publication year, aim of the study, number of participants, 
age, gender, duration of complaints, characteristics of the studies, characteristics of 
the interventions including control intervention, characteristics of the outcome, and 
finally the results. This data extraction form was designed to provide the key points 
about each study, which facilitated the comparison process between studies, as well 
as the synthesis and analysis of the papers.  
3.2.6. Data synthesis and analysis 
The Grading of Recommendations, Assessment, Development and Evaluations 
(GRADE) system was used to assess the overall quality of evidence and to grade 
the strength of recommendations based on the updated method guidelines for 
systematic reviews in the Cochrane Back Review Group (van Tulder et al., 2003). 
The final GRADE score, which indicated either very low, low, moderate or strong 
quality evidence was calculated (van Tulder et al., 2003). 
GRADE requires that after collecting and summarising the evidence, similar 
evidence in terms of intervention, population, comparator(s) and outcomes need to 
be grouped together. Then, explicit criteria provided by GRADE was used to rate the 
quality of evidence that involved study design, risk of bias, indirectness, 
inconsistency and magnitude of effect. According to the quality of the supporting 
evidence, recommendations could be characterised as weak or strong. The 
evidence was summarised in an informative summary of findings tables that 
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demonstrated the quality of evidence as well as the reasons behind the rate of quality 
(Guyatt et al., 2011).    
3.3. Results  
3.3.1. Search strategy  
The original search yielded 696 references, of which 679 were excluded after 
screening the abstracts, as they were considered irrelevant to this review or 
duplicated. Seventeen were considered relevant references, of which nine were 
excluded because they did not meet the inclusion criteria. The procedure of study 
selection is demonstrated in the study flow chart (Figure 3.1). Eight articles (RCTs 
studies) with a sample size of 492 in total were found to meet the inclusion criteria. 
Figure 3.1. Flow chart of systematic review inclusion and exclusion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching  
(n = 696) 
 
Additional records identified 
through other sources 
(n = 0) 
 
Records after duplicates removed 
(n = 443) 
Records screened 
(n = 253) 
Records excluded 
(n = 236) 
Full-text articles assessed 
for eligibility 
(n = 17) 
Full-text articles excluded 
(not an RCT, no relevant 
outcome, no relevant 
intervention) 
(n = 9) 
Studies included in 
quantitative synthesis 
(n = 8) 
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Table 3.2. Data extraction form. 
Authors Aim of the 
study 
Participants Intervention 
group(s) 
Control 
group 
Outcome 
measures 
of interest 
Results 
Perry and 
Green 
(2008) 
To examine 
the hypothesis 
that specific 
mechanical 
mid to end 
range 
mobilisation 
applied to the 
left L4/5 
zygapophysial 
joint at a rate 
of 2Hz would 
produce a 
significant 
change in SC 
during the 
treatment, 
which would 
be greater in 
the left leg 
compared to 
the 
45 asymptomatic 
males, aged 18-
25 years. 
1. Treatment: 
grade III 
unilateral PA to 
left L4/5 facet. 
 
2. Placebo: light 
pressure to left 
L4/5 facet, no 
oscillation. 
 
Subject laid 
prone as in 
other group 
with no 
manual 
contact. 
SC SC: Significant change in SC of the ipsilateral limb during 
the treatment with unilateral PA oscillatory mobilisation 
compared with placebo and control (P=0.005) groups. This 
change lasted 5 minutes. SC increased by 13.5 % during 
intervention (for the mobilisation group) that was greater to 
the placebo (-1.93%) and control (-0.87%) groups. 
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contralateral 
one, and 
greater than 
that in the 
placebo and 
control 
groups. 
Jowsey 
and Perry 
(2010) 
To establish 
whether a T4 
PA rotatory 
mobilisation 
technique 
produced any 
greater 
responses on 
the hands’ 
sympathetic 
activity 
compared to 
placebo 
treatment in 
an 
36 
Asymptomatic 
(23 females and 
13 males), aged 
18-35 years. 
 
1. Treatment: 
right T4 'screw' 
mobilisation. 
 
2. Placebo: T4 
pressure 
without 
mobilisation. 
None  SC SC: Significant change in SC from baseline to 5 minutes 
post intervention in the right hand after a right sided T4 
mobilisation compared to placebo intervention (P=0.034).  
SC in the right hand increased by 16.85% greater than 
placebo during post intervention period. 
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asymptomatic 
population. 
Thomson 
et al. 
(2009) 
To examine 
and compare 
the 
hypoalgesic 
effects of 
mobilisation 
and 
manipulation 
in the lumbar 
spine in a 
healthy 
population. 
50 asymptomatic 
subjects (21 
females and 29 
males) with a 
mean age of 27 
± 6 years. 
1. Treatment 
(group 1): a 
single HVLA 
thrust to the 
identified 
lumbar 
segment. 
 
2. Treatment 
(group 2): 
lumbar 
mobilisation into 
right rotation for 
30 seconds. 
 
3. Placebo: 30 
seconds of laser 
acupuncture 
with a laser 
pointer. 
 
None PPT PPT: Neither lumbar HVLA nor mobilisation had a 
significant effect on PPT (P=0.584). Only lumbar 
mobilisation appeared to have a greater mean increase in 
PPT and effect size (d=0.78) than the control group 
(d=0.36). 
Fryer et 
al. (2004) 
To examine 
and compare 
the effect of 
mobilisation 
96 asymptomatic 
volunteers (39 
males and 57 
1. Treatment 
(group 1): 
thoracic HVLA 
either for upper, 
None PPT PPT: A significant improvement in PPT measurement for 
mobilisation (P<0.01) and manipulation group (P=0.04), 
and a non-significant improvement shown in the sham 
group (P=0.88). PPT in the mobilisation group increased 
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and 
manipulation 
of the thoracic 
spine on PPT 
in healthy 
subjects. 
females) aged 
19-34 years 
mid or lower 
levels based on 
tender vertebra.  
 
2. Treatment 
(group 2): 
seated 
extension 
mobilisation of 
either upper, 
middle or lower 
thoracic spine 
based on 
identification of 
the most tender 
thoracic 
vertebra. 
 
3. Placebo: 30 
seconds of laser 
acupuncture 
with a laser 
pointer. 
by 28.42 kPa (d=0.72) compared to 11.88 kPa (d=0.32) for 
the manipulation group. Furthermore, a statistical 
difference was found between the mobilisation and laser 
group (P=0.01), whereas no significant difference was 
found between mobilisation and manipulation (P=0.20) or 
between laser and manipulation groups (P=0.67). 
Snodgras
s et al. 
(2014) 
To determine 
if force 
magnitude 
during 
64 patients with 
chronic, 
nonspecific neck 
1. Treatment 
(group 1): a 
single PA 
mobilisation 
None PPT PPT: The time-by-group interaction for summed PPT was 
not significant for all groups (F=1.41, P=0.242). 
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posterior-to-
anterior 
mobilisation 
affects 
immediate 
and short-term 
outcomes in 
patients with 
chronic, 
nonspecific 
neck pain. 
pain (aged 18-
55years) 
with a 30-N 
mean peak 
force. 
 
2. Treatment 
(group 2): a 
single PA 
mobilisation 
with a 90-N 
mean peak 
force. 
 
3. Placebo: 
received 
detuned-laser 
treatment.   
Yung et 
al. (2014) 
To compare 
the BP and 
HR response 
of healthy 
volunteers to 
AP pressure 
applied to the 
cervical spine 
versus 
placebo. 
39 asymptomatic 
subjects (25 
females and 14 
males) with a 
mean age of 
24.7 ± 1.9 years 
1.  Treatment: 
AP pressure to 
the right C6 
costal process. 
 
2. Placebo: light 
touch applied to 
the right C6 
costal process.  
None BP 
HR 
BP and HR: Within-group comparisons indicated 
statistically significant decrease between baseline and 
post-AP pressure in HR (AP group) (-2.8%) and systolic 
BP (both groups) (-2.4%, -2.6 %). There was no 
statistically significant difference between groups for mean 
HR, mean systolic BP and mean diastolic BP for all time 
points. 
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Salom-
Moreno 
et al. 
(2014) 
To compare 
the effects of 
thoracic thrust 
manipulation 
versus 
thoracic non-
thrust 
mobilisation in 
patients with 
bilateral neck 
pain. 
52 patients with 
bilateral chronic 
mechanical neck 
pain with a mean 
age of 33 years 
1.  Treatment 
(group 1):T3-T6 
HVLA thrust 
manipulation 
 
2. Treatment 
(group 2): grade 
III to IV central 
PA T3-T6 
mobilisation 
None PPT No statistically significant interaction for PPT at any 
location of measurements. Both groups experienced 
similar PPT increases after the intervention at all locations 
(p<0.01). Within-group and between-group effect sizes 
were small (SMD < 0.22) 
Piekarz 
and Perry 
(2016) 
To investigate 
the effects of 
increasing the 
oscillation 
frequency 
greater than 2 
Hz. 
60 asymptomatic 
male 
Mean age of 
21.53 years 
Treatment 1: PA 
L4mobilisation 
(3Hzx3x60s) 
Treatment 2: PA 
L4 mobilisation 
(2Hzx3x60s) 
Placebo: same 
hand position 
but with a static, 
non-oscillatory 
force applied to 
L4. 
Subject laid 
prone as in 
other group 
with no 
manual 
contact. 
SC SC with 3 Hz increased by 20.1%, 12.4% with 2 Hz, -1.3% 
for placebo and 3.2% for control condition from baseline to 
intervention period. Only the 3 Hz technique showed a 
significant increase in SC compared to placebo and control 
condition 
Abbreviations: C6: the 6th cervical vertebrae; L4: the 4th lumbar vertebrae; L4/5: facet joint between the 4th and the 5th lumbar vertebrae; T3: the 3rd 
thoracic vertebrae;T6: the 6th thoracic vertebrae; T4: the 4th thoracic vertebrae; III: grade three; IV: grade four; AP: anterior-to-posterior pressure; 
PA: posteroanterior accessory mobilisation; PPT: pressure pain threshold; SC: skin conductance; BP: blood pressure; HR: heart rate; HVLA: high 
velocity low amplitude.
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3.3.2. Quality of the trials 
Quality scores ranged from 5 to 9 points out of a maximum of 11 points (Table 3.3). 
The most common problems were failure to blind the clinician and failure to blind the 
subjects.
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Table 3.3. Methodological quality assessment table. 
Overall 
quality 
score 
Did the 
analysis 
include 
an 
intention- 
to-treat 
analysis? 
Was the 
timing of 
the 
outcome 
assessment 
on all 
groups 
similar? 
Was the 
drop-out-
rate 
described 
and 
acceptable? 
Was the 
compliance 
acceptable 
in all 
groups? 
Were co-
interventions 
avoided or 
similar? 
Was the 
outcome 
assessor 
blinded to the 
intervention? 
Was the care 
provider 
blinded 
to the 
intervention? 
Was the 
patient 
blinded 
to the 
intervention? 
Were the 
groups 
similar at 
baseline 
regarding 
the most 
important 
prognostic 
indicators
? 
Was the 
treatment 
allocation 
concealed? 
Was the 
method of 
randomisation 
adequate? 
Study 
 
7 No Yes Yes Yes Yes Yes No Yes No D/K Yes Jowsey and 
Perry (2010) 
 
5 No Yes Yes Yes Yes Yes No No No D/K D/K Thomson et 
al. (2009) 
 
6 No Yes Yes Yes Yes Yes No No No D/K Yes Fryer et al. 
(2004) 
 
8 No Yes Yes Yes Yes Yes No Yes No Yes Yes Perry and 
Green 
(2008) 
 
9 No Yes Yes Yes Yes Yes  No Yes Yes Yes Yes Snodgrass 
et al. (2014) 
 
5 No Yes Yes Yes Yes D/K No  D/K No  Yes  No  Yung et al. 
(2014) 
 
9 No Yes Yes Yes Yes Yes No Yes Yes Yes Yes Salom-
Moreno et 
al. (2014) 
8 No Yes Yes Yes Yes Yes No Yes No Yes Yes Piekarz and 
Perry (2016) 
Items could be addressed as Yes, No, Don’t Know (D/K).
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3.3.3. Study characteristics  
3.3.3.1. Intervention 
Table 3.4. A list of all the mobilisation techniques used within the studies. 
Authors  Interventions  
(Perry and Green, 
2008) 
Unilateral PA grade III oscillatory mobilisations, over 
the left L4/5 facet, at a rate of 2 Hz for three sets of 
one minute.  
(Jowsey and Perry, 
2010) 
A right T4 ‘screw’ grade III oscillatory mobilisation for 
three sets of one minute, at a rate of 0.5 Hz.  
(Thomson et al., 2009) Thirty seconds lumbar mobilisation into right rotation. 
(Fryer et al., 2004) A thirty second seated extension thoracic 
mobilisations for tender vertebrae.  
(Snodgrass et al., 2014) 1- A single PA grade III oscillatory cervical mobilisation 
with a 30-N mean peak force, at a rate of 1 Hz for 
three sets of one minute. 
2- A single PA grade III oscillatory cervical mobilisation 
with a 90-N mean peak force, at a rate of 1 Hz for 
three sets of one minute. 
(Yung et al., 2014) AP pressure to the right C6 costal process at a rate of 
1.5 Hz for five sets of 10 seconds.  
(Salom-Moreno et al. 
,2014) 
1.  Treatment (group 1):T3-T6 HVLA thrust 
manipulation. 
2. Treatment (group 2): grade III to IV central PA T3-
T6 mobilisation. 
(Piekarz and Perry, 
2016) 
1.Treatment (group 1): PA L4 mobilisation 
(3Hzx3x60s) 
2.Treatment (group 2): PA L4 mobilisation 
(2Hzx3x60s) 
Abbreviations: C6: the 6th cervical vertebrae; L4: the 4th lumbar vertebrae; L4/5: facet joint between 
the 4th and the 5th lumbar vertebrae; T3: the 3rd thoracic vertebrae; T6: the 6th thoracic vertebrae; T4: 
the 4th thoracic vertebrae; III: grade three; IV: grade four; AP: anterior-to-posterior pressure; PA: 
posteroanterior accessory mobilisation; HVLA: high velocity low amplitude. 
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3.3.3.2. Participants  
All the studies included both male and female participants, except for two (Perry and 
Green, 2008; Piekarz and Perry, 2016) that included only male participants. Only 
two studies used symptomatic subjects, both with chronic nonspecific neck pain 
(Salom-Moreno et al., 2014; Snodgrass et al., 2014); whereas all other included 
studies included healthy subjects. In general, the papers included in this review had 
similar inclusion/exclusion criteria and the subjects involved had similar baseline 
characteristics that improved the generalisability of the findings.  
3.3.3.3. Study outcomes 
Table 3.5. The study outcomes (positive and indifferent outcomes). 
Outcome Measures Study Outcomes N of 
Studies 
Pain related 
measures 
PPT A statistically significant difference in PPT after 
mobilisation compared to placebo and/or 
control. 
1 
No statistically significant difference in PPT 
after mobilisation compared to HVLA, placebo 
and/or control 
3 
Sympathetic 
nervous 
system 
indicators 
SC A statistically significant difference in SC after 
mobilisation compared to placebo and/or 
control. 
3 
BP  
HR 
 
No statistically significant difference in HR, 
systolic BP and diastolic BP after mobilisation 
compared to placebo. 
1 
PPT: pressure pain threshold 
SC: skin conductance 
BP: blood pressure 
HR: heart rate 
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3.3.4. GRADE score of overall quality  
3.3.4.1. Hypoalgesic Effects of Mobilisation Versus Placebo and Control 
Groups  
One study with low risk of bias (Table 3.3) examined the effect of seated extension, 
passive thoracic mobilisation on PPT measures and supported its effectiveness in 
healthy subjects compared to a placebo group (Fryer et al., 2004). One study with 
high risk of bias (Table 3.3) suggested no significant effect of passive lumbar 
mobilisation on PPT measures for mobilisation compared to a placebo group 
(Thomson et al., 2009).  
The two trials studying the hypoalgesic effects of passive spinal mobilisation were 
similar when comparing mobilisation versus no treatment, with healthy subjects and 
the same outcome measure (PPT) (Fryer et al., 2004; Thomson et al., 2009). 
Assessment of the overall quality of evidence the final GRADE score (Table 3.6) 
indicated very low evidence to support the effect of passive spinal mobilisations 
versus no treatment on PPT measurements in healthy subjects. 
 
 
 
 
 
 
 
 
 
 
80 
 
Table 3.6. GRADE Evidence profile 
intervention  Studies Type of 
evidence 
Score 
Quality 
score  
Consistenc
y score   
Directnes
s score  
Effect 
size 
score 
Overall quality 
score 
Passive 
mobilisations 
vs. no 
treatment on 
PPT  
Fryer et 
al., 2004; 
Thomson 
et al., 
2009 
+4 -3a -1b -1c 0d -1 (very low 
quality evidence) 
Passive 
mobilisations 
vs. placebo on 
sympathetic 
outcome 
measures 
Perry 
and 
Green, 
2008; 
Jowsey 
and 
Perry, 
2010; 
Yung et 
al., 2014 
+4 -3a -1b -1c 0d -1 (very low 
quality evidence) 
Passive 
mobilisations 
vs. HVLA 
thrust on PPT 
Fryer et 
al., 2004; 
Salom-
Moreno 
et al. 
,2014;Th
omson et 
al., 2009 
+4 -3a -1b -1c 0d -1 (very low 
quality evidence) 
PPT: pressure pain threshold 
HVLA: high velocity low amplitude thrust 
a Problem with more than three elements of quality (Unclear allocation concealment in all studies, 
different baseline characteristics in all studies, care providers were not blinded in all studies, patients 
blinded in only one study). 
b Lack of agreement between studies. 
c Recruitment issues decreasing generalisability. 
d Not all effect sizes >2 or <0.5 and significant. 
3.3.4.2. Sympathetic Nervous System Effects of Mobilisation Versus Placebo 
and Control Groups 
One study with a low risk of bias (Table 3.3) compared the effect of passive thoracic 
mobilisation techniques (grade III oscillatory mobilisation for three sets of one 
minute, at a rate of 0.5 Hz) on the SC measures in healthy subjects to placebo and 
control groups and suggested a significant sympathoexcitatory response (Jowsey 
and Perry, 2010). Another study with a low risk of bias (Table 3.3) examined the 
effect of lumbar mobilisation (unilateral PA grade III oscillatory mobilisations, over 
the left L4/5 facet, at a rate of 2 Hz for three sets of one minute) on the SC measures 
in healthy subjects compared to placebo and control groups and supported its 
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sympathoexcitatory response (Perry and Green, 2008). On the other hand, a third 
study with low risk of bias examined the effect of AP gentle pressure to the right C6 
costal process at a rate of 1.5 Hz for five sets of 10 seconds on the HR and BP 
measures in healthy subjects compared to the placebo group and found within-group 
(mobilisation) sympathoinhipatory response (decreased HR and systolic BP) (Yung 
et al., 2014). However, this response was not significant in comparison with placebo 
group.  
The SNS effects of passive spinal mobilisation were similar when comparing 
mobilisation versus placebo, on healthy subjects and using the sympathetic outcome 
measures (Perry and Green, 2008; Jowsey and Perry, 2010; Yung et al., 2014). 
Assessment of the overall quality of evidence using the GRADE system indicated 
very low evidence to support the effect of passive spinal mobilisations versus 
placebo on SNS measurements in healthy subjects (Table 3.6). 
3.3.4.3. Mobilisation Versus Manipulation 
Three studies compared the effect of mobilisation with HVLA thrust on PPT 
measures in healthy subjects (Fryer et al., 2004; Salom-Moreno et al., 2014; 
Thomson et al., 2009). Their findings suggested no statistically significant difference 
in PPT after mobilisation compared to HVLA. 
Based on the assessment of the overall quality of evidence the final GRADE score 
indicated very low quality evidence to support the effect of passive spinal 
mobilisations versus HVLA thrust on PPT measurements in healthy subjects (Table 
3.6). 
3.3.4.4. Additional information yielded from individual studies 
One study (Snodgrass et al., 2014) compared the effects of different force 
magnitudes of mobilisation on PPT in chronic non-specific neck pain patients. These 
authors found that a higher force magnitude of mobilisation (90-N mean peak force) 
did not lead to a significant increase in PPT compared to a lower force magnitude 
(30-N mean peak force). Moreover, no significant differences in PPT were found 
between these groups of patients and the placebo group.  
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Another study by (Piekarz and Perry, 2016) compared the effects of different rates 
(3Hz and 2Hz) of mobilisations on SC compared to placebo and control. These 
authors found that only the 3 Hz technique showed a significant increase in SC 
compared to placebo and control condition. 
3.4. Discussion 
The objective of this chapter was to systematically review randomised controlled 
trials that have assessed the effect of spinal mobilisations on hypoalgesic and SNS 
responses in healthy populations or in patients with cervical, thoracic or lumbar pain.  
The implication for investigations of neurophysiological effects of spinal 
mobilisations is that if spinal mobilisation produces hypoalgesia and 
sympathoexcitation; the dPAG of the midbrain is stimulated (Vicenzino et al., 1998). 
Therefore, if spinal mobilisation stimulates dPAG, then perhaps it may cause pain 
relief. Thus, studies on neurophysiological effects are important to drive the focus 
away from the biomechanical model toward a more global model, which covers 
spinal, peripheral and supraspinal neurophysiological effects (Bialosky et al., 2009; 
Schmid et al., 2008).  
Overall, this review found very low quality of evidence for the use of spinal 
mobilisations which affect the pain and the SNS. Two studies in this review 
established a statistically significant change in skin conductance, consistent with 
sympathetic excitation, which was observed following one application of spinal 
mobilisations and lasted for five minutes. Only one study, out of four examining the 
hypoalgesic effects in this review, showed a statistically significant change in PPT 
following spinal mobilisations (a thirty second seated extension thoracic 
mobilisations for tender vertebrae) compared to the sham group. Although the 
results should be interpreted with caution, they support the theory that spinal 
mobilisations trigger activation of sweat gland mechanisms (Bialosky et al., 2009; 
Chu et al., 2014). 
3.5. Clinical relevance of these findings 
In humans, the dPAG is responsible for mediating sympathetic activation and 
concurrent hypoalgesia (Evan, 2002). It is speculated that dPAG mechanisms 
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(supraspinal mechanisms) can be activated by stimulation of the receptors of the 
structures of a spinal segment during mobilisations (Pickar, 2002). Results from the 
studies in this review have consistently demonstrated increases in skin conductance, 
with inconsistent results regarding PPT, blood pressure and heart rate, which is 
inconsistent with the mediated effects of the dPAG. 
Dishman and Bulbulian (2000) speculated that spinal reflex pathways might be 
stimulated by the application of oscillation through spinal mobilisations. Four studies 
out of eight in this review applied oscillatory mobilisation techniques. Only two of the 
studies provide some support to this hypothesis; they reported significant 
sympathetic changes after mobilisations (Perry and Green, 2008; Jowsey and Perry, 
2010). The assumption that the oscillatory component is responsible for the 
sympathetic response after spinal mobilisations is questionable.  
Evan (2002) hypothesised that sympathetic activation after spinal mobilisations may 
result from stimulation of the sympathetic chain and related ganglia at any level of 
the spine. Two studies in this review provide some support for this hypothesis; they 
reported side specific sympathetic responses (Perry and Green, 2008; Jowsey and 
Perry, 2010). However, one study in this review, by Yung et al. (2014), did not report 
changes in blood pressure and heart rate post AP pressure applied to the right side 
of C6, where the middle and inferior cervical ganglia project their postganglionic 
axons to the heart. 
3.6. Limitations of the review 
Only papers published in English language were involved, which may lead to a 
publication, cultural or/and language bias. It was not possible to include two 
reviewers through the process of evaluation of eligibility of studies and data 
extraction in order to ensure reproducible judgements and minimise selection bias 
as recommended by the Cochrane Collaboration (Higgins and Deeks, 2008). 
However, the author had help developing the search strategy from an information 
resources specialist. In addition, a second and third reviewer were included in 
assessment of the quality of the literature. Moreover, due to the nature of this review 
the reviewer was not blinded to publication information of the paper such as authors, 
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institution, journal name and direction and magnitude of the findings as 
recommended by Montori et al. (2003).   
3.7. Conclusion 
This chapter has presented a systematic review of randomised controlled trials which 
assessed the effectiveness of spinal mobilisations on hypoalgesic and SNS 
responses in healthy populations or in patients with cervical, thoracic or lumbar pain. 
This review demonstrates that there is very low evidence to support the effect of 
passive spinal mobilisations versus no treatment or placebo on PPT and SNS 
measurements in healthy subjects or those with chronic neck pain. There is very low 
quality evidence to suggest that passive spinal mobilisation is superior to HVLA 
thrust regarding hypoalgesia in healthy subjects. To date there have been no studies 
on the PPT and SNS effects of spinal mobilisation in those with LBP. Studies 
investigating neurophysiological effects of passive spinal mobilisations in a 
symptomatic LBP population are necessary. The overall aim of this thesis was 
therefore to investigate the hypoalgesic and sympathetic effects of passive 
mobilisation treatment in those with LBP. The following chapter considers the 
measurement of these variables.  
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Chapter 4 
Methods of measuring sympathetic nervous system and hypoalgesic 
responses 
4.1. Introduction 
Recent physiotherapy research has focused on the dynamic continuum concept of 
the nervous system that includes spinal and supra-spinal responses to physiological 
and mechanical stimuli. This research measures SNS responses as a quantification 
of the proposed neurophysiological mechanism. This chapter will consider the 
methods of measuring sympathetic nervous system responses and the mobilisation 
technique that were used within the context of this thesis. In addition, consideration 
is given to the use of pressure algometry to measure PPT and Numerical Pain Rating 
Scale (NPRS) as one of the patient-reported measures that clinicians often use to 
measure pain intensity in a clinical setting (Valente et al., 2011). 
The previously reported outcome measures from the literature (skin conductance, 
skin temperature, blood pressure, heart rate, respiratory rate, salivary alpha-
amylase, pressure pain threshold and Numerical Pain Rating Scale) (Chapter 2, 
section 2.8 and 2.9) were used in this thesis as measures of hypoalgesic and 
sympathetic responses to spinal mobilisation treatment in an asymptomatic 
population and LBP patients after assessing their reliability within the context of this 
thesis (Chapter 5). The following section will detail the equipment used in 
subsequent chapters in this thesis and the specific procedure related to the use of 
each item. 
4.2. Equipment 
4.2.1. The e-Health Sensor Shield with Arduino  
Physiological recordings of skin conductance, heart rate, respiratory rate and skin 
temperature were measured by using the e-Health Sensor Shield V2.0 that collected 
continuous, non-invasive physiologic data through a number of sensors. Cooking 
Hacks designed the e-Health Sensor Shield for the use of medical researchers. It is 
usually used alongside Arduino (Figure 4.1), which is an open-source electronics 
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prototyping platform that can simplify the amount of hardware and software 
development needed to run a system.  
 
Figure 4.1. Arduino (left) and the e-Health Sensor Shield (right) (Cooking 
Hacks, 2013). 
The e-Health Sensor Shield was stacked on top of Arduino in order to allow the 
Arduino board to gather information from the different sensors (Figure 4.2). Different 
biometric sensors can be connected to the e-Health Sensor Shield; however, for the 
purposes of this thesis, only four sensors were used: airflow, body temperature, 
galvanic skin response and electrocardiogram (ECG) sensors.  
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Figure 4.2. The e-Health Sensor Shield with Arduino and related sensors 
(Cooking Hacks, 2013). 
 
The e-Health Sensor Shield, together with the e-health software coding libraries for 
the Arduino microcontroller and all the sensors, allows data to be read from each 
sensor. Information needed to configure the e-Health Shield with Arduino is available 
on the Labelium and Cooking Hacks’ official website: https://www.cooking-
hacks.com/documentation/tutorials/ehealth-biometric-sensor-platform-arduino-raspberry-
pi-medical.  For the purposes of this work, Custom written Labview (version 2013, 
National Instruments, Texas, USA) was developed to control the e-Health Shield 
device and enable data acquisition.  Two coupled e-health Shields and Arduinos 
were connected via a USB cable to a personal computer, with the following sensors 
attached: 
1. An airflow (breathing) sensor: composed of a set of two prongs that were 
placed in the nostrils (Figure 4.3). 
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Figure 4.3. Airflow sensors (Cooking Hacks, 2013). 
 
2. Two body temperature sensors: placed over the plantar surface of the big toe, 
bilaterally (Figure 4.4). 
3. Two galvanic skin response (GSR – sweat) sensors: placed over the plantar 
surface of the second and third toes, bilaterally (Figure 4.5).  The plantar 
surface of the second and third toes was selected because it has been reported 
that it is able to provide clear sympathetic responses from the lower limbs (Elie 
and Guiheneuc, 1990). Furthermore, the plantar surfaces of the second and 
third toes were selected because L5 has a coetaneous branch (the medial 
plantar nerve) that supplies them (Perry and Green, 2008); this permits the 
peripheral sympathetic response to be measured when mobilisation is later 
applied (Chapters 6 and 7). 
 
 
Figure 4.4. Skin temperature sensor (Cooking Hacks, 2013). 
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Figure 4.5. Skin conductance sensors (Cooking Hacks, 2013). 
 
4. HR sensors (ECG): connected to the chest. Neutral (White, Figure. 4.6 and 4.7) 
and positive (Red, Figure. 4.6 and 4.7) sensors were placed parallel to each other 
(heart level) while negative sensors (Black, Figs. 4.6 and 4.7) were placed below 
the neutral sensors (Figures 4.6 and 4.7). 
 
 
 
 
 
Figure 4.6. Electrocardiogram sensors (Cooking Hacks, 2013); Figure 4.7. 
Sites of ECG connections (Cooking Hacks, 2013). 
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In order to measure the skin temperature and skin conductance bilaterally, it was 
necessary to use a second Arduino and e-Health Sensor Shield, as each device has 
capability to record from one temperature and one GSR sensor. Data were recorded 
from all sensors simultaneously using the LabView environment, with signals 
sampled at 60 Hz. The duration of data acquisition was modified within each of the 
data collection protocols and will be specifically reported in each of these chapters. 
Prior to data analysis, the analogue voltage signals collected were transformed into 
relevant measurement units based on the factory supplied calibration factors. 
4.2.2. Blood pressure monitor 
Blood pressure was measured by a digital monitor (Kodea KD-202F, Shanghai 
Kodea Economic & Trade Development Co., Shanghai, China) (Figure 4.8). The cuff 
was wrapped around the left arm. It measures the pressure of the blood that is sent 
to the arteries as the blood is pumped out of the contracted heart and into the rest 
of the body (Jones et al., 2003). The recommendation is to measure blood pressure 
while the person is relaxed in a seated position (Jones et al., 2003). Two numbers 
record blood pressure: the first records systolic pressure as the heart beats, while 
the second records diastolic pressure as the heart muscle relaxes. 
 
 
 
 
 
Figure 4.8. Blood pressure monitor (Cooking Hacks, 2013). 
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4.2.3. Wagner algometer 
PPT is defined as the point at which a sensation of pressure converts into a 
sensation of pain, and it has been recognised as a valid and reliable way to quantify 
pain. As such, it is widely used in clinical and scientific research (Jones et al., 2007; 
Ylinen et al., 2007; Walton et al., 2014). PPT was measured by using a pressure 
algometer, which is a mechanical form of pain assessment. Algometry is often used 
in research to quantify pain; it showed excellent reliability to measure PPT and 
correlates well with clinical status (Fischer, 1986; Potter et al., 2006). A Wagner 
algometer (model FDK/FDN, Wagner Instruments) was used in this study. The 
instrument has a 1-cm rubber footplate and a scale that spans 2 to 20 kg. No 
calibration was required. The algometer was pressed perpendicularly onto the skin 
overlaying the test site and participants were instructed to inform the researcher 
when the algometer’s pressure became painful. At that point, a reading was taken 
and recorded (Figure 4.9).  
 
 
Figure 4.9. Wagner algometer (Buhagiar et al., 2011). 
 
 
4.2.3.1. Sites of PPT measurement 
PPT measures were taken at the following sites: 
- Paraspinal muscles at the T12 level (1.5 cm apart from the spinous process on 
both sides; right and left). These locations were measured because they were at the 
level of mobilisation (T12) to measure the local hypoalgesic response to mobilisation 
(Fryer et al., 2004; Thomson et al., 2009; Willett et al., 2010). 
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- Paraspinal muscles at the L5 level (1.5 cm apart from the spinous process on both 
sides; right and left). This level was chosen because it has been reported to be the 
most common site of symptoms within the lumbar region in patients with LBP (Louis, 
1981; Butler, 1991; Grieve, 1994). 
- The mid-point of the hand web space bilaterally (first dorsal interosseus muscle). 
The first dorsal interosseus muscle in the hand was selected as it was reported to 
produce a large amount of normative data that could be compared against PPT 
values (Vanderween et al., 1996; Chesterton et al., 2003) and could be used to 
assess whether there was a systemic hypoalgesic effect to the mobilisation 
treatment applied (Willett et al., 2010). 
4.2.4. The Numeric Pain Rating Scale (NPRS) 
An 11-point NPRS was used, with 0 being no pain and 10 being most pain 
imaginable (Figure 4.10). In clinical practice, when assessing changes in a patient’s 
condition within a single session or between treatment sessions, physiotherapists 
often use this scale and ask their patients to score their pain. It has been reported to 
be a valid and reliable scale with which to measure pain intensity (Valente et al., 
2011). This outcome measure was used only in the last phase of this research, which 
included LBP patients (Chapter 7). 
 
 
Figure 4.10. Numeric Pain Rating Scale (Dvir, 2015). 
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4.2.5. Salivary alpha-amylase (sAA) 
sAA is a digestive enzyme that separates insoluble starch into dextrin and maltose 
(Zakowskia and Bruns, 1985). sAA is produced by the salivary glands through the 
acinar cells and does not diffuse into the saliva from blood (Proctor and Carpenter, 
2007). In relation to the total proteins produced by the salivary glands, the 
percentage of sAA is between 40 and 50% (Zakowski and Bruns, 1985; Makinen, 
1989).  
In the current thesis, sAA was measured by placing swabs under the participants’ 
tongues; they were asked to give a sign when the swab was full. The swabs were 
then transferred directly into storage tubes that were labelled with the participants’ 
codes, and then placed into a box of dry ice (Figure 4.11). Then, all samples were 
centrifuged for 15 minutes at 3000 revolutions per minute at 4°C to pellet the mucins. 
Then they were transferred to a -80°C freezer for storage for no longer than 6 
months. The collection materials for the saliva samples were purchased from the 
Salimetrics Company (State College, Pennsylvania). All samples were shipped to 
the Psychology Lab at Anglia Ruskin University where the amylase assays were 
performed (Appendix 4.1 for a full description of salivary alpha-amylase assay 
protocol). 
 
 
Figure 4.11. Saliva swab and storage tube (Salimetrics, 2013). 
 
On the day of testing, the samples were centrifuged to confirm that they had 
collected the correct volume of saliva (Figure 4.12). However, weighing the tubes 
before and after sampling can achieve the same aim. For example, if a change of 
+0.5 g was measured, it was assumed that we had collected 0.5 ml of saliva. 
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Salimetrics recommends a minimum of 400 ul for duplicate testing of alpha-amylase 
concentrations (a greater volume is needed for testing using the robot), with volumes 
of 500 ul or more being preferred. The swabs hold 2 ml of saliva before becoming 
saturated; however, it was avoided for the swabs becoming fully saturated, as then 
we had no longer be measuring the correct weight of produced saliva in the time 
period as it will not be able to go into the swabs. For this reason, in addition to 
weighing the tube before and after collection, each participant was asked to give a 
sign when he/she felt that the swab was full, and the amount of time that the swab 
spent under the tongue was recorded.  
 
Figure 4.12. Centrifuge machine (Biocompare, 2017). 
 
As an alpha-amylase assay is flow-rate dependent, measuring the flow rate of each 
sample (the flow rate of the saliva into the swab) was necessary in order to correct 
for the differences that flow rate causes in terms of the concentration of the alpha-
amylase in the samples (Nater and Rohleder, 2009).   
The collection device (swab and storage tube) was weighed before and after 
sampling with a decimal balance in order to measure the rate of the saliva flow. In 
this way, we measured the real physiological difference in response to stimulus (in 
later studies, spinal mobilisation) rather than an innate difference that is caused by 
the rate of saliva flow (Nater and Rohleder, 2009). Therefore, this process allowed 
for the removal of a potential confounder, thereby yielding better results.  
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4.3. Mobilisation technique  
Recent animal studies on rats by Skyba et al. (2003) manipulated the proximal joint 
(knee joint) to the injured ankle joint (injected with capsaicin) and reported distal 
hypoalgesic effects that reached the symptomatic area as measured by mechanical 
withdrawal threshold. These distal pain-relieving effects have been attributed to the 
involvement of supraspinal mechanisms that activate the descending inhibition of 
pain, mediated by spinal serotonergic and/or adrenergic receptors that may include 
the SNS and PAG (Sluka et al., 2006). However, further research is needed to 
understand the hypoalgesic mechanisms of mobilisations. Furthermore, research on 
humans reported the wider hypoalgesic effect of mobilisation distal from the targeted 
areas (Vicenzino et al., 1996; Moss et al., 2007). Moreover, contrasting results were 
reported by Sterling et al. (2001) and Perry and Green (2008), who found there was 
a side-specific pain relieving effect after applying unilateral cervical and lumbar 
mobilisation.  
A number of studies have compared the hypoalgesic effects of manual therapy on 
the thoracic and cervical levels and found similar clinical benefits of hypoalgesia in 
the symptomatic site (Fernandez et al., 2011; Martinez et al., 2012). PPT was 
measured in the elbow in patients with epicondylalgia following cervical and thoracic 
manipulation and similar improvements were found (Fernandez et al., 2011). 
Another study demonstrated that both thoracic and cervical manipulation produced 
similar widespread hypoalgesia in patients with chronic neck pain (Martinez et al., 
2012). Another three studies compared the widespread hypoalgesic effects of 
thoracic mobilisation and thoracic manipulation in patients with chronic mechanical 
neck pain (Cleland et al., 2007; Suvarnnato et al., 2013; Salom et al., 2014). Their 
results suggested that there was no significant difference between the techniques in 
terms of PPT values at the cervical level, and that could be explained by the potential 
central mechanism of pain following manual therapy. 
The mobilisation technique chosen for this thesis was applied at the grade III 
centrally applied posteroanterior (PA) T12 position for three sets of 60 seconds with 
one-minute rest periods between sets using a pisiform grip (Figure 4.13). The 
duration of the treatment was five minutes.  
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Figure 4.13. Posteroanterior mobilisation with pisiform grip (Physiopedia, 
2017). 
 
The components of this technique were selected for the following reasons: 
- T12 was selected as the level of mobilisation because of the location of the ganglion 
of the SNS—they are found to be anterior to the costovertebral joint of the thoracic 
system. Thus, thoracic mobilisation might stimulate the preganglionic sympathetic 
cells at the thoracic and lumbar spinal levels either directly or indirectly (Sampath et 
al., 2015). These stimuli might then travel upwards to be processed at different 
levels, including the spinal and supraspinal levels. Thus, it was thought that 
mobilising the thoracic spine might lead to the stimulation of preganglionic 
sympathetic cells in the thoracolumbar spine, either directly or indirectly. 
Furthermore, the T12 was chosen because the sympathetic ganglia located between 
the T10 and L2 vertebrae supply the lower limbs (Grieve, 1994) which allows for the 
peripheral sympathetic response to mobilisation from the lower limbs (SC, ST from 
the feet) to be measured. 
 
- The direction of the mobilisation force was selected to be centrally PA. 
Biomechanically, the T12 only moves in two directions—either extension or flexion—
thus, no other directional forces are possible at this spinal level (Maitland et al., 
2005). 
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- The mobilisation was applied for three sets of 60 seconds with one-minute periods 
of rest between sets. This is consistent with clinical practice (Maitland et al., 2005) 
and with previous studies examining the sympathetic responses to mobilisation 
techniques (Sterling et al., 2001; Sterling et al., 2010; Soon et al., 2010; Willett et al., 
2010). 
 
- The oscillation frequency was set at 1 Hz (one oscillation per second), which is 
reported as the most commonly used frequency by physiotherapists in clinical 
practice (Snodgrass et al., 2006). The treating researcher was able to monitor the 
mobilisation frequency by using a metronome application on a smartphone that was 
set to make a sound each second for the duration of the treatment (five minutes). A 
headset was used so that the sound of the metronome was heard only by the treating 
researcher and not by the participants or the principal investigator.  
 
- Grade III mobilisation (large-amplitude movement that moves into stiffness or 
resistance) was used. Prior research reported that this grade might maximise the 
activation of a descending inhibitory mechanism through the stimulation of 
mechanoreceptors that might result in pain reduction in areas that are distant to the 
mobilisation (Vernon et al., 1986; Wright, 1995; Vicenzino et al., 2001; Griensven, 
2005). Furthermore, the majority of studies examining the hypoalgesic and 
sympathetic responses to mobilisation techniques have used large-amplitude (grade 
III) oscillations (Peterson et al., 1993; Chiu and Wright, 1996, 1998; McGuiness et 
al., 1997; Sterling et al., 2001; Sterling et al., 2010; Soon et al., 2010; Willett et al., 
2010). 
 
In summary, this chapter described the equipment and the specific procedures used 
to measure the sympathetic and hypoalgesic variables related to this thesis. It has 
described the rationale for the spinal mobilisation technique to be used. The 
following chapter assesses the reliability of this equipment in terms of measuring the 
related variables. 
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Chapter 5 
Within-day test-retest reliability of physiological data recordings 
5.1. Introduction 
Over the last two decades, there has been an increasing interest in the detection of 
changes in neurophysiological responses of SNS to manual therapy. Changes are 
reported for various measurements in the literature including: skin conductance, skin 
temperature, heart rate, respiratory rate, blood pressure and pressure pain threshold 
(Sterling et al., 2001; Cleland et al., 2004; Jowsey and Perry, 2010; Krouwel et al., 
2010; Willett et al., 2010; Pentelka et al., 2012). The work presented in this chapter 
was conducted to determine the within-day test-retest reliability (reproducibility) of 
the measurements described in Chapter 4, that were chosen for this research to 
assess the hypoalgesic and sympathetic responses following mobilisation treatment. 
The results of this reliability study underpin later studies presented in this thesis 
(Chapters 6 and 7) that were conducted to investigate the effects of mobilisation 
treatment on these variables in asymptomatic and LBP patients.   
To the author’s knowledge, the reliability of the e-Health Sensor Shield V2.0 and 
sAA has never been investigated. In addition, this device and associated sensors 
was specifically purchased and set-up for the experiments. It had not previously 
been used by any other members of the laboratory or supervisory team. It was 
therefore important to establish specific test-retest reliability within the context of 
studies. PPT test-retest reliability has been shown to be excellent (Potter et al., 
2006). However, reliability varies according to the PPT sites tested. Moreover, not 
all sites of measurement of PPT chosen for this thesis have been tested for reliability. 
Thus, prior to commencing the studies that will be presented later in this thesis, it 
was necessary to investigate the reliability of all six PPT sites of measurement.   
5.1.1. Aims and objectives 
The main aim of this study was to evaluate the test re-test reliability (reproducibility) 
of: i) the e-Health Sensor Shield V2.0 at measuring skin conductance, skin 
temperature, heart rate and skin temperature; ii) a Wagner algometer at measuring 
PPT (model FDK/FDN, Wagner Instruments) (at each of six sites); iii) a digital BP 
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monitor (Kodea KD-202F, Shanghai Kodea Economic & Trade Development Co., 
Shanghai, China); and iv) measurements of sAA enzyme recorded using sAA assay 
kit from Salimetrics (State College, Pennsylvania).  
Lexell and Downham (2005) defined test-retest reliability as the stability of a 
measure over time. Reproducibility examines the sensitivity limit of a measure to 
detect a response change in relation to an intervention (Beckerman et al., 2001). 
Guyatt et al. (1987) defined the sensitivity to change as the measurement’s ability to 
determine clinical differences over time. These authors describe the responsiveness 
of a measure between repeated test measurements with regard to the typical 
difference between subjects. Therefore, these changes and the amount of 
measurement error should be determined in order to establish the direct influence of 
any intervention.  
The following objectives were determined to achieve the stated aims: 
i. The retest correlation co-efficient for each physiological measurement was 
determined to provide a measure of agreement between sets of measurements. 
ii. Standard error of measurement (SEM) and confidence intervals of collected data 
were calculated to quantify the random differences in the measurement means. 
iii. SEM and smallest real difference (SRD) of collected data were calculated to 
quantify the differences in measurements between applications, in order to assess 
true changes to the intervention.  
5.2. Method 
5.2.1. Study design 
This was a within-day reliability study. 
5.2.2. Ethics approval 
This study was approved by the Faculty of Health, Psychology and Social Care 
Research Ethics Committee (Appendix 5.1). 
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5.2.3. Participants  
Fifteen asymptomatic participants were recruited from among the students at 
Manchester Metropolitan University by placing a poster advertisement on the 
Facebook page of the Psychology, Health and Social Care department. Direct 
generation of interest in the study was achieved by attending lectures and seminars 
in the department to hand out information sheets with the researcher’s contact 
information. The lectures and seminars provided a setting in which the target 
population (healthy students) could be found and could be addressed directly as a 
group, rather than as individuals.  
All volunteers who responded were interviewed by telephone to ascertain their 
appropriateness for the study (Chapter 5, section 5.2.3.1). For those that agreed to 
participate, an information sheet was provided for their consideration prior to 
commencement of data collection (Appendix 5.2). The researcher informed the 
participants of their right to withdraw at any time and they were asked to sign the 
consent form (Appendix 5.3). A screening assessment was performed on the day of 
the data collection to confirm that the participant’s status had not changed and that 
they had abstained from exercise and caffeine in the three hours prior to taking the 
measurements, and that they had refrained from consuming alcohol in the 24 hours 
prior to taking the measurements. 
5.2.3.1. Inclusion and exclusion criteria 
Potential participants were required to be healthy individuals aged between 18–55 
years, non-smokers, have an adequate understanding of the English language, able 
to provide informed consent for the study and asymptomatic of spinal pain. The 
upper limit of 55 years was used in this study in order to reduce the possibility of 
recruiting individuals with degenerative changes that could potentially affect the 
outcome measures of the study (Snodgrass et al., 2014). In order to ensure that the 
extrapolation of the target population’s results was uninhibited, both male and female 
participants were recruited. 
Potential participants for this study were excluded if they had a history of back pain 
in the previous six months, had been diagnosed with a psychiatric or medical 
disorder that may have influenced their neurophysiological responses (e.g. 
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rheumatoid arthritis, multiple sclerosis, diabetes and anxiety disorders), had 
previously had lower extremity or spinal surgery, been pregnant, had a previous 
history of trauma with related permanent sensation abnormality (dysesthesia), had 
skin disorders at the location of the electrode placement, were dependent on alcohol, 
were smokers or were incapable of providing informed consent (e.g. as a result of 
dementia or limited English language skills) (Perry et al., 2015). 
5.2.4. Confidentiality   
Each participant was assigned an alphanumeric code upon entry into the study and 
all study data were labelled using the same code. All information recorded on paper, 
and any non-computerised data were stored in a locked cabinet in room T0.18 of the 
John Dalton West building at Manchester Metropolitan University. Computerised 
data were password protected and accessible only by the named investigators. 
5.2.5. Research approach and methods 
This study used a same-subject repeated measures design. To determine the within-
day reliability, measurements were taken three times for each participant for each 
physiological measure (Figure 5.1). The within-day reliability was used rather than 
between days as the aim of the subsequent studies is to compare the within session 
effect of mobilisation with the effect of subsequent sessions. As a result, each 
physiological measure (Chapter 6 and 7) was measured before the treatment in each 
visit to measure the within session effect.  
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Figure 5.1. An illustration of the study protocol. 
5.2.6. Procedure 
Participants attended Manchester Metropolitan University on one occasion. 
Participants were asked to avoid eating, exercising and drinking any caffeinated 
beverages three hours prior to the meeting, and to refrain from consuming alcohol 
for 24 hours prior to the meeting, as these are known to be confounding factors that 
might affect the SNS activity (Wright and Vecenzino, 1995; McGuiness et al., 1997; 
Katzung, 2001; Yung et al., 2014). 
On the day of testing, an oral explanation was given to each participant to familiarise 
them with the testing and data collection areas. They were given time to reflect on 
the study information and had the opportunity to ask questions about the study. 
 
10 minutes 
pre test 
period 
Blood 
pressure 
3 trials, one 
minute 
apart 
Salivary alpha-
amylase 
(collection of 
saliva samples) 
3 trials, one 
minute apart 
Pressure pain 
threshold (six 
locations) 
 
Each site: 3 trials 
(each trial of 3 
reparations, 30 
seconds apart), one 
minute apart 
Herat rate, respiratory 
rate, skin conductance 
and skin temperature 
10-minute stabilisation 
period 
3 trials (two-minute 
period), one minute 
apart 
 
 
 
 
End of 
session 
45-60 minutes 
5 minutes 5-10 minutes 10-15 minutes 20-25 minutes 
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Then, they were asked to sign a consent form. The subject’s height (m) and weight 
(kg) was measured using a standard medical scale (Kern, MPE 250K100 HM). All 
data were collection by the primary investigator in a noise- and temperature-
controlled environment (22.2°C).  
BP and PPT were recorded and saliva samples were collected at the beginning of 
the session, followed by the measurements taken by the e-Health Sensor Shield 
V2.0. The measurements were taken in this order to prevent an earlier measurement 
from having an effect on a subsequent measurement. Thus, all the measurements 
that were simultaneously recorded by the e-Health Sensor Shield V2.0 were taken 
when the participants were in a prone lying position and they were not disturbed.  
First, BP was measured using a digital BP monitor (Kodea KD-202F, Shanghai 
Kodea Economic & Trade Development Co., Shanghai, China) by placing the cuff 
around the left arm while the participant assumed a relaxed seated position. The BP 
measurement was taken three times and with one-minute breaks in between. Saliva 
samples were collected by placing a swab under the participant’s tongue. 
Participants were asked to give a signal when the swab was full (i.e. when saliva 
was no longer absorbed into the swab and started to pool on the floor of the mouth), 
and the time the swab spent in the participant’s mouth was recorded. The swab was 
transferred directly to a storage tube that was labelled with the participant’s code 
and then it was placed into a box of dry ice. This saliva collection procedure was 
repeated three times separated by one-minute breaks. Once the testing for each 
single participant was complete, the samples were centrifuged and transferred into 
a freezer where they were stored at -80°C for six months prior to analysis. All 
samples were shipped to the Psychology Lab at Anglia Ruskin University where the 
amylase assays were performed (Appendix 4.1 for a full description of salivary alpha-
amylase assay protocol). 
Later studies in this thesis (Chapters 6 and 7) examine the extent of the hypoalgesic 
response to mobilisations applied to the asymptomatic thoracic vertebral level (T12); 
thus, PPT was measured at six sites that were justified in Chapter 4 (section 4.2.3.1). 
The sites of PPT measurements were: 
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- Paraspinal muscles at the T12 level (1.5 cm apart from the spinous process on 
both sides; right and left). 
- Paraspinal muscles at the L5 level (1.5 cm apart from the spinous process on both 
sides; right and left).  
- The mid-point of the web space of both hands (first dorsal interossei).  
Participants were required to partially undress their torso; screens were used to 
protect their dignity at all times. They were instructed to lie in a prone position on an 
adjustable treatment plinth. The primary investigator located the target spinous 
process (T12) by palpating the iliac crest and moving medially to the L4/L5 
interspace, and then moving to palpate the upwards spinous process one by one 
until the T12 was located. Then, the primary investigator followed the vertebral 
attachment of the twelfth rib in order to confirm the identification of the T12 (Cleland 
et al. 2004). The spinous process of the T12 was marked and marks were made 1.5 
cm to the right and left of the T12 spinous process. In addition, marks were made 
1.5 cm from the right and left of the L5 spinous process. The mid-point of the hand 
web space was marked bilaterally as well.  
The methodology for the measurement of the PPT was similar to that used in 
previous studies (Keating et al., 2001; Fryer et al., 2004). Three measurements were 
taken at each of the six locations separated by thirty seconds, and the set of three 
measurements was repeated three times, each one was separated by one minute.  
The algometer was pressed perpendicularly to the marked sites and the participants 
were instructed to say “now” to the researcher when the algometer’s pressure 
changed to pain, and a reading was manually recorded. However, prior to testing, a 
familiarisation PPT was applied on the palmar aspect of the hand to allow 
participants to experience PPT at that site. Each participant had three PPT readings 
and the average of each of the three readings was calculated. 
Next, the participants were instructed to lie on supine on the same adjustable 
treatment plinth. The sites of the skin where the e-Health Sensor Shield sensors 
were applied were first cleaned with isopropyl alcohol to remove any residue on the 
skin. ECG sensors were connected to the chest and airflow sensors were placed in 
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the nostrils (Chapter 4, section 4.2.1). The participants were asked to turn over to 
assume a standardised position (prone with their arms by their sides (palms up) and 
their legs supported at the knees by a single pillow), which was the same position 
used in later studies for the mobilisation treatment (Chapter 6 and 7). Body 
temperature sensors were placed on the plantar surface of the big toe bilaterally, 
and galvanic skin response (GSR – sweat) sensors were placed on the plantar 
surface of the second and third toes, bilaterally (Chapter 4, section 4.2.1) (Perry and 
Green, 2008). 
After the application of the electrodes, the participants were instructed not to sneeze, 
cough, breathe deeply, fall asleep or talk, except to indicate pain or discomfort. They 
were also asked to avoid interfering with the electrodes. 
Similar to previous studies examining SNS responses, each participant had an initial 
stabilisation period lasting for 10 minutes in order for their body to acclimatise to the 
environment (Chiu and Wright, 1996; Vicenzino et al., 1995; Cleland et al., 2004; 
Perry and Green., 2008). Data acquisition (60 Hz sampling frequency) was initiated 
and measurements were taken continuously over the next two minutes (Perry and 
Green, 2008). The two-minute measurement period was repeated three times 
separated by one-minute break in recording. As a result, each patient produced three 
sets of two-minute data for skin conductance, skin temperature, heart rate and 
respiratory rate.  
Finally, the participants were informed when the testing had ended and the 
electrodes were removed. The whole session lasted between 45 and 60 minutes. 
Each participant produced three sets of data for PPT for six different locations, three 
sets of data for BP, three saliva samples and three sets of data for respiratory rate, 
heart rate, skin temperature and skin conductance: 
 A two-minute period (Trial 1), 
 A two-minute period (Trial 2) and 
 A two-minute period (Trial 3). 
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The raw data for heart rate, respiratory rate, skin conductance and skin temperature 
were processed using custom written Mathematica code (version 10.4, Wolfram 
Research, Champaign, IL, USA). The completed calculations provided the mean 
heart rate, respiratory rate, skin conductance and skin temperature per minute 
throughout the session, and calculated the mean value (integral measurement) of 
each period of measurement (two-minute period). The integral measurement of each 
period was used for analysis. Therefore, each participant had three values for the 
following outcome measures: right skin conductance, left skin conductance, right 
skin temperature, left skin temperature, heart rate and respiratory rate (Appendix 
5.4: Example raw data trace). For pressure pain threshold data, the mean of the 
three measurements was calculated for each site; thus, every participant had three 
scores for PPT at each site of measurement. For blood pressure and salivary alpha-
amylase, each participant had three values. 
5.3. Statistical data analysis 
5.3.1. Reliability analysis 
For reliability testing, the variance in intra-day measures was calculated separately 
for each physiological variable (for right and left sides separately where applicable) 
using the intra-class correlation coefficients (ICC 2, 1; two-way random effect model; 
interaction absent; absolute agreement definition; single measure); the 
measurement of each participant was also taken by the same rater (Eliasziw et al., 
1994). Eliasziw et al. (1994) recommended that all observations of the analysis 
should be used to improve precision, including 95% confidence intervals (CI) for the 
ICC, standard error of measurement (SEM) and minimal detectable change (MDC) 
(1.96 x SEM x √2).  The ICC and CI represent reliability and assess correlation 
between test measurements (Fleiss, 1986). The SEM and MDC were calculated as 
this score of variability is important in order to assess changes to treatment when 
evaluating pre- and post-treatment measures and is in the unit of measurement of 
the device (Eliasziw et al., 1994). The SEM is a change that needed to be recorded 
in order to be 95% confident that none of the results were due to measurement 
variability (Eliasziw et al., 1994). The MDC represents the smallest change required 
to ascertain the occurrence of a true change following treatment (Eliasziw et al., 
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1994). Descriptive statistics and statistical analyses were performed on all data using 
Statistical Package for Social Scientists (IBM SPSS Statistics V. 23; IBM Corp., 
Armonk, NY, USA). 
5.3.2 Results 
Nine females and six males participated in this within-day reliability study. 
Participants had an age range of 24.40–48.92 years, and a mean age of 32.9 years 
(SD 5.86); their mean body mass index (BMI) was 26.35 kg/m2 (SD 4.63), and they 
had a BMI range of 20.20–37.30 kg/m2. No adverse effects were reported by any of 
the participants upon completion of the study.  
5.3.2.1 Reliability of skin conductance measurements 
An integral reading was calculated for the three data sets. Each set consisted of two-
minute periods of time. Therefore, each participant had three readings for right skin 
conductance and three readings for left skin conductance. The reliability results for 
skin conductance are displayed in Table 5.1. Descriptive statistics for all three 
measurements of right and left skin conductance are displayed in Figure 5.2.  
Table 5.1. Within-day reliability of skin conductance measurements (n=15) 
 Within-day ICC Within-day CI Within-day 
SEM (v) 
Within-day 
MDC (v) 
SC (right side) 0.988 0.971–0.996 ± 0.02 0.056 
SC (left side) 0.985 0.963–0.994 ± 0.02 0.062 
Abbreviations: ICC: intraclass correlation coefficient; CI: 95% confidence interval; SEM: standard 
error of measurement; MDC: minimal detectable change; SC: skin conductance; v: voltage.  
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Figure 5.2. Skin conductance measurements for all three trials. The data are 
medians. Error bars represent non-outlier range (n=15). 
5.3.2.2. Reliability of skin temperature measurements 
The integral reading was calculated for the three data sets. Each set consisted of 
two-minute periods. Therefore, each participant had three readings for right skin 
temperature and three readings for left skin temperature. The reliability results for 
skin temperature are displayed in Table 5.2. Descriptive statistics for all three 
measurements of right and left skin temperature are displayed in Figure 5.3.  
Table 5.2. Within-day reliability of skin temperature measurements (n=15) 
 Within-day ICC Within-day CI Within-day 
SEM (°C) 
Within-day 
MDC (°C) 
ST (right side) 0.997 0.993–0.999 ± 0.5 1.5 
ST (left side) 0.987 0.969–0.995 ± 0.59 1.64 
Abbreviations: ICC: intraclass correlation coefficient; CI: 95% confidence interval; SEM: standard 
error of measurement; MDC: minimal detectable change; ST: skin Temperature; °C: Celsius.  
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Figure 5.3. Skin temperature measurements for all three trials. The data are 
medians. Error bars represent non-outlier range (n=15). 
5.3.2.3. Results of reliability of respiratory rate measurements 
The number of breathing cycles (inhalations and exhalations) per minute was 
calculated for the three data sets. Each set consisted of a two-minute period of time 
and the mean of the two-minute rate was calculated. Therefore, each participant had 
three readings for respiratory rate. The reliability results for respiratory are displayed 
in Table 5.3. Descriptive statistics for all three measurements of respiratory are 
displayed in Figure 5.4.  
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Table 5.3. Within-day reliability of respiratory rate measurements (n=15) 
 Within-day ICC Within-day CI Within-day SEM 
(breaths/minute) 
Within-day MDC 
(breaths/minute) 
RR 0.889 0.736–0.959 ± 0.58 1.59 
Abbreviations: ICC: intraclass correlation coefficient; CI: 95% confidence interval; SEM: standard 
error of measurement; MDC: minimal detectable change; RR: respiratory rate. 
 
 
Figure 5.4. Respiratory rate measurements for all three trials. The data are 
medians. Error bars represent non-outlier range (n=15). 
5.3.2.4. Reliability of heart rate measurements 
The number of heart beats per minute (heart rate) was calculated for the three data 
sets. Each set consisted of two-minute period of time and the mean of the rate of the 
two minutes was calculated. Therefore, each participant had three readings for heart 
rate. The reliability results for heart rate are displayed in Table 5.4. Descriptive 
statistics for all three measurements of heart rate are displayed in Figure 5.5. 
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Table 5.4. Within-day reliability of heart rate measurements (n=15) 
 Within-day ICC Within-day CI Within-day 
SEM  
(beats /minute) 
Within-day 
MDC  
(beats /minute) 
HR 0.86 0.855–0.949 ± 1.97 5.45 
Abbreviations: ICC: intraclass correlation coefficient; CI: 95% confidence interval; SEM: standard 
error of measurement; MDC: minimal detectable change; HR: heart rate. 
 
 
Figure 5.5. Heart rate measurements for all three trials. The data are medians. 
Error bars represent non-outlier range (n=15). 
5.3.2.5. Reliability of blood pressure measurements 
Systolic and diastolic BP measurements were recorded three times. Therefore, each 
participant had three readings for BP. The reliability results for blood pressure are 
displayed in Table 5.5. Descriptive statistics for all three measurements of systolic 
BP (SBP) and diastolic BP (DBP) are displayed in Figures 5.6 and 5.7.  
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Table 5.5. Within-day reliability of blood pressure measurements (n=15) 
 Within-day ICC Within-day CI Within-day 
SEM (mmHg) 
Within-day 
MDC (mmHg) 
SBP 0.773 0.467–0.917 ± 2.65 7.34 
DBP 0.535 -0.043–0.826 ± 2.4 6.65 
Abbreviations: ICC: intraclass correlation coefficient; CI: 95% confidence interval; SEM: standard 
error of measurement; MDC: minimal detectable change; SBP: systolic blood pressure; DBP: diastolic 
blood pressure. 
 
 
Figure 5.6. Systolic blood pressure measurements for all three trials. The 
data are medians. Error bars represent non-outlier range (n=15). 
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 Figure 5.7. Diastolic blood pressure measurements for all three trials. The 
data are medians. Error bars represent non-outlier range (n=15). 
5.3.2.6. Reliability of pressure pain threshold measurements 
The mean for the three measurement sets (each set consisted of three 
measurements) at each location was used for the analysis. Descriptive statistics for 
all PPT measurements are displayed in Figure 5.8. The reliability results for all PPT 
data (Table 5.6) at the T12 paravertebral muscles, L5 paravertebral muscles, 1st 
dorsal interossei muscles were excellent (ICC 0.79–0.97) (Fleiss, 1986). 
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Figure 5.8. PPT measurements for all three trials of paravertebral muscles 
(T12 and L5) and 1st dorsal interossei muscles. The data are medians. Error 
bars represent non-outlier range (n=15). 
Table 5.6. Within-day reliability of PPT measurements (n=15) 
 
Abbreviations: ICC: intraclass correlation coefficient; CI: 95% confidence interval; SEM: standard 
error of measurement; MDC: minimal detectable change. R: right; L: left; L5: 5th lumbar vertebra; 
T12: 12th thoracic vertebra; 1stDI: first dorsal interossei muscles. 
 
PPT sites Within-day ICC Within-day CI Within-day SEM 
(N/cm2) 
Within-day MDC 
(N/cm2) 
L5R   0.964 0.941–0.987 3.617 10.026 
L5L 0.94 0.859–0.978 3.297 9.139 
T12R 0.904 0.774–0.965 2.874 7.967 
T12L 0.971 0.932–0.989 3.487 9.666 
1st DIR 0.939 0.855–0.978 2.326 6.447 
1st DIL 0.792 0.513–0.924 1.496 4.147 
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5.3.2.7 Reliability of salivary alpha-amylase measurements 
The sAA was measured three times using sAA assay kit from Salimetrics (State 
College, Pennsylvania). Therefore, each participant had three readings for sAA. The 
reliability results for salivary alpha-amylase are displayed in Table 5.7. Descriptive 
statistics for all three measurements are displayed in Figure 5.9.  
Table 5.7. Within-day reliability of salivary alpha-amylase measurements 
(n=15) 
 Within-day ICC Within-day CI Within-day 
SEM  
(U/m) 
Within-day 
MDC  
(U/m) 
sAA 0.709 0.301–0.894 ± 8.297 22.99 
Abbreviations: ICC: intraclass correlation coefficient; CI: 95% confidence interval; SEM: standard 
error of measurement; MDC: minimal detectable change; sAA: salivary alpha-amylase; U/m: unit per 
minute.  
 
 
Figure 5.9. Salivary alpha-amylase measurements for all three trials. The data 
are medians. Error bars represent non-outlier range (n=15). 
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5.4 Discussion and conclusion  
The results of this reliability study demonstrated that the within-day test-retest 
reliability of skin conductance, skin temperature, heart rate, respiratory rate, systolic 
blood pressure and PPT measurements were excellent (ICCs of 0.77 to 0.99). On 
the other hand, the reliability of diastolic blood pressure and salivary alpha-amylase 
measurements were demonstrated to be fair to good (ICCs of 0.55 and 0.7, 
respectively). The work also quantified the minimal detectable change for each of 
the physiological parameters and will therefore inform the interpretation of the results 
in subsequent chapters.  
As this was the first study to assess the reliability of the e-Health Sensor Shield V2.0 
for measuring skin conductance, respiratory rate, heart rate and skin temperature 
and the first study to assess the reliability of measuring the sAA enzyme, 
comparisons with previous work were difficult. 
For blood pressure, the reliability result for systolic blood pressure was excellent 
(ICC 0.77), whereas, for diastolic blood pressure, reliability was fair to good (ICC 
0.55). Although the mercury sphygmomanometer is considered the gold standard 
for monitoring blood pressure, concerns about the safety of the mercury led to the 
widespread use of digital blood pressure readers (Skirton et al., 2011). The literature 
review (Chapter 2, Table 2.2) identified three studies that examined the effect of 
spinal mobilisation on blood pressure values (McGuiness et al., 1997; Vicenzino et 
al., 1998 and Yung et al., 2014); these studies used different digital, electronic blood 
pressure readers. However, reliability results were reported by only one study; they 
were for systolic and diastolic blood pressure with an ICC of 0.9 and 0.88 (Yung et 
al., 2014). It has been reported that bias may possibly exist when using electronic 
devices because they tend to give a high initial reading compared to repeated 
measurements within a short time frame (Skirton et al., 2011). When ischemia is 
maintained in the arm distal to the cuff for more than 10 seconds while the cuff is 
inflated, a change in the blood pressure measurement may occur during repeated 
measures (Eguchi et al., 2009). Therefore, if ischemia is maintained and the interval 
time is not adequate for full return of blood flow within the artery, this would explain 
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the variations, especially in diastolic blood pressure measurements, which lead to 
lower ICCs than systolic blood pressure.  
For the pressure pain threshold, the reliability results for all the PPT data at the T12 
paravertebral muscles, L5 paravertebral muscles and 1st dorsal interossei muscles 
were excellent (ICC 0.79–0.97). PPT at the paravertebral sites at the level of T12 
has not been used in previous research thus comparisons were difficult (Chapter 2, 
Table 2.2). The reliability of PPT at the left paravertebral site at the level of L5 and 
left 1st dorsal interossei muscles has been tested by Willett et al. (2010), who 
reported an ICC of 0.94 and 0.93 at these sites compared to 0.94 and 0.79 reported 
by this reliability study. However, their reliability measure was based on one set of 
measurements of three repetitions of PPT compared to three sets of measurements 
(each of three repetitions) used in this study.  
Using a convenience sample is considered a limitation in this reliability study, as our 
participants were asymptomatic volunteers who may not represent a normal patient 
population. However, it was important to use strict criteria in order to control for any 
confounding variables that might bias the values measured. Therefore, the 
advantages of recruiting asymptomatic participants might outweigh the 
disadvantages as utilising asymptomatic participants allowed for this strict control. 
Also, a mechanical algometer was used in this study whereby the pressure rate 
applied by the examiner could not be controlled. An electronic algometer where there 
is no reliance on the examiner reaction time is considered more accurate (Vaughan 
et al., 2007). 
In summary, the e-Health Sensor Shield, along with other equipment tested, is 
reliable and suitable for use in the next stage of the research to investigate the effects 
of mobilisation treatment on these variables in an asymptomatic population and 
NSCLBP patients. The following chapter assesses the effects of spinal mobilisation 
on these measurements in an asymptomatic population.  
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Chapter 6 
A single-arm trial investigating the neurophysiological responses of the 
sympathetic nervous system (SNS) to passive accessory mobilisations in 
an asymptomatic population 
6.1. Introduction  
Although spinal mobilisation has been shown to produce hypoalgesic and 
sympathetic responses, both local and remote, from the treated areas (Krowel et al., 
2010; Willett et al., 2010), no studies have established whether these effects occur 
when mobilising spinal levels that are remote from the treated level. Therefore, the 
purpose of this preclinical study was to provide empirical evidence of the 
neurophysiological effects (as measured by SNS activity and PPT) of the thoracic 
mobilisation technique where the lumbar spine is the targeted level. Another goal 
was to compare observed SNS and pain responses of the study’s participants and 
to compare and discuss these findings with those of previously conducted studies 
that used other mobilisation techniques. 
6.1.1. Research question 
What are the immediate and cumulative effects of thoracic mobilisation treatment on 
pain and sympathetic measures in an asymptomatic population? 
6.1.2. Objectives 
 To determine the neurophysiological responses of the SNS to thoracic 
mobilisations in an asymptomatic population. 
 To determine the extent of the hypoalgesic effect (thoracic, lumbar and 
systemic levels) resulting from thoracic mobilisation in an asymptomatic 
population. 
 To examine the possibility of a dose-dependent effect of thoracic mobilisation 
on sympathetic and PPT changes in an asymptomatic population. 
 To generate data to permit power calculations for the clinical study of 
NSCLBP patients. 
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6.2. Method 
6.2.1. Study design 
This was a single-arm repeated measure design. 
6.2.2. Ethics approval 
This study was approved by the Faculty of Health, Psychology and Social Care 
Research Ethics Committee (Appendix 6.1). 
6.2.3. Participants 
6.2.3.1. Power calculation 
Based on an intra-subject standard deviation of .07 from the reliability study (Chapter 
5) (Appendix 6.2), a power analysis calculation revealed that 14 participants would 
enable a difference in skin conductance values (primary outcome measure) from a 
baseline of 7.5% to be detected at a 5% significance level with 80% power (Rigby 
and Vail, 1998). 
𝑛 =
 2 ×  𝑆𝐷2
(𝑚𝑑)2
× 7.8 
𝑛 =
 2 × (0.07)2
(0.075)2
× 7.8 = 14 
A 7.5% skin conductance value change was selected as it represents a clinically 
significant difference that has been supported by the results of other studies (Perry 
and Green, 2008; Perry et al., 2015). 
Fourteen participants were recruited from among the students at Manchester 
Metropolitan University by placing a poster advertisement on the Facebook page of 
the Psychology, Health and Social Care department. Direct generation of interest in 
this study was achieved by attending lectures and seminars in the department to 
hand out information sheets with the researcher’s contact information. The lectures 
and seminars provided a setting in which the target population could be found 
(Section 6.2.3.2) and could be addressed directly as a group, rather than as 
individuals.  
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All volunteers who responded were interviewed by telephone to ascertain their 
appropriateness for the study. For those that agreed to participate, an information 
sheet was provided for their consideration prior to commencement of the data 
collection (Appendix 6.3). The researcher informed the participants of their right to 
withdraw at any time and they were asked to sign the consent form (Appendix 6.4). 
A screening assessment was performed on the day of the data collection to confirm 
that the participant’s status had not changed and that they had abstained from 
exercise and caffeine in the three hours prior to their appointment with the researcher 
and that they had refrained from consuming alcohol in the 24 hours prior to taking 
the measurements. 
6.2.3.2. Inclusion and exclusion criteria 
Potential participants were required to be healthy individuals aged between 18–55 
years, non-smokers, have an adequate understanding of the English language, able 
to provide informed consent for the study and be asymptomatic of spinal pain in the 
last six months. The upper limit of 55 years was used to reduce the possibility of 
recruiting individuals with spinal or lower limb degenerative changes that could 
potentially affect the outcome measures of the study (Snodgrass et al., 2014). In 
order to ensure that the extrapolation of the target population’s results was 
uninhibited, both male and female participants were recruited. 
Potential participants for this study were excluded if they had a history of back pain 
in the previous six months, had been diagnosed with a psychiatric or medical 
disorder that may have influenced their neurophysiological responses (e.g. 
rheumatoid arthritis, multiple sclerosis, diabetes and anxiety disorders), had 
previously had lower extremity or spinal surgery, been pregnant, had a previous 
history of trauma with related permanent sensation abnormality (dysaesthesia), had 
skin disorders at the location of the electrode placement, were dependent on alcohol, 
were smokers or were incapable of providing informed consent (e.g. as a result of 
dementia or limited English language skills) (Perry et al., 2015). 
Additionally, those with any contraindication, precautions to thoracic mobilisations 
(Grieve, 1991) were also excluded, which included: 
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•Bone disease of the spine (osteoporosis, osteopenia) 
•Active inflammatory and infective arthritis  
•Rheumatoid collagen necrosis of vertebral ligaments 
•Signs and symptoms of spinal cord involvement; or involvement of more than 
one spinal nerve root on one side, or two adjacent roots in one lower limb only 
•Cauda equina lesions producing disturbance of bladder and/or bowel function 
•Malignancy involving the vertebral column 
•The presence of neurological signs  
•Spondylolisthesis 
•Osteoporosis 
•Dizziness 
•Congenital generalised hypermobility (Ehlers-Danlos syndrome) 
•Advanced spinal or lower limbs degenerative changes 
•History of spinal or lower limbs steroid therapy 
•Ongoing Anticoagulant therapy 
6.2.4. Confidentiality 
Each participant was assigned an alphanumeric code upon entry into the study and 
all study data was labelled using the same code. All information recorded on paper, 
and any non-computerised data were stored in a locked cabinet in room T0.18 of the 
John Dalton West building at Manchester Metropolitan University. Computerised 
data were password protected and accessible only by the named investigators. 
6.2.5. Instrumentation and measurements 
6.2.5.1. Procedure 
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Participants presented at Manchester Metropolitan University on three occasions 
with a minimum interval of two days and a maximum interval of seven days to 
replicate clinical practice. Participants were asked to avoid eating, exercising and 
drinking any caffeine products for the three hours prior to the meeting and to refrain 
from alcohol intake for 24 hours prior to the meeting, as these are known 
confounding factors that might affect SNS activity (Wright and Vecenzino., 1995; 
McGuiness et al., 1997; Katzung, 2001).  
Visits 1, 2 and 3 
On each day of testing, the primary researcher provided a verbal explanation to 
participants about the testing procedure. They were also asked to sign a consent 
form. Subject height (m) and weight (kg) were measured using a standard medical 
scale (Kern, MPE 250K100HM). All data collection was performed in a temperature 
(22.2°C) - and noise-controlled environment and collected by the primary 
investigator.  
An overview of the study protocol is shown in Figure 6.1. Salivary alpha-amylase, 
blood pressure were measured at the beginning of the session. Participants were 
asked to partially undress the top half of the body; screens were used for privacy. 
They were then instructed to lie face down on an adjustable treatment plinth. The 
primary investigator introduced the treating researcher (a senior lecturer with 
experience in manual therapy) who located the target spinous process (T12). The 
methodology for the PPT measurement was similar to that used in chapter 5 (Section 
5.2.6). Then, measurements taken using the e-Health Sensor Shield V2.0 (heart 
rate, respiratory rate, skin conductance and skin temperature) were continuously 
recorded before, during and after the mobilisation technique. Similar to previous 
studies examining SNS responses, the participants had an initial 10-minute 
stabilisation period so their bodies could adjust to the environment (Vicenzino et al., 
1995; Chiu and Wright, 1996; Cleland et al., 2002; Perry and Green, 2008). The 
sensors were then activated, and measurements were taken over the next two 
minutes (pretreatment) (Perry and Green, 2008).The treating researcher returned to 
the testing room to perform the mobilisation technique and was allowed to adjust the 
plinth height to the appropriate specifications (hips level). 
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At the exact time the treating researcher started the mobilisation, the primary 
investigator initiated the data acquisition to record treatment phase measurements. 
The grade III technique was centrally applied postero-anterior (PA) to T12 for three 
sets of 60 sec with one-minute rest periods between sets. The treatment lasted for 
five minutes (Figure 6.2).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1. An illustration of the study protocol. 
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Figure 6.2. Central postero-anterior mobilisation technique (Physiopedia, 
2017). 
Following the implementation of the mobilisation technique, the primary investigator 
ended the recording of the treatment phase measurements. At this time, the treating 
researcher left the treatment room, and the primary investigator began a five minutes 
time count after the treatment. The posttreatment phase of recording started from 
the fourth minute of the five-minute period after treatment; it lasted for two minutes 
to measure the latent SNS responses to mobilisation while the participants were in 
a prone position. 
Next, the participants were informed when the recording of the posttreatment 
phase ended, and the electrodes were removed. 
Each participant produced three sets of data for respiratory rate, heart rate, skin 
temperature and skin conductance: 
 A two-minute period at baseline (pretreatment), 
 A five-minute intervention period (treatment) and 
 A two-minute final resting period (posttreatment). 
The laptop screen was turned in the opposite direction from the plinth where the 
participant was lying, and the treating researcher stood beside it. Thus, it was 
ensured that the participant and the treating researcher were blinded to the effect of 
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the mobilisation, thereby enhancing the internal validity of the study. In addition to 
this, all the mobilisation treatments were carried out by the same researcher to avoid 
any individual variations in terms of technique application.  
Finally, salivary alpha-amylase, blood pressure and pressure pain threshold were 
measured at the end of the session (Section 5.2.6). This order was selected in order 
to avoid any potential effects of one measurement on previous measurements. Each 
participant produced two sets of data for BP, PPT and sAA: one at the begining of 
the session and one at the end of the session. 
6.2.6. Data analysis 
The raw data for heart rate, respiratory rate, skin conductance and skin temperature 
were processed using custom written Mathematica code (version 10.4, Wolfram 
Research, Champaign, IL, USA). The software calculated the mean heart rate, 
respiratory rate, skin conductance and skin temperature of each minute throughout 
the session and the mean value (integral measurement) of each period 
(pretreatment, treatment and posttreatment). The pretreatment period consisted of 
two minutes following a stabilisation period of ten minutes. The treatment period 
consisted of the five minutes when the mobilisation was performed. The final two 
minutes of the five minutes posttreatment period were used for analysis. Therefore, 
for each visit, each participant had three values for the following outcome measures: 
skin conductance (right and left), skin temperature (right and left), heart rate and 
respiratory rate. For pressure pain threshold data, the mean of the three 
measurements was calculated for each site; thus, every participant had two scores 
for PPT at each site of measurement for each visit. For blood pressure and salivary 
alpha-amylase, each participant had two scores for each of the three visits. 
Descriptive statistics were calculated for all data using the Statistical Package for the 
Social Sciences (IBM SPSS Statistics V. 23; IBM Corp., Armonk, NY, USA). All data 
were tested for normality using the Shapiro-Wilk test. The effect of mobilisation was 
analysed using the two-way repeated measure analysis of variance (ANOVA). For 
blood pressure, salivary alpha-amylase and pressure pain threshold, the two 
independent variables were time, which had two levels (before and after 
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mobilisation), and visit, which had three levels (visit 1, visit 2 and visit 3). For heart 
rate, respiratory rate, skin conductance and skin temperature, the two independent 
variables were time, which had three levels (before, during and after mobilisation) 
and visit, which had three levels (visit 1, visit 2 and visit 3). As ANOVA is considered 
to be robust to minor deviation from normality (Agresti and Finaly, 2009), it was used 
when minor deviation from normality was evident. The departure from normality was 
assessed by histogram and normal Q-Q (quantile-quantile) plot to examine the 
shape of the distribution (Sabin and Stafford, 1990). Minor departure from normality 
was due to some minor outlier case in the lower end of the distribution (Sabin and 
Stafford, 1990). For major normality departure data (where the distribution is 
skewed), transformation was performed using square root or logarithmic 
transformation (Sabin and Stafford, 1990). All transformed data were rechecked for 
normality, and, where the deviations were not resolved, the Friedman test was used 
(the critical χ² (df = 2, p=0.05) = 5.99) or Wilcoxon signed-rank tests (Martin et al., 
1993). Wilcoxon signed-rank test conducted where there was two testing points (pre-
treatment and post-treatment), and Friedman test was conducted where there was 
more than two testing points (pretreatment, mobilisation and posttreatment). For 
multiple testing, a Bonferroni correction was applied, resulting in a critical level set 
at α < 0.017 (0.05/3). 
In order to compare our results with previous studies, differences in the mean of all 
physiological measures before and after mobilisation were presented as 
percentages of change. The percentage of change for all measures was calculated 
for the three visits using the following formula:  
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑜𝑠𝑡−𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
× 100  . 
In addition, the percentage of change for skin conductance, skin temperature, heart 
rate and respiratory rate, where measures were recorded during intervention, was 
also calculated using the following formula:  
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑𝑢𝑟𝑖𝑛𝑔−𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
× 100 . 
The calculations were repeated for each of the three visits. 
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6.3. Results  
A total of 14 participants (nine females and five males) participated in this study. The 
mean age of 33.22 years (SD= 5.34); the range was 25.48 to 43.76 years. Mean 
BMI was 26.55 kg/m2 (SD= 5.04), and BMI range was 18.56 to 39.16 kg/m2. All 
participants completed the study without reporting any adverse effects. There were 
no missing data from any visit. 
6.3.1. Results of mobilisation treatment on blood pressure 
There was a non-significant decrease in systolic blood pressure after mobilisation 
for the first and second visits compared to the baseline level with mean difference 
values of -0.07±12.7 mmHg and -0.07±8.5 mmHg (F(1, 13) =0.388, p= 0.544). A 
non-significant increase was evident in the third visit with a mean difference value of 
3.9±13.3 mmHg (Figure 6.3).  
 
Figure 6.3. Systolic blood pressure response at three visits. The data are 
medians. Error bars represent non-outlier range (n=14). 
There was a non-significant main effect of the visit day on systolic blood pressure, 
which indicated no difference among the three visits of treatment (F(2, 26) =0.960, 
p=0.396). The interaction between the time of measurement (before or after 
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mobilisation) and the visit day (1, 2 or 3) was not significant (F(2, 26) =0.591, 
p=0.561).  
For diastolic blood pressure, there was a significant increase after mobilisation 
compared to baseline values that was evident in all visits with mean difference 
values of 8.1±16.3 mmHg, 2.9±10 mmHg and 7.2±14.6 mmHg (F(1, 13) =6.349, 
p=0.026) (Figure 6.4). There was a non-significant main effect of the visit day on 
measurements of diastolic blood pressure (F(2, 26) =0.099, p=0.906). However, only 
changes within the first and third visits (8.07 mmHg, 7.2 mmHg) exceeded the MDC 
calculated in the reliability study (6.6 mmHg). The interaction between the time of 
measurement (before or after mobilisation) and the visit day (1, 2 or 3) was not 
significant (F(2, 26) =0.657, p=0.527). In order to compare the results with previous 
studies, the percentage of change in systolic BP and diastolic BP for the three visits 
were calculated and are displayed in Table 6.1. 
 
 
Figure 6.4. Diastolic blood pressure response at three visits. The data are 
medians. Error bars represent non-outlier range (n=14). 
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Table 6.1. Percentage (%) change in systolic and diastolic blood pressure at 
each visit. The data are means ± standard deviation (n=14). 
 Visit 1 Visit 2 Visit 3 
SPB 0.47±11.6 0.29±7.7 3.64±12 
DBP 11.58±24 4.04±13 10.78±18.1 
Abbreviations: SBP: systolic blood pressure; DBP: diastolic blood pressure. 
6.3.2. Results of mobilisation treatment on heart rate and respiratory rate 
For each visit, there was a significant increase in heart rate measurements during 
mobilisation treatment compared to baseline values with mean difference values of 
0.2±8.4 beat/minute, 7.8±10.2 beat/minute and 5.5±7.3 beat/minute (visits 1 to 3, 
respectively) (F(2, 26) =6.459, p=0.005).There was also a significant decrease in 
heart rate measurements during the final rest period within all visits compared to 
baseline values with mean difference values of -3.2±10.2 beat/minute, -0.4±11.2 
beat/minute and -1.5±9.7 beat/minute (Figure 6.5). 
 
 
Figure 6.5. Heart rate response at three visits. The data are medians. Error 
bars represent non-outlier range (n=14). 
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Bonferroni pairwise comparisons showed that this difference lies between baseline 
and mobilisation measurements (p=0.047) and between mobilisation and final rest 
period measurements (p=0.007). However, only the differences that occurred during 
the treatment period at the second (7.8 beat/minute) and third visits (5.5 beat/minute) 
exceeded the MDC reported in the reliability study (5.4 beat/minute). There was a 
non-significant main effect of the visit day on measurements of HR (F(2, 26) =1.145, 
p=0.334). The interaction between the time of measurement and the visit day (1, 2 
or 3) was not significant (F(4, 52) =1.915, p=0.122). 
For all visits, there was a significant increase in respiratory rate measurements 
during mobilisation treatment compared to baseline values with mean difference 
values of 3.6±4.3 breaths/minute, 6.1±6.8 breaths/minute and 6±4.3 breaths/minute 
(F(1.305, 16.961) =24.193, p= 0.001). Also, there was a significant decrease in 
respiratory rate measurements during the final rest period within all visits compared 
to mobilisation values. The mean difference values of respiratory rate measurements 
during the final rest period compare to baseline values were -0.04±3.5 
breath/minute, 0.3±1.8 breaths/minute and 0.2±4.5 breaths/minute (Figure 6.6). 
 
Figure 6.6. Respiratory rate response at three visits. The data are medians. 
Error bars represent non-outlier range (n=14). 
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For respiratory rate, there was a significant main effect the visit day on respiratory 
rate (F(2, 26) =13.360, p=0.001). Bonferroni pairwise comparisons showed a 
significant difference (increase) between baseline and mobilisation measurements 
(p=0.000) and between mobilisation and final rest period measurements (decrease) 
(p=0.001). Only the changes within the mobilisation period in relation to baseline 
measures within all visits (3.6 breaths/m, 6.1 breaths/m and 6 breaths/m) exceeded 
the MDC (1.6 breath/minute). 
Furthermore, post hoc analysis indicated a significant difference between the first 
and third visits (p=0.001) and between the second and third visits (p=0.003). The 
interaction between the time of measurement and the visit day was not significant 
(F(4, 52) =0.959, p=0.438). In order to compare our results with previous studies, 
differences in the mean of heart rate and respiratory rate measures before and after 
mobilisation were presented as percentages of change. The percentage of change 
for the three visits are displayed in Table 6.2. 
Table 6.2. Percentage of change (%) in heart rate and respiratory rate at each 
visit. The data are means ± standard deviation (n=14). 
  
Visit 1 
 
 
Visit 2 
 
 
Visit 3 
  
Baseline to 
treatment 
 
Baseline to 
final rest 
period 
 
Baseline to 
treatment 
 
Baseline to 
final rest 
period 
 
Baseline to 
treatment 
 
Baseline to 
final rest 
period 
 
HR 
0.74±12.2 -4.2±15.02 11.86±16 -0.20±17.2 8±10.7 -1.84±13.8 
 
RR 
23.6±31.03 1.5±19 35.9±42.4 1.63±11 31.58±26.9 1.54±23.04 
Abbreviations: HR: heart rate; RR: respiratory rate.  
6.3.3. Results of mobilisation treatment on skin conductance and skin 
temperature 
For the three visits, there was a non-significant change in skin conductance level 
(right side) with a slight decrease during the mobilisation period compared to the 
baseline level with mean difference values of -0.01±0.08 v, -0.01±0.05 v and -
0.04±0.1 v (Figure 6.7). For skin conductance level (left side), the results showed 
the same trend except for the first visit where there was a slight non-significant 
increase during the mobilisation period compared to the baseline level with a mean 
difference value of 0.004±0.06 v. Skin conductance level for both sides tended to 
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non-significantly increase during the final rest period compared to the treatment 
period (Figure 6.8) (Table 6.3).  
For the three visits, the skin temperature results showed that there was a non-
significant change in skin temperature level (both side) with values tending to 
increase or decrease slightly during the mobilisation period compared to the baseline 
level with mean difference values ranged between -0.07±0.3°C and 0.03±0.5°C. 
However, the skin temperature level for both sides tended to return to their baseline 
values during the final rest period (Figure 6.9 and 6.10) (Table 6.3). 
 
Figure 6.7. Right skin conductance response at three visits. The data are 
medians. Error bars represent non-outlier range (n=14). 
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Figure 6.8. Left skin conductance response at three visits. The data are 
medians. Error bars represent non-outlier range (n=14). 
 
Figure 6.9. Right skin temperature response at three visits. The data are 
medians. Error bars represent non-outlier range (n=14). 
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Figure 6.10. Left skin temperature response at three visits. The data are 
medians. Error bars represent non-outlier range (n=14). 
In order to compare the results with previous studies, differences in the mean of skin 
conductance and skin temperature measures before and after mobilisation were 
presented as percentages of change. The percentage of change for the three visits 
are displayed in Table 6.4. 
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Table 6.3. Results of skin conductance (v) and skin temperature (°C) including mean values before, during and after 
mobilisation, chi-square and p values from the Friedman test. The data are means ± standard deviation (n=14). 
 Visit 1 Visit 2 Visit 3  
 
Outcome 
measure 
 
PRE 
 
MOB 
 
POST 
 
Chi-
square 
 
p 
 
PRE 
 
MOB 
 
POST 
 
Chi-
square 
 
p 
 
PRE 
 
MOB 
 
POST 
 
Chi-
square 
 
p 
 
RT SC 
 
-.35±.3 
 
-.36±.3 
 
-.35±.3 
 
 
2.7 
 
.26 
 
-.19±.1 
 
-.21±.2 
 
-.21±.2 
 
 
.143 
 
.93 
 
-.24±.1 
 
-.28±.2 
 
-.26±.2 
 
 
.571 
 
.75 
 
LT SC 
 
-.38±.3 
 
-.37±.3 
 
-.35±.3 
 
 
2.286 
 
.32 
 
-.23±.2 
 
-.23±.2 
 
-.23±.2 
 
 
1.286 
 
.53 
 
-.22±.1 
 
-.27±.2 
 
-.26±.2 
 
 
2.714 
 
.26 
 
RT ST 
 
 
28.4±3.1 
 
28.3±3.2 
 
28.3±3.3 
 
2.714 
 
.26 
 
28.9±3.1 
 
29.01±3.1 
 
28.9±3.1 
 
4.429 
 
.11 
 
28.7±3.1 
 
28.6±3.1 
 
28.6±3.1 
 
3.571 
 
.17 
 
LT ST 
 
 
28.2±2.7 
 
28.1±2.8 
 
28.2±2.9 
 
.143 
 
.93 
 
28.7±2.6 
 
28.8±2.7 
 
28.7±2.7 
 
2.714 
 
.26 
 
28.6±3 
 
28.7±3.1 
 
28.6±3.1 
 
4.429 
 
.11 
Abbreviations: RT SC: right skin conductance; LT SC: left skin conductance; RT ST: right skin temperature; LT ST: left skin temperature.
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Table 6.4. Percentage (%) of change in skin conductance and skin temperature (right and left sides) for each visit. The 
data are means ± standard deviation (n=14). 
  
Visit 1 
 
Visit 2 
 
Visit 3 
  
Baseline to treatment 
 
Baseline to final rest 
period 
 
Baseline to treatment 
 
Baseline to final rest 
period 
 
Baseline to treatment 
 
Baseline to final rest 
period 
 
RT SC 
 
10.04±38.12 
 
-1.2±26.5 
 
-9.51±61.5 
 
0.62±49.8 
 
14.22±38.2 
 
12.05±36.4 
 
LT SC 
 
4.5±32.8 
 
-3±41.7 
 
-2.9±41.5 
 
8.24±33.6 
 
13.75±28.15 
 
18.06±36.14 
 
RT ST 
 
-0.4±1.2 
 
 
-0.11±1.8 
 
0.1±1.7 
 
0.04±3 
 
-0.23±0.9 
 
-0.2±1.9 
 
LT ST 
 
-0.2±1.2 
 
 
0.02±1.8 
 
0.3±2.1 
 
-0.13±3.4 
 
0.06±1.8 
 
-0.2±2.5 
Abbreviations: RT SC: right skin conductance; LT SC: left skin conductance; RT ST: right skin temperature; LT ST: left skin temperature
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6.3.4. Results of mobilisation on pressure pain thresholds 
At all locations of PPT, values after mobilisation exceeded baseline measurements 
(Figure 6.11). There was a non-significant trend toward an increase in PPT 
measurements that was evident at all measurement sites within all visits with mean 
difference values ranged between 0.5±5.2 N/cm2 and 5.8±9.9 N/cm2 except at the 
right 1st dorsal interosseous muscle (F(1,13)= 6.800,p=0.022) with the difference in 
mean calculated to be 2.33 N/cm2 and 3.02 N/cm2 which did not exceed the MDC 
5.9 N/cm2 reported in the reliability study (Table 6.5) (Table 6.6). 
Table 6.5. Mean differences (N/cm2) in pressure pain threshold for all the 
sites of measurement at each visit. The data are means ± standard deviation 
(n=14). 
 
Outcome 
measure 
 
Visit 1 
 
Visit 2 
 
Visit 3 
 
RT T12 
 
 
1.5±9.9 
 
1.5±7.3 
 
1.8±9 
 
LT T12 
 
 
3.8±6.6 
 
3.5±7.8 
 
1.6±11.03 
 
RT L5 
 
 
1.7±11.4 
 
2.3±7.3 
 
1.2±7.5 
 
LT L5 
 
 
2.4±10.5 
 
1.3±8.9 
 
5.8±9.9 
 
RT 1stDI 
 
 
1.7±3.8 
 
1.4±3.4 
 
2.3±3.3 
 
LT 1stDI 
 
 
0.6±5.2 
 
1.62±4.4 
 
3.02±3.9 
Abbreviations: RTL5: right 5th lumbar para-spinal muscles; LTL5: left 5th lumbar para-spinal muscles; 
RTT12: right 12th thoracic para-spinal muscles; LTT12: left 12th thoracic para-spinal muscles; 
RT1STDI: right first dorsal interosseous muscle; LT1STDI: left first dorsal interosseous muscle. 
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Pressure pain threshold of right thoracic paraspinal 
muscles (N/cm2) 
Pressure pain threshold of left thoracic paraspinal 
muscles (N/cm2) 
  
Pressure pain threshold of right lumbar paraspinal 
muscles (N/cm2) 
Pressure pain threshold of left lumbar paraspinal 
muscles (N/cm2) 
 
 
Pressure pain threshold of right 1st dorsl interosseous 
muscle (N/cm2) 
Pressure pain threshold of left 1st dorsal interosseous 
muscle (N/cm2) 
Figure 6.11. Pressure pain threshold response of all sites of measurements at three 
visits. The data are medians. Error bars represent non-
outlier range (n=14). 
 
 Pretreatment 
 Posttreatment 
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There was a significant main effect of the visit day on PPT at three sites (right L5, 
left L5 and right T12). Bonferroni pairwise comparisons showed that these 
differences were between the second and third visits for the right (p=0.01) and left 
L5 sites (p=0.04) and between the first and third visits (p=0.025) and the second and 
third visits (p=0.003) for right T12 site. The interaction between the time of 
measurement and the visit day (1, 2 or 3) was not significant across all the of 
measurement sites. In order to compare my results with previous studies, 
differences in the mean of PPT before and after mobilisation were presented as 
percentages of change (Table 6.7). 
 
Table 6.6. Two-way ANOVA results of pressure pain threshold for all sites of 
measurements (n=14). 
  
RT T12 
 
LT T12 
 
RT L5 
 
LT L5 
 
RT 1ST DI 
 
LT 1ST DI 
 
Time 
 
 
F(1,13)= 0.775, 
p=0.395 
 
F(1,13)
= 3.210, 
p=0.096 
 
F(1,13)= 
1.021, 
p=0.331 
 
F(1,13)= 
2.234, 
p=0.159 
 
F(1,13)= 
6.800, 
p=0.022* 
 
F(1,13)= 2.651, 
p =0.127 
 
Visit 
 
 
F(2,26)= 6.514, 
p=0.005* 
 
F(2,26)
= 3.116, 
p=0.061 
 
F(2,26)=3.813
, 
p =0.035* 
 
F(2,26)=4.291
, 
p=0.025* 
 
F(2,26)=3.005
, 
p=0.067 
 
F(1.388,18.047)=1.46
1, 
p=0.250 
 
Visit * 
Time 
 
 
F(1.386,18.022)=0.
008, 
p=0.971 
 
F(2,26)
= .376, 
p=0.690 
 
F(2,26)=0.069
, 
P=0.933 
 
F(2,26)= 
1.603, 
p=0.220 
 
F(2,26)= 
0.378, 
p=0.689 
 
F(1.306,16.975)=2.79
5, 
p=0.105 
Abbreviations: RTL: right lumbar para-spinal muscles; LTL: left lumbar para-spinal muscles; RTT12: 
right 12th thoracic para-spinal muscles; LTT12: left 12th thoracic para-spinal muscles; RT1STDI: right 
first dorsal interosseous muscle; LT1STDI: left first dorsal interosseous muscle. 
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Table 6.7. Percentage of change (%) in pressure pain threshold for all the 
sites of measurement at each visit. The data are means ± standard deviation 
(n=14). 
 
Outcome 
measure 
 
Visit 1 
 
Visit 2 
 
Visit 3 
 
RT T12 
 
 
3.1±18.4 
 
2.8±15.1 
 
3.7±17 
 
LT T12 
 
 
8.1±12.6 
 
6.4±14.7 
 
2.9±18.6 
 
RT L5 
 
 
5.9±25.9 
 
4.1±15.1 
 
2.9±14.6 
 
LT L5 
 
 
7.8±25.02 
 
2.6±19.4 
 
10.5±17.9 
 
RT 1stDI 
 
 
6.3±14.9 
 
4.8±12.1 
 
7.4±12.4 
 
LT 1stDI 
 
 
4.7±14.9 
 
6.6±15.1 
 
10.8±15.1 
Abbreviations: RTL: right lumbar para-spinal muscles; LTL: left lumbar para-spinal muscles; RTT12: 
right 12th thoracic para-spinal muscles; LTT12: left 12th thoracic para-spinal muscles; RT1STDI: right 
first dorsal interosseous muscle; LT1STDI: left first dorsal interosseous muscle. 
6.3.5. Results of mobilisation on salivary alpha-amylase  
The results indicated a significant increase between pre and post mobilisation values 
within the first visit with a mean difference value of 12.03±20.7 U/m (z= -2.2, p= 
0.03). However, this significant change (12.02 U/m) did not exceed the MDC 
calculated in the reliability study (23 U/m). There was a non-significant decrease 
within the second and third visits level with mean difference value of -7.9±13.6 U/m 
and -1.5±19.9 U/m (z= -1.8, p= 0.079; z= -0.22, p =0.83) (Figure 6.12). Differences 
in the mean of salivary alpha-amylase before and after mobilisation were presented 
as percentages of change and are displayed in Table 6.8. 
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Figure 6.12. Salivary alpha-amylase response at three visits. The data are 
medians. Error bars represent non-outlier range (n=14). 
Table 6.8. Percentage of change (%) in salivary alpha-amylase at each visit. 
The data are means ± standard deviation (n=14). 
 
sAA 
Visit 1 Visit 2 Visit 3 
109.3±126.4 -0.7±54.2 -1.6±60.6 
Abbreviation: sAA: salivary alpha-amylase.  
6.3.6. Summary of findings 
 There was an increase in diastolic blood pressure after mobilisation. 
However, only differences within the first and third visits for diastolic blood 
pressure were significant and exceeded the MDC (6.65 mmHg). Differences 
were not significant between visits. 
 There was an increase in heart rate and respiratory rate measurements 
during mobilisation treatment that decreased during the final rest period 
measurements within all visits. This increase was significant within all visits 
for respiratory rate and within the second and third visits for heart rate 
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measurements that also exceeded the MDC (5.45 beat/minute, 1.59 
breath/minute). Differences between visits were significant only between the 
first and third visits.  
 The increase in pressure pain threshold was evident at all measurement sites 
within all visits. There was a significant difference in PPT measurements at 
the hand, left lumbar para-spinal muscles (within the third visit) and the left 
thoracic para-spinal muscles (within the first visit). However, the changes 
failed to exceed the MDC reported in the reliability study (right hand: 6.4 
N/cm2, left hand: 4.1 N/cm2, left lumbar: 9.1 N/cm2; left thoracic: 9.7 N/cm2).  
 There was a non-significant difference in skin conductance and skin 
temperature measurements within or between the three visits. 
 There was an increase in mean salivary alpha-amylase after mobilisation 
within the first visit, but that decreased within the second and third visits. 
Although the difference within the first visit was significant, it did not exceed 
the MDC (22.99 Unit/minute).  
6.4. Discussion  
6.4.1. The effects of mobilisation treatment on measures of SNS  
6.4.1.1. Blood pressure, respiratory rate and heart rate 
The results demonstrated an increase in heart rate and respiratory rate 
measurements during mobilisation treatment that decreased during the final rest 
period measurements within all visits. This result was significant within all visits for 
respiratory rate and within the second and third visits for heart rate measurements. 
All these differences exceeded the MDC reported by the reliability study indicating 
that the results are clinically significant. There was an increase in diastolic blood 
pressure after mobilisation, but only differences within the first and third visits were 
significant. 
These results are similar to findings from other studies that reported increased heart 
rate, respiratory rate and/or blood pressure following cervical mobilisation (Petersen 
et al., 1993; Vicenzino et al., 1995; Wright, 1995; McGuiness et al., 1997). The 
authors suggested this was due to the descending pain inhibitory pathways from 
143 
 
dPAG in the midbrain. Another proposal by those authors for the resultant 
sympathoexcitatory response following mobilisation treatment was direct stimulation 
to the cervical ganglia and sympathetic fibres as they are located close to the cervical 
level treated (C5/6). These ganglia connect with organs like the heart through 
postganglionic fibres. Performing pressure to the neck might cause an increase or 
decrease to the carotid baroreceptors’ function. This can affect heart rate and 
peripheral vascular resistance (Thoren and Lundin, 1983). However, on both sides 
of the spine, the sympathetic trunk extends parallel to the spine and might be moved 
during mobilisation, thus causing stimulation of ganglia along the trunk (Butler 1991).  
6.4.1.2. Skin conductance and skin temperature 
There was a non-significant difference in skin conductance and skin temperature 
measurements within or between the three visits. Supporting results have been 
reported by Chiu and Wright (1998), who found no significant sympathetic change 
in skin conductance or skin temperature following cervical mobilisation. The authors 
attributed this to the slow rate of mobilisation and the small sample size of the study 
(n = 16). On the other hand, a number of studies have reported significant 
sympathoexcitation in skin conductance and/or skin temperature as evidence of the 
descending inhibitory mediated response of the dorsal periaqueductal gray (dPAG) 
following cervical mobilisation (Peterson et al., 1993; Chiu and Wright et al., 1996; 
Sterling et al., 2001; La Touche et al., 2012), thoracic mobilisation (Cleland et al., 
2004; Jowsey and Perry, 2010) and lumbar mobilisation (Perry and Green, 2008; 
Piekarz and Perry, 2016). The difference in the responses following mobilisation to 
different levels of the spine might be due to the different peripheral coetaneous 
innervations or central processing systems for different regions (Perry at al. 2015). 
However, due to the small sample size in the preclinical study of this thesis (n=14), 
the results should be interpreted with caution.  
 
6.4.1.3. Salivary alpha-amylase 
There was an increase in mean sAA after mobilisation within the first visit, but that 
decreased within the second and third visits. Although the difference within the first 
visit was significant, it did not exceed the MDC. It was hypothesised that thoracic 
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manipulative treatment has the ability to modulate the sympathetic activity by 
activating the thoracic sympathetic chain ganglia that might cause initial sympathetic 
stimulation that is followed by a prolonged reduction of sympathetic outflow (Wallace 
et al., 2003). Thus, as samples were collected 10 minutes after the mobilisation, it 
might be suggested that the initial increase in the sAA within the second and third 
visits was transient. 
6.4.2. The effects of mobilisation treatment on pressure pain threshold 
The mechanical PPT of the thoracic level was significantly increased following 
thoracic mobilisation by 8.1% within the first visit. This local hypoalgesic response 
to spinal mobilisation might be explained by the local stimulation of the low threshold 
mechanoreceptors in articular and peri-articular structures following thoracic 
mobilisation that might inhibit the small diameter, high threshold mechanoreceptors 
at the level of spine that result in pain modulation in the dorsal horn of the spinal 
cord (Melzack and Wall, 1965). Zusman (1986) questioned this preferential ability 
and argued that the proposed hypoalgesic responses of spinal mobilisation might be 
the result of the suggested ability of the repetitive movement during the application 
of mobilisation to decrease activity of joint afferents. This might explained other 
significant increase that was recorded over the lumbar level of 10.5% within the third 
visit. The pathway emerging from PAG is another possible mechanism as 
widespread hypoalgesia was demonstrated as occurring away from the treated area 
distally over the hands of 7.4% and 10.8%. 
This widespread effect of thoracic mobilisation on PPT was shown by other 
investigations that reported a hypoalgesic effect distal to the area of mobilisation and 
that supported the concept that response to mobilisation is not specific or local to 
the treatment area (Vicenzino et al., 1996; Moss et al., 2007; Krouwel et al., 2010; 
Willett et al., 2010; Pentelka et al., 2012). The hypoalgesic response recorded in 
asymptomatic subjects might suggest the ability of mobilisation to produce 
hypoalgesia where pain and dysfunction are absent (Willett et al., 2010). However, 
this significant hypoalgesic response was not evident in all locations at all visits. All 
statistically significant percentages of change exceeded neither the MDC values 
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calculated in the reliability study for each measurement site, nor the clinically 
significant change of 15% reported by Moss et al. (2007). 
6.5. Limitations of the study  
As a result of being a single-arm study, no control or placebo groups were used 
which would have been essential to thoroughly investigate the effectiveness of 
mobilisation treatment. However, previous studies have examined this effect using 
placebo controlled or controlled studies (Vicenzino et al., 1996; Sterling et al., 2001; 
Moss et al., 2007). Furthermore, looking at the effectiveness of mobilisation as a 
treatment form was not the aim of this study. The intra-therapist reliability for 
performing consistent mobilisation techniques was not tested before conducting this 
study, and the results of this research are limited to the short-term effects following 
the application of three mobilisation treatments. Furthermore, as physical 
assessment was not part of this phase of the study, physiological measurements in 
normal participants may have been affected if they had an asymptomatic 
dysfunctional component of their neuro-musculoskeletal system. However, 
conducting this preclinical study generated data used for the power analysis for the 
clinical study which minimised the risk of type I and type II errors (the study being 
underpowered or needing to recruit more samples). The effect of extraneous 
variables has been reduced by using strict criteria for inclusion and exclusion. In 
addition, the influence of diurnal variation has been controlled by determining similar 
appointment times for all visits of each participant. 
6.6. Conclusion  
The purpose of this preclinical study was to provide empirical evidence of the 
neurophysiological effects (as measured by SNS activity and PPT) of the thoracic 
mobilisation technique of the lumbar spine in asymptomatic subjects over a course 
of three doses. These findings revealed significant sympathoexcitatory effects in 
terms of blood pressure, heart rate and respiratory rate where there were non-
significant results for peripheral sympathetic measures (skin conductance and skin 
temperature). Significant hypoalgesic effects were evident in some locations, 
including distal areas, but not at all visits. The next stage of the thesis was therefore 
to examine the effects of mobilisation treatment on hypoalgesia and sympathetic 
146 
 
activity in patients with nonspecific chronic low back pain over a course of three 
doses of mobilisation treatment and is detailed in the following Chapter. 
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Chapter 7 
A single-arm clinical trial investigating the neurophysiological responses 
of the sympathetic nervous system to passive accessory mobilisations 
in a symptomatic population with nonspecific chronic low back pain 
7.1. Introduction  
Although clinical research supports the patient-reported benefits of mobilisation 
treatment in the management of nonspecific chronic low back pain (NSCLBP), the 
neurophysiological mechanisms behind these effects within patient populations 
remain unknown (Sparkers, 2005). A number of studies have explored sympathetic 
responses as a measure of the neurophysiological response of various mobilisation 
treatment techniques in the cervical, thoracic and lumbar spinal levels, as well as in 
the upper and lower limbs (Peterson et al., 1993; Vicenzino et al., 1995; Sterling et 
al., 2001; Perry and Green, 2008; Jowsey and Perry, 2010). The results reported 
various sympathetic changes among cardiopulmonary, sudomotor and cutaneous 
vasomotor functions (Peterson et al., 1993; Chiu and Wright, 1996; Vicenzino et al., 
1998; Sterling et al., 2001). Their findings reinforce the proposed sympathetic 
mechanism behind the efficacy of the application of spinal mobilisation techniques. 
However, among these studies, only a limited number involved a symptomatic 
population that reported on symptoms only in the cervical and thoracic levels and 
not in the lumbar level. 
As stated in Chapter 3 and summarised in Table 3.3 there have been no clinical 
studies investigating the neurophysiological responses to spinal mobilisation 
treatment using a lower back pain (LBP) patient population. Although patient-
reported outcome measures can be used by physiotherapists to assess the pain and 
functional responses of their patients to the prescribed treatment, to date, there is 
no non-invasive measure available to assess the physiological response. Thus, the 
aim of this study was to observe, in a clinical population with NSCLBP, the immediate 
and cumulative neurophysiological responses of the SNS to mobilisation treatment, 
as it is one of the most commonly utilised physiotherapy treatments in the 
management of NSCLBP. Another aim was to determine if there is a correlation 
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between these neurophysiological responses and patient-reported outcome 
measures.  
7.1.1. Research question 
What are the immediate and cumulative effects of thoracic mobilisation treatment on 
hypoalgesic and sympathetic measures in patients with NSCLBP? 
7.1.2. Objectives 
-To determine the neurophysiological responses of the SNS to thoracic mobilisations 
in a symptomatic population with NSCLPB. 
-To determine the extent of the hypoalgesic effect (thoracic, lumbar and systemic 
levels) resulting from thoracic mobilisation in a symptomatic population with 
NSCLPB. 
-To examine the possibility of a dose-dependent effect of thoracic mobilisation on 
sympathetic and PPT changes in a symptomatic population with NSCLPB. 
-To establish whether there is a correlation between Numeric Pain Rating Scale 
(NPRS) changes and PPT changes after thoracic mobilisation in a symptomatic 
population with NSCLPB.  
7.2. Method 
7.2.1. Study design 
This study utilised a single-arm clinical trial.  
7.2.2. Ethics approval 
This study was approved by the Faculty of Health, Psychology and Social Care 
Research Ethics Committee at Manchester Metropolitan University (Appendix 7.1). 
In addition, as this study was conducted at King Fahad University Hospital (KFUH) 
in eastern Saudi Arabia, approval was obtained from the research committee of the 
University of Dammam (Appendix 7.2). The head of the Physical Therapy 
department at the university hospital also reviewed the protocol and gave signed 
permission for the research to be conducted within the department on patients 
referred for LBP physiotherapy treatment (Appendix 7.3).  
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7.2.3. Participants 
7.2.3.1. Sample size calculation 
Based on the mean change presented in chapter 6, between visits 1 and 2 (Appendix 
7.4) (15% mean change in SC; 21% standard deviation), a sample size calculation 
revealed that 31 participants would be needed to see a difference in skin 
conductance values (primary outcome measure) from a baseline of 15%, at the 5% 
significance level with 80% power (Sim and Wright, 2005). Taking into account a 
20% anticipated dropout rate, 37 participants were needed to offset possible loss to 
follow-up (Sim and Wright, 2005). 
7.2.3.2. Patient recruitment 
A purposive convenience sample was recruited for this study. Patients with non-
specific chronic low back pain (NSCLBP) diagnosed and referred by the orthopaedic 
physicians to the physical therapy department were screened for eligibility criteria 
from October 2016 to February 2017 (n = 64). In the current study, NSLBP was 
defined as lumbar pain with or without referred pain provoked by posture, movement 
and/or palpation of the lumbar musculature. Inclusion criteria were the following: LBP 
symptoms of a mechanical, nociceptive nature (NSLBP), a history of NSLBP of 
insidious onset of more than 12 weeks duration, an age from 18 to 55 years, non-
smoker, male or female gender, possession of an adequate understanding of the 
Arabic language and the ability to provide informed consent for the study. In order 
to ensure that the results extrapolation to the target population, both male and 
female were recruited. 
Potential participants for this study were excluded (n = 28) if they had undergone 
physiotherapy treatment within the previous six months. Additionally, participants 
were excluded if they had been diagnosed with a psychiatric or medical disorder that 
may have influenced their neurophysiological responses (e.g. rheumatoid arthritis, 
multiple sclerosis, diabetes and anxiety disorders), had previously had lower 
extremity or spinal surgery, been pregnant, had a previous history of trauma with 
related permanent sensation abnormality (dysaesthesia), had skin disorders at the 
location of the electrode placement, were dependent on alcohol, were smokers or 
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were incapable of providing informed consent (e.g. as a result of dementia or limited 
Arabic language skills) (Perry et al., 2015). 
Excluded were also those with any contraindication, precautions or red flags to 
thoracic mobilisations (Grieve, 1991): 
•Malignancy involving the vertebral column 
•Cauda equina lesions producing disturbance of bladder and/or bowel function 
•Signs and symptoms of spinal cord involvement; or involvement of more than one 
spinal nerve root on one side, or two adjacent roots in one lower limb only 
•Rheumatoid collagen necrosis of vertebral ligaments 
•Active inflammatory and infective arthritis  
•Bone disease of the spine (osteoporosis, osteopenia) 
Precautions to thoracic mobilisations (Grieve, 1991): 
•The presence of neurological signs  
•Osteoporosis 
•Spondylolisthesis 
•Dizziness 
•Congenital generalised hypermobility (Ehlers-Danlos syndrome) 
•Advanced spinal or lower limbs degenerative changes 
•History of spinal or lower limbs steroid therapy 
•Ongoing anticoagulant therapy 
Red flags to mobilisations (CSAG, 1994) 
 Age of onset <20 or >55 years 
 Violent trauma, e.g. fall from a height, road traffic accident 
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 Constant progressive, non-mechanical pain 
 Thoracic pain 
 Past medical history of carcinoma 
 Systemic steroids 
 Drug abuse, HIV 
 Systematically unwell 
 Weight loss 
 Persistent severe restriction of lumbar flexion 
 Widespread neurology 
 Structural deformity 
7.2.4. Confidentiality 
Each participant was assigned an alphanumeric code upon entry to the study, and 
all study data were labelled using the same code. All written information on paper or 
any non-computerised data was stored in a locked cabinet. All electronic data 
recorded by the e-Health Sensor Shield for Arduino were anonymised and secured 
in a locked cabinet within the hospital department. Computerised data were 
password protected and accessible only to the named investigators. 
7.2.5. Research approach and methods 
7.2.5.1. Procedure 
The majority of the appointments were scheduled at least a month after the referral 
date. All potential participants were seen by the primary investigator who explained 
the study and their right to withdraw from it at any time and that this would not deny 
them the usual physical therapy treatment. In addition to the verbal explanation, 
participants were given the opportunity to ask questions. Patients who agreed to 
participate were assessed for their eligibility for inclusion in the study on the same 
day. In addition, the primary investigator asked for their permission to access their 
medical record file in order to confirm their eligibility. If they were deemed eligible, 
they were given a patient information sheet (Appendix 7.5). A cooling off period of 
48 hours was allowed between the initial assessment and data collection for 
participants’ consideration of the information provided. If they still wished to 
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participate a consent form was signed on the day of data collection (Appendix 7.6). 
Then they were given three appointments with a minimum interval of two days and 
a maximum interval of seven days.  
The initial assessment was the same as the standard physiotherapy examination. 
The standard subjective assessment was completed, including demographic 
information (age, gender, occupation and social status), current and past 
medications and past medical history. In addition, information about their symptoms, 
including location, distribution, onset, duration, nature of the symptoms, were 
documented, as well as their functional limitations and pain intensity using the 
NPRS. Physical examination included lumbar and lumbopelvic examinations, 
neurological conductance assessment (reflexes, myotomes and dermatomes), 
neurodynamic assessment (straight leg raise test, femoral nerve test and slump test) 
and palpation of lumbar segmental motion (Freburger and Riddle, 2001; Maitland et 
al., 2005; Shacklock, 2005).  
All participants signed a consent form prior to data collection. The exact procedure 
that was used in chapter 6 was also used this chapter. Each participant presented 
to the Physical Therapy Department at KFUH on three occasions. All participants 
completed their three visits while they were on the waiting list, thus ensuring that the 
effect of spinal mobilisation was not mixed with that of other types of treatment during 
that period. All treatments and data collection were performed in the same area in 
order to decrease any environmental variance. 
Visits 1, 2 and 3 
The salivary alpha-amylase, blood pressure and pressure pain threshold were 
measured at the beginning of session. Then, measurements taken using the e-
Health Sensor Shield V2.0 were continuously recorded before, during and after the 
mobilisation technique. Finally, salivary alpha-amylase, blood pressure and 
pressure pain threshold were measured at the end of the session. This order was 
selected to avoid any potential effects from each measurement on the previous 
measurements. 
One more outcome measure which was not used in phase 2 was used in this phase. 
Participants were asked to verbally rate their pain after PA force applied to their 
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symptomatic lumbar level on an 11-point Numerical Pain Rating Scale (NPRS) 
before and after the mobilisation treatment. An overview of the study protocol is 
shown in Figure 7.1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1. An illustration of the study protocol for each of the three visits. 
 
Each participant produced two sets of data for NRPS, blood pressure, pressure pain 
threshold and salivary alpha-amylase: one at the beginning and end of each session. 
Each participant produced three sets of data for respiratory rate, heart rate, skin 
temperature and skin conductance: 
 
10 minutes pre 
test period 
Blood pressure 
Salivary alpha-
amylase 
(collection of 
saliva samples) 
 
 
 
Numerical pain 
rating scale 
Pressure pain 
threshold (six 
sites), 3 
repetitions, 30 
seconds apart 
 
Herat rate, respiratory 
rate, skin conductance 
and skin temperature 
10-minute stabilisation 
period 
Two-minute period at 
baseline 
Five-minute intervention 
period  
Two-minute final resting 
period (posttreatment) 
Numerical pain 
rating scale 
Pressure pain 
threshold (six 
sites), 3 
repetitions, 30 
seconds apart 
 
Blood pressure 
Salivary alpha-
amylase (collection 
of saliva samples) 
 
 
 
 
45-60 minutes 
3-5 minutes  5-10 minutes 25-30 minutes 5-10 minutes 3-5 minutes 
154 
 
 A two-minute period at baseline (pretreatment), 
 A five-minute intervention period (treatment) and 
 A two-minute final resting period (post-treatment). 
Due to hospital policy, two physiotherapists applied the mobilisation technique. A 
male therapist applied the treatment for the male patients; a female therapist applied 
the technique for the female patients. Both physiotherapists had MSc degrees in 
musculoskeletal physiotherapy and 10 years of experience in manual therapy. 
However, standardisation of mobilisation technique was attempted to insure that 
each patient receive the same amount of force. This was done by demonstrating the 
technique on colleagues, who rated the amount of force they felt on their lumbar 
area. Several applications were performed until each colleague confirmed that the 
identical amount of force had been applied. 
All the measurements for all patients were taken by the primary investigator. Patients 
were scheduled at the same diurnal times for the three visits in an attempt to 
enhance patients’ compliance and decrease measurement variations. The analysis 
of data was conducted when all patients finished all their visits in order to blind the 
primary researcher to any responses through data collection. All patients received 
advice to stay active and return to work. At the end of the study, all patients had the 
opportunity to ask questions about the effects of the mobilisation treatment on their 
pain and neurophysiological status.  
7.2.6. Data analysis 
The raw data for heart rate, respiratory rate, skin conductance and skin temperature 
were processed using custom written Mathematica code (version 10.4, Wolfram 
Research, Champaign, IL, USA). The software calculated the mean heart rate, 
respiratory rate, skin conductance and skin temperature of each minute throughout 
the session and the mean value (integral measurement) of each period 
(pretreatment, treatment and posttreatment). The pretreatment period consisted of 
two minutes following a stabilisation period of ten minutes. The treatment period 
consisted of the five minutes when the mobilisation was performed. The final two 
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minutes of the five minutes posttreatment period were used for analysis. Therefore, 
for each visit, each participant had three values for the following outcome measures: 
skin conductance (right and left), skin temperature (right and left), heart rate and 
respiratory rate. For pressure pain threshold data, the mean of the three 
measurements was calculated for each site; thus, every participant had two scores 
for pressure pain threshold at each site of measurement for each visit. For blood 
pressure and salivary alpha-amylase, each participant had two scores for each of 
the three visits. 
Descriptive statistics were calculated for all data using the Statistical Package for 
the Social Sciences (IBM SPSS Statistics V. 23; IBM Corp., Armonk, NY, USA). All 
data were tested for normality using the Shapiro-Wilk test. The effect of mobilisation 
was analysed using the two-way repeated measure analysis of variance (ANOVA). 
For blood pressure, salivary alpha-amylase and pressure pain threshold, the two 
independent variables were time, which had two levels (before and after 
mobilisation), and visit, which had three levels (visit 1, visit2 and visit 3). For heart 
rate, respiratory rate, skin conductance and skin temperature, the two independent 
variables were time, which had three levels (before, during and after mobilisation) 
and visit, which had three levels (visit 1, visit 2 and visit 3). As ANOVA is considered 
to be robust to minor deviation from normality (Agresti and Finaly, 2009), it was used 
when minor deviation from normality was evident. The departure from normality was 
assessed by histogram and normal Q-Q (quantile-quantile) plot to examine the 
shape of the distribution (Sabin and Stafford, 1990). Minor departure from normality 
was due to some minor outlier case in the lower end of the distribution (Sabin and 
Stafford, 1990). For major normality departure data (where the distribution is 
skewed), transformation was performed using square root or logarithmic 
transformation (Sabin and Stafford, 1990). All transformed data were rechecked for 
normality, and, where the deviations were not resolved, the Friedman test was used 
(the critical χ² (df = 2, p=0.05) = 5.99) (Martin et al., 1993). Wilcoxon signed-rank test 
conducted where there was two testing points (pretreatment and posttreatment), and 
Friedman test was conducted where there was more than two testing points 
(pretreatment, mobilisation and posttreatment). For multiple testing, a Bonferroni 
correction applied, resulting in a critical level set at α < 0.017 (0.05/3). 
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In order to compare our results with previous studies, differences in the mean of all 
physiological measures before and after mobilisation were presented as 
percentages of change. The percentage of change for all measures was calculated 
for the three visits using the following formula:  
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑜𝑠𝑡−𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
× 100  . 
In addition, the percentage of change for skin conductance, skin temperature, heart 
rate and respiratory rate, where measures were recorded during intervention, was 
also calculated using the following formula:  
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑𝑢𝑟𝑖𝑛𝑔−𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑝𝑟𝑒
× 100 . 
The steps were repeated for each of the three visits. 
Spearman’s correlations were performed to examine the relationship between the 
percentage of change in PPT at the level of mobilisation and the percentage of 
change in Numerical Pain Rating Scale (NPRS).  
7.3. Results  
Thirty six patients with NSCLBP completed all visits. There were no adverse events. 
The demographic data and details about lumbar symptomatic level and duration of 
symptoms are displayed in Table 7.1. 
Table 7.1. Participants’ demographic data and details. 
Number of 
participants 
Sex Age (years) BMI (kg/m2) Duration of 
symptoms 
(weeks) 
Symptomatic 
level (number 
of participants) 
N = 36 Female = 22 
Male = 14 
Mean= 39.3 
SD = 10.01 
Mean = 29.33 
SD= 5.4 
Mean = 56.7 
SD= 55.4 
L5 = 27 
L4 = 8 
L3 = 1 
Abbreviations: BMI: body mass index; SD: standard deviation; L3: 3rd lumbar vertebra; L4: 4th lumbar 
vertebra; L5: 5th lumbar vertebra.   
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7.3.1. Results of mobilisation treatment on blood pressure 
There was a non-significant decrease in systolic blood pressure after mobilisation 
for the first visit compared to the baseline level with a mean difference value of -
1.6±8.7 mmHg (F(1, 35)  = 0.009, p =0.926). However, a non-significant increase 
was evident in the second and third visits with mean difference values of 1.6±11 
mmHg and 0.3±10.5 mmHg (Figure 7.2).  
 
 
Figure 7.2. Systolic blood pressure response at three visits. The data are 
medians. Error bars represent non-outlier range (n=36). 
There was a significant main effect of the visit day on systolic blood pressure which 
indicated the difference among the three visits of treatment (F(2, 70)  = 4.529, p = 
0.014). Bonferroni pairwise comparisons showed that this difference between the 
first and second visits was significant (p = 0.015). The interaction between the time 
of measurement (before or after mobilisation) and the visit day (1, 2 or 3) was not 
significant (F(2, 70)  = 0.939, p = 0.396). For diastolic blood pressure, there was a 
non-significant increase after mobilisation compared to baseline values that was 
evident in all visits with mean difference values of 0.2+/-7.6 mmHg, 5±12.3 mmHg 
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and 1.5±15.4 mmHg (F(1, 35)  = 3.476, p = 0.071; F(2, 70)  = 1.964, p = 0.148) 
(Figure 7.3). The interaction between the time of measurement (before or after 
mobilisation) and the visit day (1, 2 or 3) was not significant (F(2, 70)  = 1.478, p = 
0.235). However, t-tests revealed a significant increase in diastolic blood pressure 
measurement within the second visit with a mean difference value of 5±12.3 mmHg 
(p = 0.02). In order to compare our results with previous studies, the percentage of 
change in systolic BP and diastolic BP for the three visits were calculated and are 
displayed in Table 7.2. 
 
 
Figure 7.3. Diastolic blood pressure response at three visits. The data are 
medians. Error bars represent non-outlier range (n=36). 
 
Table 7.2. Percentage (%) of change in systolic blood pressure and diastolic 
blood pressure at each visit. The data are means ± standard deviation (n=36). 
 Visit 1 Visit 2 Visit 3 
SPB -0.9±7.1 1.8±9 0.73±8.7 
DBP 0.5±8.8 7.6±16.1 3.02±17.7 
Abbreviations: SBP: systolic blood pressure; DBP: diastolic blood pressure. 
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7.3.2. Results of mobilisation treatment on heart rate and respiratory rate 
There was a non-significant decrease in heart rate measurements during 
mobilisation treatment for the first and second visits compared to the baseline level 
with mean difference values of -0.9±6.5 beats/minute and -0.6±11 beats/minute (F(2, 
70)  = 2.352, p = 0.103). However, a non-significant increase was evident in the third 
visit with a mean difference value 0.8±7.8 beats/minute (Figure 7.4). Also, there was 
a non-significant decrease in heart rate measurements during the final rest period 
within the first and third visits compared to baseline values with mean difference 
values of -4.3±7.6 beats/minute and -1.6±10.4 beats/minute. However, there was a 
non-significant increase in heart rate measurements during the final rest period 
within the second visit compared to baseline values with a mean difference value of 
0.5±9.1 beats/minute. 
 
 
Figure 7.4. Heart rate response at three visits. The data are medians. Error 
bars represent non-outlier range (n=36). 
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For all visits, there was a non-significant change in respiratory rate measurements 
during mobilisation treatment compared to baseline values with mean difference 
values of 0.4±3.2 breaths/minute, -0.1±2.4 breaths/minute and 0.07±2.3 
breaths/minute (F(2, 70)  = 0.923, p = 0.402). Also, there was a non-significant 
decrease in respiratory rate measurements during the final rest period within all visits 
compared to mobilisation values. The mean difference values of respiratory rate 
measurements during the final rest period compare to baseline values were -
0.04±4.1 breaths/minute, -0.5±3.7 breaths/minute and -0.5±2.5 breaths/minute 
(Figure 7.5). 
 
 
 
Figure 7.5. Respiratory rate response at three visits. The data are medians. 
Error bars represent non-outlier range (n=36). 
There was a non-significant main effect the visit day on measurements of heart rate 
(F(2, 70)  = 0.197, p = 0.821). The interaction between the time of measurement 
(before or after mobilisation) and the visit day (1, 2 or 3) was not significant (F(4, 
140)  = 2.048, p = 0.091). 
161 
 
For respiratory rate, there was a non-significant main effect the visit day on 
measurements of respiratory rate (F(2, 70)  = 0.427, p = 0.654). The interaction 
between the time of measurement (before or after mobilisation) and the visit day (1, 
2 or 3) was not significant (F(3.094, 108.301)  = 0.292, p = 0.837). In order to 
compare my results with previous studies, differences in the mean of heart rate and 
respiratory rate measures before and after mobilisation were presented as 
percentages of change. The percentage of change for the three visits are displayed 
in Table 7.3. 
 
Table 7.3. Percentage (%) of change in heart rate and respiratory rate at each 
visit. The data are means ± standard deviation (n=36). 
 Visit 1 Visit 2 Visit 3 
 Baseline to 
treatment 
Baseline to 
final rest 
period 
Baseline to 
treatment 
Baseline to 
final rest 
period 
Baseline to 
treatment 
Baseline to 
final rest 
period 
HR -0.3±9.3 -5.2±10.4 0.5±15.2 1.64±13.8 1.4±11.2 -1.41±14.3 
RR 3.7±20 2.2±25.7 0.21±13.6 -1.17±20.6 0.87±13.3 -1.88±13.9 
Abbreviations: HR: heart rate; RR: respiratory rate.  
7.3.3. Results of mobilisation treatment on skin conductance and skin 
temperature 
At each of the three visits, there was a significant change in right skin conductance 
level with an observable increase during the mobilisation period 
(sympathoexcitation) compared to the baseline level with mean difference values 
ranged between 0.05±0.1v to 0.06±0.1v (Table 7.4) (Figures 7.6 and 7.7). In 
addition, there was a further significant increase in skin conductance during the final 
rest period compared to the treatment period (Table 7.4) (Figure 7.8 and 7.9). For 
skin temperature values, there was a significant decrease during the mobilisation 
period compared to baseline values that continued to decrease for the final rest 
period with mean difference values ranged between -0.3±0.5°C to -0.05±0.6°C 
(Table 7.4). 
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Table 7.4. Mean differences in skin conductance (v) and skin temperature 
(°C) for both sites of measurement at each visit. The data are means ± 
standard deviation (n=36). 
  
Visit 1 
 
 
Visit 2 
 
 
Visit 3 
  
Baseline to 
treatment 
 
Baseline to 
final rest 
period 
 
Baseline to 
treatment 
 
Baseline to 
final rest 
period 
 
Baseline to 
treatment 
 
Baseline to 
final rest 
period 
 
SC(RT) 
0.05±0.1 0.06±0.1 0.06±0.1 0.06±0.1 0.06±0.1 0.06±0.1 
 
SC(LT) 
0.004±0.05 -0.007±0.06 0.009±0.08 0.005±0.08 0.01±0.08 0.001±0.1 
 
ST(RT) 
 
-0.3±0.05 -0.3±0.05 -0.3±0.05 -0.3±0.05 -0.2±0.05 -0.3±0.06 
 
ST(RT) 
 
-0.02±0.05 -0.05±0.06 -0.01±0.5 -0.02±0.8 -0.1±0.4 -0.2±0.6 
Abbreviations: SC: skin conductance; ST: skin temperature; RT: right; LT: left. 
 
Figure 7.6. Right skin conductance response at three visits. The data are 
medians. Error bars represent non-outlier range (n=36). 
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Figure 7.7. Left skin conductance response at three visits. The data are 
medians. Error bars represent non-outlier range (n=36). 
 
Figure 7.8. Right skin temperature response at three visits. The data are medians. 
Error bars represent non-outlier range (n=36). 
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Figure 7.9. Left skin temperature response at three visits. The data are 
medians. Error bars represent non-outlier range (n=36). 
 
Post hoc analysis using the Wilcoxon signed-rank test was conducted to locate 
where differences existed between repeated measures (Table 7.5). However, only 
skin conductance changes among all visits reached the MDC (0.06 v); skin 
temperature values failed to reach the MDC value (1.5 °C). The percentage of 
change between skin conductance and skin temperature for the three visits is 
displayed in Table 7.6. 
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Table 7.5. Results of skin conductance (v) and skin temperature (°C) including mean values before, during and after 
mobilisation, chi-square and p values from the Friedman test. 1: pre-mobilisation, 2: during mobilisation and 3: post-
mobilisation. The data are means ± standard deviation (n=36). 
 Visit 1 Visit 2 Visit 3 
Outcome 
measure 
Pre- 
mobilisati
on 
During- 
mobilisati
on 
Post-
mobilisatio
n 
Chi-
square 
p Pre- 
mobilis
ation 
During- 
mobilis
ation 
Post-
mobilisati
on 
Chi-
square 
p Pre- 
mobilisa
tion 
During- 
mobilis
ation 
Post-
mobilisat
ion 
Chi-
square 
p 
RT SC 0.98±0.9 1.04± 
0.9 
1.04±0.9 12.06 
 
0.00 
(1,2) = 0.008 
(2,3) = 0.28 
(1,3) = 0.004 
0.86±0.
7 
0.92±0.
7 
0.92±0.7 6.89 0.03 
 (1,2) = 
0.004 
(2,3) = 0.91 
(1,3) = 0.002 
0.83±0.
6 
0.89±0.
6 
0.89±0.7 9.17 0.01 
 (1,2) =0.006 
(2,3) = 0.35 
(1,3) = 0.004 
LT SC -0.25± 
0.2 
-0.25± 
0.2 
-0.26±0.2 0.056 0.97 
(1,2) = 0.65 
(2,3) = 0.93 
(1,3) = 0.59 
-
0.23±0.
15 
-
0.22±0.
17 
-
0.23±0.18 
1.03 0.59 
(1,2) = 0.768 
(2,3) = 0.062 
(1,3) = 0.912 
-
0.23±0.
15 
-0.22+/-
0.16 
-
0.23±0.1
8 
0.38 0.82 
(1,2) = 0.69 
(2,3) = 0.25 
(1,3) = 0.85 
RT ST 
 
29.2±3.8 28.91±3.8 28.88±3.8 11.56 0.00 
(1,2) = 0.003 
(2,3) = 0.37 
(1,3) = .001 
29.67±
2.8 
29.4±2.
8 
29.41±2.8 7.87 0.02 
(1,2) = 0.002 
(2,3) = 0.96 
(1,3) = 0.002 
29.78±2
.6 
29.53±
2.6 
29.5±2.7 9.17 0.01 
 (1,2) = 0.007 
(2,3) = 0.39 
(1,3) = 0.01 
LT ST 
 
26.5±1.8 26.48±1.9 26.45±1.9 27.06 0.000 
(1,2) = 0.02 
(2,3) = 0.017 
(1,3) = 0.009 
26.98±
2.2 
26.97±
2.3 
26.97±2.2 13.7 0.001 
(1,2) = 0.38 
(2,3) = 0.213 
(1,3) = 0.144 
27.44±2
.4 
27.34±
2.3 
27.29±2.
3 
16.32 0.000 
(1,2) = 0.05 
(2,3) = 0.06 
(1,3) = 0.05 
Abbreviations: RT SC: right skin conductance; LT SC: left skin conductance; RT ST: right skin temperature; LT ST: left skin temperature.
166 
 
Table 7.6. Percentage (%) of change in skin conductance and skin 
temperature (right and left side) at each visit. The data are means ± standard 
deviation (n=36). 
 Visit 1 Visit 2 Visit 3 
 Baseline to 
treatment 
Baseline to 
final rest 
period 
Baseline to 
treatment 
Baseline to 
final rest 
period 
Baseline to 
treatment 
Baseline to 
final rest 
period 
RT SC 6.16±21.5 6.91±20.4 7.23±17.5 18.99±66.8 5.98±20.9 8.41±14.9 
LT SC 6.51±38.9 14.1±50.7 -2.3±28.3 2.4±31.4 4.36±56.8 7.55±65.02 
RT ST -0.72±1.2 
 
-0.82±1.3 -0.69±1.3 -0.68±1.2 -0.63±1.4 -0.73±1.5 
LT ST -0.09±1.7 
 
-0.21±2.1 -0.02±2 0.003±3.04 -0.35±1.6 -0.51±2.1 
Abbreviations: RT SC: right skin conductance; LT SC: left skin conductance; RT ST: right skin 
temperature; LT ST: left skin temperature. 
7.3.4. Results of mobilisation on pressure pain threshold 
There was a non-significant decrease in PPT measurements that was evident at all 
measurement sites (except right thoracic paraspinal muscles) within the first visit 
with mean difference values ranged between -0.3±5.5 N/cm2 and -3.5±10.6 N/cm2 
(Table 7.7). Also, there was a non-significant increase in PPT measurements that 
was evident at all measurement sites within the second (except left lumbar 
paraspinal muscles) and third visits with mean difference values ranged between 
0.1±8.8 N/cm2 and 4.2±10.1 N/cm2 (Table 7.7) (Figure 7.10). However, the t-test 
revealed significant differences in the PPT measurements at the thoracic para-spinal 
level within the third visit (p =0.028, p = 0.017) with mean difference values of 3.1 
N/cm2 and 4.23 N/cm2 and a significant difference at the right hand site within the 
second visit (p = 0.03) with a mean difference of 1.9 N/cm2. These changes failed to 
exceed the MDC reported in the reliability study (8.3 N/cm2, 8.9 N/cm2and 5.9 N/cm2) 
(Table 7.8). 
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Table 7.7. Mean differences (N/cm2) in pressure pain threshold for all the 
sites of measurement at each visit. The data are means ± standard deviation 
(n=36). 
Outcome 
measure 
 
Visit 1 
 
Visit 2 
 
Visit 3 
 
RT T12 
 
0.17±14.2 0.75±10.5 3.1±8.1 
 
LT T12 
 
-1.44±16.6 1.74±9.3 4.23±10.1 
 
RT L 
 
-3.5±10.6 0.11±8.8 1.7±9.9 
 
LT L 
 
-2.1±11.2 -0.6±9.8 0.91±10.1 
 
RT 1stDI 
 
-0.27±5.8 1.87±5.05 1.96±4.6 
 
LT 1stDI 
 
-0.41±5.4 1.3±4.3 1.04±4.2 
Abbreviations: RTL: right lumbar para-spinal muscles; LTL: left lumbar para-spinal muscles; RTT12: 
right 12th thoracic para-spinal muscles; LTT12: left 12th thoracic para-spinal muscles; RT1STDI: right 
first dorsal interosseous muscle; LT1STDI: left first dorsal interosseous muscle. 
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Pressure pain threshold of right thoracic paraspinal 
muscles (N/cm2) 
Pressure pain threshold of left thoracic paraspinal 
muscles (N/cm2) 
 
 
Pressure pain threshold of right lumbar paraspinal 
muscles (N/cm2) 
Pressure pain threshold of left lumbar paraspinal 
muscles (N/cm2) 
  
Pressure pain threshold of right 1st dorsal 
interosseous muscle (N/cm2) 
Pressure pain threshold of left 1st dorsal interosseous 
muscle (N/cm2) 
Figure 7.10. Pressure pain threshold response at three visits. The data are 
medians. Error bars represent non-outlier range (n=36).  
 
 Pretreatment 
 Posttreatment 
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There was a significant main effect of the visit day on PPT at three sites (right lumbar 
paraspinal muscles, left lumbar paraspinal muscles and left paraspinal muscles at 
the 12th thoracic level). Bonferroni pairwise comparisons showed that these 
differences were between the first and second visits for the three sites (p = 0.006; p 
= 0.005; p = 0.002). The interaction between the time of measurement and the visit 
day (1, 2 or 3) was not significant across the measurement sites except for the right 
lumbar para-spinal muscles and the right first dorsal interosseous (F(2,70) = 7.552, 
p = 0.001; F(2,70) = 4.402, p = 0.016). In order to compare my results with previous 
studies, differences in the mean of PPT before and after mobilisation were presented 
as a percentage of change (Table 7.9). 
 
Table 7.8. Two-way ANOVA results of pressure pain threshold for all 
measurement sites. 
 RTL 
 
LTL RTT12 LTT12 RT1STDI LT1STDI 
Time 
 
F(1,35) = 0.155, 
p = 0.696 
 
F(1,35) = 0.159, 
p = 0.693 
F(1,35) = 1.011, 
p = 0.322 
F(1,35) = 0.987, 
p = 0.327 
F(1,35) = 2.816, 
p = 0.102 
F(1,35) = 1.587, 
p = 0.216 
Visit 
 
F(1.519,53.159) 
= 
6.127,p = 0.008, 
(1,2)p = 0.006* 
 
F(1.699,59.472) 
= 
5.700,p = 0.008, 
(1,2)p = 0.005* 
F(1.685,58.972) 
= 
1.606, p = 0.212 
F(1.670,58.434) 
= 
7.740,p = 0.002, 
(1,2)p = 0.002* 
F(1.593,55.771) 
=1.110,p = 
0.325 
F(2,70) = 2.229, 
p = 0.115 
Visit 
* 
Time 
 
F(2,70) = 7.552, 
p = 0.001 
F(2,70) = 1.564, 
p = 0.217 
F(2,70) = 0.925, 
p = 0.401 
F(1.612,56.430) 
= 
2.712,p = 0.086 
F(2,70) = 4.402, 
p = 0.016 
F(2,70) = 1.527, 
p = 0.224 
Abbreviations: RTL: right lumbar para-spinal muscles; LTL: left lumbar para-spinal muscles; RTT12: 
right 12th thoracic para-spinal muscles; LTT12: left 12th thoracic para-spinal muscles; RT1STDI: right 
first dorsal interosseous muscle; LT1STDI: left first dorsal interosseous muscle. 
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Table 7.9. Percentage of change (%) in pressure pain threshold for all the 
sites of measurement at each visit. The data are means ± standard deviation 
(n=36). 
 
Outcome 
measure 
 
Visit 1 
 
Visit 2 
 
Visit 3 
 
RT T12 
 
6.3±38.8 4.9±22.7 
 
5.8±14.9 
 
 
LT T12 
 
3.3±26.9 5.5±19.1 
 
7.6±18.7 
 
RT L 
 
-4.3±18.2 4.7±16.9 
 
5.5±18.9 
 
 
LT L 
 
-2.9±18.8 2.4±20.1 
 
2.9±18.4 
 
RT 1stDI 
 
-0.2±17.6 6.7±18.9 
 
5.6±14.5 
 
LT 1stDI 
 
0.04±14.9 
 
4.01±13.4 
 
2.6±11.9 
Abbreviations: RTL: right lumbar para-spinal muscles; LTL: left lumbar para-spinal muscles; RTT12: 
right 12th thoracic para-spinal muscles; LTT12: left 12th thoracic para-spinal muscles; RT1STDI: right 
first dorsal interosseous muscle; LT1STDI: left first dorsal interosseous muscle. 
7.3.5. Results of mobilisation on salivary alpha-amylase 
For the first and second visits, there was a non-significant increase in mean salivary 
alpha-amylase after mobilisation compared to the baseline level with mean 
difference values of 3.9±25.4 U/m and 19.3±62.7 U/m (z =-1.28, p =0.198; z =-1.57, 
p =0.116).. However, for the third visit; the results showed that there was a non-
significant decrease in mean salivary alpha-amylase after mobilisation compared to 
the baseline level with a mean difference value of -2.7±60.7 U/m (z =-0.786, p = 
0.432) (Figure 7.11). Differences in the mean of salivary alpha-amylase before and 
after mobilisation were presented as percentages of change and are displayed in 
Table 7.10. 
 
 
171 
 
 
Figure 7.11. Salivary alpha-amylase response at three visits. The data are 
medians. Error bars represent non-outlier range (n=36). 
 
Table 7.10. Percentage of change (%) in salivary alpha-amylase at each visit. 
The data are means ±standard deviation (n=36). 
 
sAA 
Visit 1 Visit 2 Visit 3 
98.9±249 68.5±145.4 79.4±201.2 
Abbreviation: sAA: salivary alpha-amylase.  
7.3.6. Results of mobilisation on the Numerical Pain Rating Scale 
At each of the three visits, there was a significant change in the NPRS level with an 
observable decrease after mobilisation compared to the baseline level with mean 
difference values of -2±1.4, -1.5±1.7 and -1.03±1 (F(1, 35)  = 66.218, p = 0.001) 
(Figure 7.12).  
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Figure 7.12. Numerical Pain Rating Scale response at three visits. The data 
are medians. Error bars represent non-outlier range (n=36). 
The two-way ANOVA (sphericity assumed) indicated a significant main effect of the 
visit day on measurements of NPRS (F(1, 35)  = 66.218, p = 0.001; F(2, 70)  = 7.315, 
p = 0.001). The interaction between the time of measurement (before or after 
mobilisation) and the visit day (1, 2 or 3) was significant (F(2,70)  = 8.719, p = 0.001). 
Bonferroni pairwise comparisons showed that this difference was p = 0.014 between 
the first and second visits, and that it was p = 0.009 between the first and third visits.  
7.3.7. The relationship between change in NPRS and change in PPT 
Spearman’s correlations were performed to examine the relationship between the 
percentage of change in PPT at the level of mobilisation and the percentage of 
change in NPRS for the three visits. There was no association between the change 
in PPT and the change in NPRS in all visits (visit 1: p = 0.930, r =-0.015; visit 2: p = 
0.248, r =-0.197; visit 3: p = 0.107, r = 0.273).  
 
173 
 
7.3.8. Summary of findings 
 There was an increase in systolic blood pressure and diastolic blood pressure 
after mobilisation. Only the change in diastolic blood pressure within the 
second visit reached a level of significance that did not exceed that of the 
MDC (6.65mmHg).  
 There was a slight change in heart rate and respiratory rate measurements 
during mobilisation treatment and the final rest period compared to the 
pretreatment measurements. However, only the change in heart rate during 
the final rest period compared to the baseline measurement within the first 
visit was significant, but it did not exceed the MDC (5.45beat/minute). 
 The increase in pressure pain threshold was evident in the second and third 
visits, but not in the first visit; the most significant increase occurred only at 
the level of mobilisation in the third visit. In addition, the increase in the right 
hand PPT within the second visit reached a significant level. However, these 
significant changes did not reach the MDC values (right hand: 6.4N/cm2, right 
thoracic: 7.9N/cm2; left thoracic: 9.7N/cm2). 
 There was an increase in the right skin conductance during mobilisation 
treatment compared to the pretreatment measurement that continued to 
increase during the final rest period, was significant within all visits and 
reached the MDC (0.056v). 
 There was a decrease in the right and left skin temperature measurements 
during mobilisation treatment compared to the pretreatment that continued to 
decrease during the final rest period measurements and was significant within 
all visits, but did not reach the MDC value (right skin temperature:1.5°C, left 
skin temperature: 1.6°C) reported in the reliability study. 
 There was a significant decrease in the Numerical Pain Rating Scale 
measurement within all visits. 
 There was a non-significant difference between before and after mobilisation 
values of salivary alpha-amylase within all visits. However, there was an 
increase in the mean value after mobilisation within the first and second visits, 
but it decreased within the third visit.  
174 
 
 There was no association between the change in NPRS and the change in 
PPT in all visits. 
7.4. Discussion 
7.4.1. The effects of mobilisation treatment on measures of SNS  
7.4.1.1. Blood pressure, respiratory rate and heart rate 
The results of this study demonstrated that application of a posteroanterior grade III 
mobilisation technique centrally to T12 in patients with nonspecific chronic low back 
pain produced increases in systolic and diastolic blood pressure. The increase in 
heart rate and respiratory rate during mobilisation period was not evident in all visits. 
However, the decrease in heart rate and respiratory rate measurements during the 
final resting period compared to the measurements during mobilisation period was 
evident in most of the visits with significant results reported within the first visit.  
These results suggested that thoracic mobilisation alerts the sympathetic nervous 
system in patients with nonspecific chronic low back pain. A possible explanation for 
the sympathetic activation following mobilisation treatment is the descending pain 
inhibitory pathways from dPAG in the midbrain as similar respiratory and 
cardiovascular results have been reported following dPAG stimulation in rats (Lovick, 
1991; McGuiness et al., 1997). It has been suggested that blood pressure could be 
determined by the peripheral vascular resistance that has been found to be 
controlled by the lateral region within the PAG, suggesting a somatotopic component 
within the PAG (Carrive and Bandler, 1991). Another explanation might be the 
stimulation of ganglia along the trunk resulting from the movement of the sympathetic 
truck during the mobilisation irrespective of the level of mobilisation (Butler 1991).  
Furthermore, performing pressure to the back might stimulate the baroreceptors 
(sensitive mechanoreceptors) within the spinal tissue that might have the ability to 
produce similar cardiovascular changes by their afferent inputs that stimulate PAG 
activity (Rea and Eckberg, 1987). 
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7.4.1.2. Skin conductance and skin temperature 
My findings suggested that thoracic mobilisation stimulates the sympathetic nervous 
system, resulting in a peripheral vasoconstrictive effect evidenced by an increase in 
skin conductance and a decrease in skin temperature in patients with nonspecific 
chronic low back pain. A number of studies have reported similar results with 
significant sympathoexcitation in skin conductance and/or skin temperature as 
evidence of the descending inhibitory mediated response of the dorsal 
periaqueductal gray (dPAG) following cervical mobilisation (Peterson et al., 1993; 
Chiu and Wright et al., 1996; Sterling et al., 2001; La Touche et al., 2012), thoracic 
mobilisation (Cleland et al., 2004; Jowsey and Perry, 2010) and lumbar mobilisation 
(Perry and Green, 2008; Piekarz and Perry, 2016). 
The present study demonstrated unilateral effects in terms of significant changes in 
skin conductance in the right lower limb. The direct stimulation of the sympathetic 
fibres resulting from the close anatomical location between thoracic vertebrae and 
ganglia leading to a simple spinal reflex responsible for the SNS activity might 
explain the unilateral response (Slater, 2002). Furthermore, this unilateral response 
might be explained by the specific mediation within the global PAG that need further 
understanding to explain the different sympathetic responses seen in manual 
therapy studies (Mouton et al., 1997). A side-specific response has been reported 
by Perry and Green (2008) who recorded an increase in skin conductance in the 
lower limbs that was specific to the side of treatment, following unilateral lumbar 
mobilisation in asymptomatic population. 
7.4.1.3. Salivary alpha-amylase 
The results showed that there was a non-significant difference between before and 
after mobilisation values of sAA within all visits. As it was not feasible to collect the 
saliva samples during the course of the procedure, samples were collected 10 
minutes after the mobilisation. Therefore, it may be that any initial increase in the 
sAA was transient and therefore not detected using the protocol employed here. 
Further work should consider taking salivary samples at an early time point to 
determine if an initial transient change does occur. 
176 
 
7.4.2. The effects of mobilisation treatment on pain measures 
The hypoalgesic response to mobilisation was manifested by changes in the 
Numerical Pain Rating Scale and pressure pain threshold. A significant trend of 
decreased NPRS measures was observed in NSCLBP patients within all visits that 
may suggest that this mobilisation technique was an adequate stimulus to decrease 
pain scores. The mechanical PPT of the thoracic level was significantly increased 
following thoracic mobilisation in the order of 5.77% and 7.63% within the third visit 
of NSCLBP patients. This local hypoalgesic response to spinal mobilisation might be 
explained by the local inhibitory cord reflex that represents the gate control 
mechanism suggested by Melzack and Wall (1965). However, Zusman (1986) 
argued that the proposed hypoalgesic responses of spinal mobilisation might be the 
result of the suggested ability of the repetitive movement during the application of 
mobilisation to decrease activity of joint afferents. 
Other significant increases were recorded in the order of 6.65% distally over the right 
hand within the second visit in patients with NSCLBP. The pathway emerging from 
PAG is a possible mechanism for the widespread hypoalgesia that was 
demonstrated as occurring away from the treated area. However, all significant 
percentages of change did not exceed the 15% reported by Moss et al. (2007) that 
represents a clinically significant change or the MDC values calculated in the 
reliability study for each measurement site. 
7.4.3. The relationship between change in NPRS and change in PPT 
There was no association between PPT values and NPRS reported by patients at 
all visits. This negative correlation has been reported in the literature by Sterling et 
al. (2001) whose study examined this correlation between PPT and the Visual 
Analogue Scale (VAS) in patients with neck pain. These findings may suggest that 
different aspects of pain experience are measured by PPT (neurophysiological 
outcome) and NPRS (patient reported outcome) may be mediated by various 
hypoalgesic mechanisms. This may explain the observed change in pain intensity in 
all visits but not in pressure pain threshold.  However, as the application of spinal 
mobilisation consists of pressure force, pressure pain threshold may not be a 
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meaningful measure of patient’s pain response which also consist of applied 
pressure force (Snodgrass et al., 2014). 
7.5. Limitations of the study 
As a single-arm design was used where no placebo controlled group was used in 
this study that would have been essential to investigate the effectiveness of 
mobilisation treatment. However, previous studies have examined this effect using 
placebo controlled or controlled studies (Vicenzino et al., 1996; Sterling et al., 2001; 
Moss et al., 2007). Furthermore, looking at the effectiveness of mobilisation as a 
treatment form was not the aim of this thesis. Although the use of a control group is 
simple and cheap, the specific effect of mobilisation treatment cannot be 
distinguished from the placebo effects (Vickers and de Craen, 2000). The use of a 
placebo group allows for the separation of the specific effects of mobilisation 
treatment from the nonspecific effects (Hancock et al., 2006). As the underlying 
mechanisms behind the effectiveness of mobilisation treatment are yet to be 
established, the developing of a placebo that contains the non-specific component 
but not the specific component is difficult (Bogduk and Mercer, 2004). Hancock et 
al. (2006) asked 25 experts in the field of manual therapy to rate the appropriateness 
of ten different placebo techniques. Their findings suggested a very low agreement 
level between experts due to different beliefs about the active components of manual 
therapy.  
Although the natural resolution of symptoms cannot be ruled out from the results of 
this study, it was an uncommon aspect of this study that the immediate intervention 
effects were investigated in LBP patient with symptoms of a chronic nature.  
Due to the hospital policy, two clinicians performed the technique where a male 
physiotherapist performed the technique on male patients and a female 
physiotherapist performed it on female patients. The intra-therapist reliability for 
performing consistent mobilisation technique was not tested before conducting this 
study. Thus, there might be a degree of variation between applicants. However, all 
mobilisation techniques were performed in a predetermined, standardised manner 
as stated in section 7.2.5.1. Furthermore, the effect of the extraneous variables was 
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reduced by using strict inclusion and exclusion criteria and similar appointment times 
for all visits for treatment in an attempt to control the influence of diurnal variation. 
The results of this research are limited to the short-term effects following the 
application of three doses of mobilisation treatment, whereas in clinical practice, the 
number of treatment sessions may vary according to the patient’s condition. In this 
study, the long-term effects following mobilisation were not investigated, which would 
have enhanced the clinical relevance of the results. Empirical evidence suggests 
that 24-48 hours following intervention some patients experience improvement as 
the initial soreness decreases. Thus, research should consider looking at the longer-
term effects of mobilisation. However, the number of treatment sessions was 
standardised for both asymptomatic and patient participants in the preclinical and 
clinical studies for this thesis, and the analysis of the data was postponed until the 
completion of all the visits of each participant. 
It has been suggested that emotion centres (e.g. dorso-lateral prefrontal cortex) and 
PAG can be stimulated as a result of event anticipation resulting in modulation of 
pain perception within the brain stem (Wager et al., 2004). Thus, instigation of 
mobilisation treatment as an event might have the ability to initiate central processing 
and related clinical benefits. Although the present study attempted to control the 
possible confounding variables influencing the sympathetic activity, determining the 
potential effect of intervention expectation on sympathetic function was not possible 
(Bialosky et al., 2008). 
Although the external validity of this study was enhanced because trained 
physiotherapists treated the NSCLBP patients within a clinical setting, it was limited 
to the NSCLBP patients as a result of the use of the convenience sample of NSCLBP 
patients. The results of this study might have been different if tailored mobilisation 
techniques had been applied to the patients based on the assessment of their spinal 
stiffness and pain as routinely performed by clinicians. Finally, the results of this 
clinical study evaluated the effects of only one treatment technique. Further studies 
are required to investigate the influence of other mobilisation techniques in normal 
patient populations and, more importantly, in populations where a pragmatic choice 
of technique and direction of mobilisation are considered.  
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7.6. Conclusion  
The clinical study examined the effects of mobilisation treatment on hypoalgesia and 
sympathetic activity in patients with NSCLBP over a course of three doses of 
mobilisation treatment in a clinical setting. Results showed significant peripheral 
detectable sympathoexcitatory effects in the lower limbs in terms of increased skin 
conductance and decreased skin temperature following thoracic mobilisation that 
were not detected in asymptomatic participants. These peripheral sympathetic 
responses occurred concurrently with hypoalgesic effects in terms of a significant 
increase in pressure pain threshold values and a significant decrease in NPRS 
measures. However, the significant pressure pain threshold values were not evident 
in all locations, and there was no association between changes in pressure pain 
threshold and changes in NPRS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
180 
 
Chapter 8 
Discussion and conclusion 
The following section discusses all the previous chapters and identifies the gaps 
revealed by the literature review in order to place the results chapters of this thesis 
(Chapters 5, 6 and 7) within the current context of the area of research related to 
hypoalgesia and the sympathetic effects of spinal mobilisation as a management of 
CLBP. 
Currently, the dynamic continuum concept of the neuro-musculoskeletal system and 
its responding ability to various stimuli (mechanical, chemical, thermal, nociceptive 
and cognitive) at different levels, including the peripheral, spinal and supra-spinal 
levels, is well recognized. However, the ability of researchers and clinicians to 
quantify and qualify the proposed mechanisms of intervention action programmes 
are yet to be developed. Although the use of standard LBP patient-reported outcome 
measures might help clinicians to clinically assess the pain and functional status of 
their patients, these measures suffer from a degree of subjectivity. Therefore, a 
number of authors have called for more objective change indicators that are not 
influenced by the psychological or cognitive status of the patient (Perry et al., 2015). 
A recognized concept within the manual therapy field is that hypoalgesia is related 
to sympathoexcitation; this leads researchers to measure the sympathetic 
responses as an immediate physiological measure following manual interventions. 
However, most of the available research in this area has measured these responses 
from the upper extremities, and limited research has been conducted on specific 
patient populations. Although different tools have been used to quantify these 
various physiological responses, their measurement stability and variability have not 
been established by the published research. 
The first study for this thesis was conducted to determine the test-retest reliability 
(reproducibility) of the e-Health Sensor Shield V2.0 at measuring skin conductance, 
respiratory rate, heart rate and skin temperature. In addition, the study attempted to 
determine the reliability of a Wagner algometer in measuring PPTs, the reliability of 
a digital blood pressure monitor and the reliability of measuring the sAA enzyme, 
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which is linked to arousal of the SNS. This was necessary to establish the reliability 
of this equipment before using it in preclinical and clinical studies, as well as in future 
clinical research. The findings of this reliability study indicated that the test-retest 
reliability within a day of skin conductance, respiratory rate, heart rate and skin 
temperature, systolic blood pressure and PPT measurements was excellent (ICCs 
of 0.77 to 0.99). On the other hand, the reliability of diastolic blood pressure and sAA 
measurements was demonstrated to be fair to good (ICCs of 0.55 and 0.7, 
respectively). Therefore, this equipment was considered reliable and suitable for 
measures for the next stage of the research to investigate the effects of mobilisation 
treatment on these variables in an asymptomatic population and in lower back pain 
patients. 
Further analysis of the data from the reliability study was conducted to calculate the 
MDC for all measures that are independent of any measurement error and could be 
considered as real change ascribable to the treatment. However, the values for MDC 
might not necessarily represent the patient-perceived measure of the minimal clinical 
importance difference; thus, further research is warranted in this area utilising a 
patient population. To the author’s knowledge this is the first study to measure the 
normative values of skin conductance, respiratory rate, heart rate and skin 
temperature (e-Health Sensor Shield V2.0), blood pressure (digital monitor), PPT 
(Wangar algometer) and sAA in a laboratory environment. These results should aid 
further research in determining whether such intervention causes any real change 
apart from measurement error. 
The use of spinal mobilisations has been recommended by the NICE Guidelines for 
the management of LBP (2009) and the Chartered Society of Physiotherapy (CSP) 
(2006). However, there is lack of research in the literature regarding the sympathetic 
responses as a result of these techniques within a LBP population. Therefore, a 
preclinical study was designed and conducted to provide normative values for 
sympathetic measures as a result of these techniques. This was followed by a 
clinical study investigating these responses to mobilisation that included patients 
with LBP. Thus, the overall aim of this thesis was to investigate the hypoalgesic and 
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sympathetic effects of passive thoracic mobilisation treatment in those with and 
without LBP. 
8.1. The effects of mobilisation treatment on pain measures 
In the clinical study, the hypoalgesic response to mobilisation was manifested by 
changes in the NPRS and PPT. A significant decrease in NPRS measures was 
observed in LBP patients within all visits. This suggests that this mobilisation 
technique was an adequate stimulus to decrease pain scores. The mechanical PPT 
of the thoracic level was significantly increased by 8.1% following thoracic 
mobilisation within the first visit of asymptomatic subjects, and by 5.77% and 7.63% 
at the thoracic level within the third visit of LBP patients. Other significant increases 
were recorded over the lumbar level of 10.5% and 7.4%, 10.8% distally over the 
hands within the third visit in asymptomatic subjects and by 6.65% distally over the 
right hand within the second visit in patients with LBP. The hypoalgesic response 
recorded in asymptomatic subjects suggests that the mobilisation technique can 
produce hypoalgesia where pain and dysfunction are absent (Willett et al., 2010). 
However, this significant hypoalgesic response was not evident in all locations at all 
visits for both studies. This might be due to the sample size being too small to detect 
changes in some PPT as estimation was only based on skin conductance data. All 
significant percentages of change did not exceed the MDC values of 15% reported 
by Moss et al. (2007) which indicates that although statistically significant, these 
changes were not clinically significant. 
Furthermore, in the clinical study, the PPT measurements following the first session 
demonstrated decreasing values in contrast to the second and third visits. It has 
been established that a treatment reaction, in terms of the worsening of the 
symptoms or the emergence of new symptoms as minor adverse reactions, following 
manual therapy is common during the first 24 hour (Thiel et al., 2007). As a result, 
this may explain the slight decrease in PPT measurements following the first 
mobilisation treatment. Other studies examined the effect of different lumbar 
mobilisation doses on the PPT of asymptomatic subjects and found a significant 
increase with both doses at all measurement locations (Krouwel et al., 2010; Willett 
et al., 2010; Pentelka et al., 2012). However, the positive treatment effect seen in 
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those studies may have been enhanced by the expectations of the participants 
(asymptomatic physiotherapy students). 
The local hypoalgesic effect was evident in a number of visits for both asymptomatic 
and symptomatic subjects in this study. This local hypoalgesic response to spinal 
mobilisation might be explained by the local inhibitory cord reflex that represents the 
gate control mechanism suggested by Melzack and Wall (1965). The stimulation of 
the low threshold mechanoreceptors in articular and peri-articular structures 
following spinal mobilisation might inhibit the small diameter, high threshold 
mechanoreceptors at the level of spine that result in pain modulation in the dorsal 
horn of the spinal cord. However, this preferential ability of the spinal mobilisation 
toward stimulation of the low threshold mechanoreceptors apart from high threshold 
neurons has been questioned (Zusman, 1986). Zusman (1986) argued that the 
proposed hypoalgesic responses of spinal mobilisation might be the result of the 
suggested ability of the repetitive movement during the application of mobilisation to 
decrease activity of joint afferents by inhibiting reflex muscle contraction and 
reducing intra-articular pressure. Furthermore, this spinal movement created 
through the mobilisation may lead to a hypoalgesic effect at more than one level of 
the spine, which may explain the segmental hypoalgesic response reported at the 
lumbar level in asymptomatic participants. These local and segmental mechanisms 
were supported by functional magnetic resonance imaging (MRI) that was used in 
an animal study conducted by Malisza et al. (2003) which demonstrated decreased 
activity of pain in specific areas at the spinal cord following mobilisation in rats. 
In addition to the previously mentioned local mechanisms, the pathway emerging 
from PAG is another possible mechanism because this study demonstrated 
widespread hypoalgesia occurring away from the treated area. This widespread 
effect of thoracic mobilisation on PPT that was demonstrated in some visits of the 
asymptomatic and LBP patients was shown by other investigations that reported a 
hypoalgesic effect distal to the area of mobilisation and that supported the concept 
that response to mobilisation is not specific or local to the treatment area (Vicenzino 
et al., 1996; Moss et al., 2007; Krouwel et al., 2010; Willett et al., 2010; Pentelka et 
al., 2012). This effect may be indicative of mobilisation’s ability to initiate the neural 
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response from higher structures in the CNS that result in the therapeutic effect being 
seen. It has been suggested that the remote hypoalgesic effect from the treated area 
may indicate the stimulation of the descending inhibitory pathways following 
mobilisation (Moss et al., 2007). However, this widespread hypoalgesic effect was 
not evident in a significant number of studies. 
However, various studies have demonstrated that, due to the lower density of 
mechanoreceptors in the thoracic and lumbar spine compared to the cervical spine 
level, PPT values were found to increase in the caudal direction (Keating et al., 2001; 
Potter et al., 2006). This could explain the greater percentage of change in PPT 
following cervical mobilisation as the gate mechanism relies on large diameter 
neurons to inhibit the small neurons responsible for nociceptive signals. A decreased 
receptive field of mechanoreceptors in the thoracic and lumbar spine would decrease 
the gate control ability to create a greater hypoalgesic effect and may explain the 
small percentage of change reported by the current study compared to other studies. 
In the literature, the increase in the percentage of change in PPT ranged from 
12.69% to 26% following cervical mobilisation, both local and remote from where the 
mobilisation was applied (Vicenzino et al., 1996; Wright and Vicenzino, 1998: 
Sterling et al., 2001). An increase in the order of 26% at the elbow was recorded by 
Vicenzino et al. (1996) following cervical mobilisation in tennis elbow patients, 
compared to another study with a similar methodology but which included 
asymptomatic participants and recorded a change of 23.5% (Vicenzino et al., 1995). 
Therefore, the inherent variations among sites might explain the differences in the 
response range. However, most of those studies were conducted by the same group 
of researchers and used the same crossover design. Participants’ gender might be 
another possible reason behind the higher percentages in previous studies. In the 
clinical study 61% of the patients were female, who have been shown to have lower 
values of pressure pain threshold compared to males (Riley et al., 1998). 
Furthermore, Fryer et al. (2004) suggested that the large variation between studies 
assessing pain with an algometer might be explained by the subjective experience 
that varies in terms of perception from one to another person. However, a previous 
study investigating the effect of mobilisation reported the percentages of change in 
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the absence of true difference values and used these percentages for analysis, 
which might have affected their conclusions (Bonate, 2000). Another possible 
reason for the differences in the percentage of change of PPT reported by the current 
clinical study and previous studies might be the differences in the duration of the 
symptoms experienced by the participants. A mean value of six to eight months has 
been reported as the duration of symptoms in previous studies (Vicenzino et al., 
1996; Wright and Vicenzino, 1998: Sterling et al., 2001), whereas a longer duration 
was reported by the current study (a mean value of 56 weeks). Although the inclusion 
of symptoms with longer durations might reflect clinical populations, it may lead to 
variations among multiple factors, including processing of pain, functional levels and 
pain beliefs. 
8.2. The relationship between PPT and NPRS 
There was no association between PPT values and NPRS reported by patients at 
all visits. Although the differences in PPT suggest the activation of the hypoalgesic 
mechanism, pain measures as reported by patients using the NPRS are more 
clinically relevant. These findings may suggest that hypoalgesia measured by PPT 
and NPRS may be mediated by various hypoalgesic mechanisms. This has been 
reported in patients with neck pain by Sterling et al. (2001) whose study examined 
this correlation between PPT and the Visual Analogue Scale. However, the PPT is 
largely used as a pain measure both for patients and for the asymptomatic 
population; thus, further research is warranted in this area to examine the correlation 
between different patient-reported measures and PPT. 
8.3. The effects of mobilisation treatment on measures of SNS 
8.3.1. Skin conductance and skin temperature 
The findings obtained for indicators of SNS activity suggest that thoracic mobilisation 
stimulates the SNS, resulting in a peripheral vasoconstrictive effect evidenced by an 
increase in skin conductance and a decrease in skin temperature within all sessions 
in patients with LBP, with no significant changes reported by asymptomatic 
participants. There was an increase in the right skin conductance during mobilisation 
treatment compared to the pretreatment measurement that continued to increase 
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during the final rest period, which was significant within all visits and also reached 
the MDC. Furthermore, there was a significant decrease within all visits in the right 
and left skin temperature measurements during mobilisation treatment compared to 
baseline that continued to decrease during the final rest period measurements, but 
did not reach the MDC value reported in the reliability study. However, thermal 
asymmetry between lower limbs was evident in the baseline measurements of LBP 
patients but not in asymptomatic participants. The baseline measurements of skin 
temperature in LBP patients ranged from 29.2 ± 3.8°C to 29.8 ± 2.6°C for the right 
lower limb and from 26.5 ± 1.8°C to 27.4 ± 2.4°C for the left lower limb. This 
asymmetry might be explained by the potential root lesions of L5 and S1 that are 
common in patients with LBP and represented on the plantar area. Peripheral 
circulatory changes that are more distinct distally or the abnormal distribution of 
weight in those patients might influence the plantar temperature (Zaproudina et al., 
2006). Muscle function disturbances might cause this change in the above skin 
temperature as the active muscle produces energy as heat (Takahashi et al., 1994). 
The symptomatic participants in our study suffered from LBP without radicular 
referred leg pain due to disc prolapse or possible vascular diseases; thus, more 
significant findings of skin temperature might be seen in patients with radiculopathies 
after spine operation. The skin temperature was measured noninvasively in this 
study; thus, it might be possible to use skin temperature as objective indicator to 
follow the sympathetic disturbances by evaluating the vasomotor activity of the 
sympathetic nerve fibres in musculoskeletal disorders. 
Our results support findings by other similar studies demonstrating an increased 
sympathetic activity response to SMT (Peterson et al., 1993; Vicenzino et al., 1996; 
Vicenzino et al., 1998; Cleland et al., 2004; Perry and Green, 2008; Jowsey and 
Perry, 2010; Piekarz and Perry, 2016). Our findings show that peripheral 
sympathetic changes in the lower limb can be measured following thoracic 
mobilisation not only in a laboratory setting but also in a clinical environment and in 
patient populations. In the right lower limb, the mean percentage change in skin 
conductance values ranged from 5.98% to 18.99%, which reached significance at 
all visits in the clinical study. Several studies have demonstrated the bilateral 
sympatoexcitatory response following mobilisation as evidence of the descending 
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inhibitory mediated response of the dorsal periaqueductal gray (dPAG) (Slater and 
Wright, 1995; Sterling et al., 2001). The present study demonstrated specific side 
effects in terms of significant changes in skin conductance in the right lower limb in 
LBP patients. Considering previous studies that applied thoracic mobilisation 
techniques, it was noted that the magnitude of bilateral sympathetic responses was 
usually different between sides and that might this be explained by the specific 
mediation within the global PAG. The PAG consists of highly specialised functional 
regions and subregions. Medullary control nuclei are responsible for the modulation 
of dPAG regions in animals leading to unilateral and bilateral projections (Mouton et 
al., 1997). Further understanding of the mediation by the specific central structures 
may help to explain the different sympathetic responses seen in manual therapy 
studies. Somatospecific representation of the dPAG, rather than general 
representation, could be another supra-spinal explanation for the unilateral 
response. A side-specific response has been reported by Perry and Green (2008) 
who recorded an increase in skin conductance in the lower limbs that was specific 
to the side of treatment, following unilateral lumbar mobilisation. It is also possible 
that the unilateral response was due to the direct stimulation of the sympathetic 
fibres resulting from the close anatomical location between thoracic vertebrae and 
ganglia leading to a simple spinal reflex responsible for the SNS activity (Slater, 
2002). 
Findings from the clinical study support the results of previous studies that have 
noted similar effects in skin conductance after thoracic mobilisation treatment, such 
as those by Jowsey and Perry (2010) who reported an increase in range from 1.56% 
to 8.12% in the upper limbs after thoracic mobilisation was applied to T4 in an 
asymptomatic population. Perry and Green (2008) reported an increase of 13.5% in 
the lower limbs in asymptomatic participants after lumbar mobilisation. Also, these 
findings support the results of studies that applied mobilisation to the cervical level 
and reported significant sympathetic changes in the upper limbs (Petersen et al., 
1993; Chiu and Wright, 1996; Sterling et al., 2001). Sterling et al. (2001) reported a 
16% increase in skin conductance in the treatment period for the treatment condition. 
Chiu and Wright (1996) reported that skin conductance increased by 50-60% above 
baseline values following central PA cervical mobilisation at the rate of 2Hz, which 
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was consistent with a study by Petersen et al. (1993). The difference in the 
magnitude of the responses following mobilisation to different levels of the spine 
might be due to the different peripheral cutaneous innervations or central processing 
systems for different regions (Perry at al. 2015). This suggests that the mobilisation 
grade used in this study was not the optimal one for producing the maximal 
magnitude in sympathetic change. It has been hypothesised that the movement 
component of mobilisation might be an important factor in maximising the 
sympathetic response by increasing the mechanical effects on the level mobilised 
(Piekarz and Perry, 2016). Pickar and Kang (2006) suggested that discharge from 
the muscle spindle is increased with high velocity loading compared with lower 
forces. Recent research has shown that skin conductance activity increased more 
following 2Hz mobilisation frequency compared to lower frequencies (0.5Hz), thus 
emphasising the role of oscillation in responses to mobilisation treatment (Chiu and 
Wright, 1996; Perry et al., 2008; Jowsey and Perry, 2010). Vicenzino et al. (1995) 
also suggested that reaching the maximum sympathetic activity more rapidly due to 
an increase in synaptic efficiency in the afferent sensory pathways might lead to 
increased hypoalgesia. Unfortunately, the present study did not measure the time to 
maximum sympathetic response that would determine if there is a correlation 
between frequency of mobilisation and faster sympathetic change. However, the 
results of the current study suggest the use of skin conductance as a proxy measure 
for the sympathetic function of the postganglionic efferent to quantify the 
neurophysiological response to different treatments in physiotherapy (Perry and 
Green, 2008). The findings support the theoretical framework for the choice of 
thoracic mobilisation in patients with NSCLBP to affect the peripheral sympathetic 
outflow to the lower limbs and, potentially, the lower limb symptoms common in LPB 
patients. 
A possible explanation for the non-significant results of skin conductance and skin 
temperature in the asymptomatic population in comparison with the significant 
results seen in the patient population might be the presence of the enhanced dorsal 
horn excitability in spinal pain patients (Boal and Gillette, 2004; Bakkum et al., 2007). 
Taylor and Murphy (2009), using functional MRI, have reported a correlation 
between lumbar dysfunction and neuroplastic changes to the dorsal horn and central 
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pain structures in the midbrain, brainstem, amygdala and thalamus, as well as SNS 
synaptic activity (Nagai et al., 2004). However, this theory needs further investigation 
to correlate sympathetic responses to treatment with pain and functional disability 
measures recorded over a full course of treatment and to correlate these findings 
with functional MRI results. Due to the small sample size in the preclinical study of 
this thesis (n=14), the results should be interpreted with caution. 
It has been suggested that emotion centres (e.g. dorso-lateral prefrontal cortex) and 
PAG can be stimulated as a result of event anticipation resulting in modulation of 
pain perception within the brain stem (Wager et al., 2004). Thus, instigation of 
mobilisation treatment as an event might have the ability to initiate central processing 
and related clinical benefits. Although the present study attempted to control the 
possible confounding variables influencing sympathetic activity, determining the 
potential effect of intervention expectation on sympathetic function was not possible 
(Bialosky et al., 2008). 
8.3.2. Blood pressure, respiratory rate and heart rate 
LBP patients demonstrated higher baseline measurements among three visits in 
terms of heart rate, which ranged from 68.9 ± 9.2 to 71.3 ± 9.8 beats/min compared 
to 66.55 ± 4.6 to 69.6 ± 7.7 beats/min in asymptomatic participants. The baseline 
systolic and diastolic blood pressure measurements were also higher in the LBP 
patients, and ranged from 122.5 ± 14.3 to 127.9 ± 14.9 mmHg and 81.9 ± 12 to 86.6 
± 11.6 mmHg, respectively. Asymptomatic participants had lower systolic and 
diastolic blood pressure ranging from 110.7 ± 14.9 to 114.1 ± 12.9 mmHg and 77 ± 
8.2 to 80.2 ± 12.4 mmHg, respectively, from three visits. Similar results have been 
reported by Shankar et al. (2011), who showed higher basal ranges of systolic and 
diastolic blood pressure in a group of chronic low back patients compared to a control 
group. This might be explained by increased sympathetic cardiovascular activity in 
the pain group compared to the control group. Furthermore, other studies have 
reported similar higher sympathetic tone in other pain patients (e.g. myofascial and 
arthritis pain) and suggested a sympathetic dominance in these patients (Collin et 
al., 1982; Perry et al., 1989). 
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Our results demonstrated that, for an asymptomatic population, there was a 
statistically significant increase within all visits in heart rate and respiratory 
measurements during mobilisation treatment that decreased during the final rest 
period measurements. This was significant within all visits for respiratory rate and 
within the second and third visits for heart rate measurements. All these changes 
exceeded the MDC reported by the reliability study indicating that the results had 
clinical as well as statistical significance. There was an increase in systolic blood 
pressure and diastolic blood pressure after mobilisation, but only the differences 
within the first and third visits were significant. For LBP patients in the clinical study, 
there was an increase in systolic blood pressure and diastolic blood pressure after 
mobilisation. Only changes in diastolic blood pressure within the second visit 
reached statistical significance, but none were clinically significant. Furthermore, 
there was a slight increase in heart rate and respiratory rate measurements during 
mobilisation treatment that decreased during the final rest period compared to the 
pretreatment measurements. However, only changes in heart rate during the final 
rest period, compared to the baseline measurement within the first visit, were 
significant, but they did not reach clinical significance as determined by the MDC in 
the reliability study (chapter 5). 
These results are similar to findings from other studies that reported increased heart 
rate, respiratory rate and blood pressure following central PA cervical mobilisation 
(McGuiness et al., 1997). McGuiness et al. (1997) reported a significant increase in 
respiratory rate in the order of 44% during the mobilisation period and in heart rate 
in the order of 10.5%, while systolic blood pressure increased by 12.5% and diastolic 
blood pressure increased by 4.5%. The authors suggested this was due to the 
descending pain inhibitory pathways from dPAG in the midbrain. Another proposal 
by those authors for the resultant sympathoexcitatory response following 
mobilisation treatment was direct stimulation to the cervical ganglia and sympathetic 
fibres as they are located close to the cervical level treated (C5/6). These ganglia 
connect with organs like the heart through fibres. Performing pressure to the neck 
might cause an increase or decrease to the carotid baroreceptors’ function. This can 
affect heart rate and peripheral vascular resistance (Thoren and Lundin, 1983). 
However, on both sides of the spine, the sympathetic trunk extends parallel to the 
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spine and might be moved during mobilisation, thus causing stimulation of ganglia 
along the trunk (Butler 1991). 
Similar respiratory and cardiovascular results have been reported following dPAG 
stimulation in rats (Lovick, 1991). The agreement between results of animal studies 
with this study and other similar human studies may support the involvement of the 
descending pain inhibitory system emerging from the dPAG as a possible 
mechanism behind the effectiveness of manual therapy (Petersen et al., 1993; 
Vicenzino et al., 1995; Wright, 1995). Studies of both unilateral and central PA 
cervical mobilisation have reported an increase in blood pressure and a decrease in 
skin temperature distally at the hand, which suggests peripheral vasoconstriction 
(Petersen et al., 1993; Vicenzino et al., 1995; Wright, 1995). It has been suggested 
that arterial blood pressure could be determined by the peripheral vascular 
resistance that has been found to be controlled by the lateral region within the PAG, 
suggesting a somatotopic component within the PAG (Carrive and Bandler, 1991). 
The pre-motor neurons that control cardiac, respiratory, vasomotor and sudomotor 
functions have been shown to emerge from regions within the brainstem and located 
caudal to the PAG (McAllen et al., 1995; Shafton and McAllen, 2013). Therefore, the 
concurrent hypoalgesia with the various sympathetic functions seen following 
mobilisation might point to the implication of a supramedullary integratory centre (the 
PAG) (Vicenzino et al., 1998). 
Furthermore, central to the hypothesis that spinal mobilisation may stimulate the pain 
inhibitory pathways emerging from the PAG is the ability of this technique to 
stimulate receptors located within the spinal tissue (joint, capsule, connective tissue, 
tendons and ligaments) that may directly or indirectly activate mechanisms 
originating from the PAG. In addition to these receptors, baroreceptors are found 
within the vascular tree that may have the ability to cause cardiovascular changes 
similar to the changes seen in this study (Rea and Eckberg, 1987). As a result, the 
PAG activity might be activated by afferent input from receptors located within the 
musculoskeletal and cardiovascular systems (Yezierski, 1991). 
On the other hand, these findings were in contrast to the results from a study 
conducted by Yung et al. (2014) who reported a significant drop in heart rate values 
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in an AP cervical mobilisation group compared to a placebo group in a pain-free 
population. In addition, the results demonstrated a drop in systolic blood pressure in 
both mobilisation and placebo groups. However, these changes did not reach the 
MDC or cause any pulselessness, and the change in systolic blood pressure did not 
reach close to 50 mmHg. The authors explained this sympatho-inhibitory effect, as 
opposed to other similar studies of different mechanisms, as the result of various 
techniques of manual therapy. This study performed unilateral AP pressure to the 
right side that might lead to left side circulation which, in turn, may prevent any true 
cardiovascular response. Other contrasting results were reported by studies 
investigating the effects of manipulation on blood pressure, and they demonstrate a 
sympatho-inhibitory response in terms of decreased blood pressure (McKnight and 
DeBoer, 1988; Yates et al., 1988). However, this form of manual therapy is different 
from mobilisation in terms of speed and duration of treatment and might be expected 
to exert different responses in SNS functions. 
8.3.3. Salivary alpha-amylase 
sAA was used in this study as a noninvasive biomarker to investigate the 
sympathetic response after thoracic mobilisation. For asymptomatic participants, 
there was an increase in mean sAA after mobilisation within the first visit and a 
decrease within the second and second visits. Although the difference within the first 
visit was significant, it did not exceed the MDC. For LBP patients, there was a non-
significant difference between before and after mobilisation values of sAA within all 
visits. As it was not feasible to collect the saliva samples during the course of the 
procedure, samples were collected 10 min after the mobilisation. This may be 
explained by the likely transience in the initial increase in the sAA. 
It was hypothesised that manipulative treatment like the rib raising technique has the 
ability to modulate the sympathetic activity by activating the thoracic sympathetic 
chain ganglia that might cause initial sympathetic stimulation that is followed by a 
prolonged reduction of sympathetic outflow (Wallace et al., 2003). Henderson et al. 
(2010) tested this hypothesis using a saliva biomarker by collecting saliva 
immediately and at 10 min following rib raising, and they found a significant decrease 
in sAA in the treatment group compared to the placebo group. However, the saliva 
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samples were collected differently in this study by using the passive drool method 
and not by means of an oral swab. Furthermore, it was not stated whether the 
salivary flow rate was considered to correct the alpha-amylase assay results. 
8.4. Recommendations for future work 
The following is a detailed synopsis of the important areas for future research that 
were highlighted by the results of this study: 
 The preclinical and clinical study for this thesis explored the immediate 
hypoalgesic and sympathetic effects following mobilisation treatment. Further 
work could explore longer-term follow-up (24, 48 or 72 hours) after a single 
dose of treatment. 
 No association was found between the values of PPT and NPRS in patients 
with LBP. The clinical relevance of the change in PPT values needs to be 
examined in future research with the incorporation of different, related 
measures of pain. 
 For experimental purposes, all patients in the clinical study were treated using 
a pre-determined mobilisation technique. However, in clinical practice, the 
choice of treatment depends on the findings of physiotherapy assessment 
when the patient responds to a trial intervention dose. It might be of interest 
to exclude the immediate responders to a trial dose from further research and 
examine the response over a course of intervention. 
 There may be the potential to integrate spinal mobilisation with strategies 
such as pharmacology, graded movement and patient education, as these 
strategies are known to affect the process of CNS. Therefore, RCTs are 
warranted for symptomatic subjects with pain and impaired function in order 
to produce a more advanced paradigm, which contributes to beneficial clinical 
guidelines for patients. 
 RCTs are needed on symptomatic subjects to examine the 
neurophysiological effects of spinal mobilisation techniques of different rates, 
amplitudes and duration of sets, as well as in comparison with other forms of 
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treatment. The exploration of the extent of hypoalgesia over time might be 
necessary to ascertain the duration of the treatment effect. Skyba et al. (2003) 
demonstrated that 45 min was the lasting effect of mechanical hypoalgesia 
following lower limb mobilisation. 
 The exploration of patients’ expectations and beliefs was not part of the initial 
assessment in the clinical study. In addition, there was limited communication 
with the participants throughout the studies, and this might have influenced 
the response to mobilisation. Further research should examine whether the 
clinical effect of mobilisation could be influenced by the level of 
communication with participants. 
 It has been suggested that emotion centres (e.g. dorso-lateral prefrontal 
cortex) and the PAG can be stimulated as a result of event anticipation 
resulting in modulation of pain perception within the brain stem (Wager et al., 
2004). Thus, instigation of mobilisation treatment as an event might have the 
ability to initiate central processing and related clinical benefits. Although the 
present study attempted to control the possible confounding variables 
influencing sympathetic activity, determining the potential effect of 
intervention expectation on sympathetic function was not possible (Bialosky 
et al., 2008). Further studies are recommended to investigate the relationship 
between the magnitude of hypoalgesia and sympathetic activity following 
mobilisation and the expectations of patients. Furthermore, focus groups or 
interviews could be used to explore the experiences of patients who receive 
mobilisation. 
 Taylor and Murphy (2009) have reported (using functional MRI) a correlation 
between lumbar dysfunction and neuroplastic changes to the dorsal horn and 
central pain structures (midbrain, brainstem, amygdala and thalamus), as well 
as SNS synaptic activity (Nagai et al., 2004). However, this theory needs 
further investigation to correlate sympathetic responses to mobilisation 
treatment with pain and functional disability measures throughout a full course 
of treatment and to correlate these findings directly with functional MRI 
results. 
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8.5. Original contribution to knowledge 
 The reliability study in this thesis was the first to assess the reliability in a 
laboratory sitting of the e-Health Sensor Shield V2.0 at measuring skin 
conductance, respiratory rate, heart rate and skin temperature. Furthermore, 
it was the first to assess the reliability of measuring the sAA enzyme, which 
is linked to arousal of the SNS. Although the reliability of PPT measures has 
been tested previously, the sites used for measurements in this study have 
not been previously tested for reliability. 
 The clinical study was the first to investigate the sympathetic effects of 
mobilisation treatment in NSCLBP patients. These results inform the current 
evidence and help clinicians in the decision-making process. 
 This is the first study to highlight the potential influence of thoracic 
mobilisation on salivary biomarker indicators as a sympathetic measure. 
 This is the first study to assess the extent of hypoalgesic effects in the lumbar 
area following thoracic mobilisation in an asymptomatic population. 
 This is the first study to examine the extent of the hypoalgesic effects over the 
lumbar and distal areas following thoracic mobilisation in LBP patients. 
 This is the first study to examine the dose-dependent effect of mobilisation on 
sympathetic activity. 
 The clinical study found a dissociation between PPT values and NPRS 
measures that was reported by patients with LBP. This calls into question 
other studies that have reported PPT in isolation as it could be suggested that 
a change in this measure may not reflect a change in patient-reported 
measures of pain. 
 The clinical study suggests that various hypoalgesic mechanisms may be 
responsible for changes seen in PPT and NPRS. 
8.6. Conclusions 
The aim of this series of investigations was to advance the knowledge surrounding 
the mechanisms behind the clinical benefits of mobilisation treatment in patients with 
CLBP. The results of this reliability study demonstrated that the test-retest within a 
day reliability of skin conductance, respiratory rate, heart rate and skin temperature, 
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SBP and PPT measurements were excellent the reliability of DBP and sAA 
measurements was fair to good respectively. The preclinical study findings in 
asymptomatic subjects revealed significant sympathoexitatory effects in terms of BP, 
HR and RR where there were insignificant results with regard to peripheral 
sympathetic measures (SC and ST). Significant hypoalgesic effects were evident in 
some locations, including distal areas, but not at all visits. 
The clinical study in patients with NSCLBP showed significant peripheral detectable 
sympathoexcitatory effects in the lower limbs in terms of increased SC and 
decreased ST following thoracic mobilisation that were not detected in asymptomatic 
participants. These peripheral sympathetic responses occurred concurrently with 
significant hypoalgesic effects with an increase in PPT values and a significant 
decrease in NPRS. However, the statistical significant PPT values were not evident 
in all locations and these changes were not clinically significant. There was no 
association between changes in PPT and changes in NPRS. 
Results suggest that peripheral sympathetic measures might be used as a 
noninvasive indicator of neurophysiological changes present with lumbar conditions. 
These changes might include adaptive neuroplasticity, as well as dorsal horn and 
central processing. 
Although the design of the study does not infer results regarding cause and effect, it 
presents new information that informs future research in the area of the mechanism 
of action of manual therapy and management strategies for LBP. 
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Appendices 
Appendix 3.1. Criteria list for the methodological quality assessment 
(adapted from van Tulder et al., 2003) 
A/ Was the method of randomization adequate? Yes/No/Don’t know 
B/ Was the treatment allocation concealed? Yes/No/Don’t know 
C/ Were the groups similar at baseline regarding the most important prognostic 
indicators? Yes/No/Don’t know 
D/ Was the patient blinded to the intervention? Yes/No/Don’t know 
E/ Was the care provider blinded to the intervention? Yes/No/Don’t know 
F/ Was the outcome assessor blinded to the intervention? Yes/No/Don’t know 
G/ Were co-interventions avoided or similar? Yes/No/Don’t know 
H/ Was the compliance acceptable in all groups? Yes/No/Don’t know 
I/ Was the drop-out rate described and acceptable? Yes/No/Don’t know 
J/ Was the timing of the outcome assessment in all groups similar? Yes/No/Don’t 
know 
K/ Did the analysis include an intention-to-treat analysis? Yes/No/Don’t know 
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Appendix 4.1. Salivary alpha-amylase assay protocol 
Step 1: Read and prepare reagents according to the Reagent Preparation section 
before beginning assay. Determine your plate layout 
Step 2: Keep the desired number of strips in the strip holder and place the remaining 
strips back in the bag.  
Step 3: Set your plate reader to incubate at 37ºC, and to read in center measurement 
kinetic mode initially at one minute, then again two minutes later. Choose the 405 
nm filter with no reference filter. For plate readers without these options, incubation 
can take place in a plate incubator/rotator with manual movement of the plate into 
and out of the plate reader for the 1 minute and 3 minute readings. Kit validation was 
performed under these conditions.  
Step 4: Heat the α-Amylase Substrate to 37ºC in the trough provided. (For ease of 
use we recommend using a preheated 37ºC microtiter plate incubator.) Be sure the 
α-Amylase Substrate has reached 37ºC before use. A minimum warm up time of 20 
minutes, from room temperature, in a preheated microtiter plate incubator is 
recommended. (If using any other incubator it can take an hour or more to reach 
37ºC.) Keep trough covered to prevent evaporation.  
Step 5: Saliva samples are to be diluted with the α-Amylase Diluent provided. 
Prepare a 1:10 dilution of the saliva by pipetting 10 μL of saliva into 90 μL α-Amylase 
Diluent. Mix well. Further dilute by pipetting 10 μL of the 1:10 dilution into 190 μL α-
Amylase Diluent (1:20). Final dilution is 1:200. The remainder of the 1:10 dilution 
may be set aside in case a different final dilution is necessary. 
Step 6: Add 8 μL of controls and/or diluted saliva samples to individual wells.  
Step 7: Add 320 μL of the preheated (37ºC) α-Amylase Substrate to each well 
simultaneously using a multichannel pipette. Discard pipette tips to avoid reagent 
contamination. Do not return any of the α-Amylase Substrate left in the tips to 
the bulk tray once you have dispensed it into the wells. This could contaminate 
the bulk tray contents and affect any subsequent testing. Any well containing 
bubbles at the time of reading must be repeated.  
Step 8: If reading kinetically in a programmable 37ºC plate reader, immediately 
place plate in reader and start reader. Wells are very full. Program plate reader 
to mix slowly or liquid could spill into the plate reader.  
Otherwise, follow these steps:  
immediately and mix (500-600 RPM) at 37ºC.  
 Optical Density (OD) at exactly 1 
minute, and then return to mixing at 37ºC. Save 1 minute OD readings.  
exactly 3 minutes. Save 3 minute OD 
readings.  
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Calibration  
This procedure is standardized using the millimolar absorptivity of 2-chloro-p-
nitrophenol under the test conditions described.  
Quality Control  
The Salimetrics’ High and Low α-Amylase Controls should be run at least once on 
each day of testing. The control ranges established at Salimetrics are to be used as 
a guide. Each laboratory should establish its own range. Variations between 
laboratories may be caused by differences in techniques and instrumentation. 
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Appendix 5.1. Manchester Metropolitan University Ethics Approval for 
reliability study 
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Appendix 5. 2. Participant Information Sheet (reliability study) 
Participant Information Sheet 
Study Title: The reliability of The e-Health Sensor Shield V2.0, Wagner algometer 
and salivary alpha amylase measurements in asymptomatic population. 
The Principal Investigator:  
Mrs. Wafa AL Muslem, PhD student, Health Psychology and Social Care 
department, Manchester Metropolitan University. 
wafa_hashim@hotmail.com 
wafa-hashem.a.al-muslem@stu.mmu.ac.uk 
00447874107120 
The Director of Studies:  
Dr. Peter Goodwin, Health Psychology and Social Care department, Manchester 
Metropolitan University 
P.Goodwin@mmu.ac.uk 
01612472941 
 
I would like to invite you to take part in a research study. This study has been 
reviewed by the Faculty Ethics Committee. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please 
take time to read the following information carefully. Ask questions if anything you 
read is not clear or would like more information. Take time to decide whether or not 
to take part.   
 
What is the purpose of the study? 
You are invited to participate in this study that aims to determine the reliability of The 
e-Health Sensor Shield V2.0 at measuring blood pressure, respiratory rate, heart 
rate, skin temperature and sweat levels responses. Also, to determine the reliability 
of a Wagner algometer at measuring pressure tolerance and the reliability of 
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measuring alpha amylase from your saliva. This data can then be used to determine 
if this equipment are reliable and stable measuring tools for future use in hospitals 
with patients with low back pain undergoing physiotherapeutic treatment.  
Who can take part? 
We are looking for healthy individuals aged 18-55 years, male and female gender, 
who able to provide informed consent for the study and asymptomatic of spinal pain. 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through the information 
sheet. We will then ask you to sign a consent form to show you agreed to take part. 
You are free to withdraw at any time, without giving a reason.  
What will happen to me if I take part? 
If you are prepared to be involved in the study you will be required to attend the Jon 
Dalton Building on one occasion. The visit will consist of a brief, 5 minutes, interview 
to determine your suitability for inclusion to the study. You will be asked about your 
current and past health, any current medications any conditions that may affect the 
results of the study. The principal investigator will invite you to discuss any aspects 
of the study. Following that, if you wish to take part in the study, you will be asked to 
sign the consent form. It is important that prior to your visits, you try not exercise or 
eat any food for 3 hours or have any drinks that contain caffeine (tea, coffee, coca 
cola) and refrain from alcohol for up to 24 hours. This is essential as the 
measurements will be affected by food and certain drinks.      
What will I have to do? 
First, we will measure your blood pressure using the sphygmomanometer (3 times 
with one minute rest). After that in order to measure the level of alpha-amylase, you 
will be asked to express saliva directly into cryotubes through a small straw (3 times 
with one minute rest). Then, we will measure the pressure tolerance over your lower 
back, The Wagner algometer will be pressed perpendicularly and you will be 
instructed to inform the researcher when the algometer’s pressure changes to pain 
and a reading will be recorded (3 times with one minute rest).  
You will then be required to lie on your front, on a treatment coach. In order to 
measure your heart rate, skin temperature, respiratory rate and sweat levels 
responses, it is necessary to place small electrodes on your body. Airflow (breathing) 
will be measured by a set of two prongs, which are placed in the nostrils. Heart rate 
sensors will be connected to your back. Body temperature sensor will be placed over 
the planter surface of the big toe. Sweat level sensors will be placed over the planter 
surface of the second and third toes. The sites of the skin where the electrodes will 
be applied will be cleaned first with isopropyl alcohol to remove any unwanted skin 
residue. You will be instructed not to deep breath, cough, fall asleep, sneeze, 
interfere with the electrodes or talk except to indicate pain or discomfort. To allow 
your body to acclimate to the environment, you will have an initial 10-minute 
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stabilisation period, and then we will begin to take recordings from the applied 
sensors over the next eight minutes.  
The whole session should not take more than 45 minutes and you will be informed 
when the period of the test has ended. 
Expenses and payments? 
Reasonable expenses will be made to volunteers for taking part in the study.  
What are the possible disadvantages and risks of taking part? 
It is not anticipated that you will experience any abnormal responses from any of the 
measurement procedures. However, if you experience any undue discomfort, the 
test will be terminated immediately upon your request.  
What are the possible benefits of taking part? 
You will not get benefits of taking part but the information we get from the study will 
help to improve the treatment of people with low back pain.  
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
primary researcher who will do the best to answer your questions 
(00447874107120). If you remain unhappy and wish to complain formally you can 
do this through contacting the primary supervisor, 
Dr Peter Goodwin 
Manchester Metropolitan University 
Birley Building 
Birley Fields Campus 
53 Bonsall Street 
Manchester 
M15 6GX 
Tel: 01612472941 
Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential, and any information about you which leaves the university 
will have your name and address removed so that you cannot be recognised. 
However, your involvement in the study may be revealed as others may see you 
entering or leaving the testing rooms. 
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What will happen if I don’t carry on with the study? 
If you withdraw from the study all the information and data collected from you, to 
date, will be kept and used for study purposes. 
What will happen to the results of the research study? 
Before presenting or publishing any data from this study, data will be anonymised. 
Who is organising or sponsoring the research? 
This study is organised by Manchester Metropolitan University and sponsored by 
Saudi Cultural Bureau.   
 
Thank you for taking the time to read the information and if you want any more 
information please do not hesitate to contact the primary researcher 
(00447874107120). 
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Appendix 5.3. Consent form (reliability study) 
 
Participant Name:                                                                              Date of Birth: 
Contact Telephone Number: 
Study 1- CONSENT FORM 
Title of Project: The reliability of The e-Health Sensor Shield V2.0, Wagner algometer and 
salivary alpha amylase measurements in asymptomatic population. 
Name of Researcher: Mrs. Wafa AL Muslem, PhD student, Health Psychology and Social Care 
department, Manchester Metropolitan University. 
Please initial all boxes  
1. I confirm that I have read and understand the information sheet dated [23rd July 2015] 
version [1.0] for the above study.  I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
   
2. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected. 
 
3. I agree to take part in the above study.    
 
 
            
Name of Participant   Date    Signature 
                                
            
Name of Person   Date    Signature  
taking consent.  
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Appendix 5. 4: Example raw data trace 
Right skin 
conductance 
Right skin 
temperature 
 Left skin 
conductance 
Left skin 
temperature 
 ECG AirFlow 
0.351562 2.651367 0.327148 2.700195 1.821289 0.03418 
0.361328 2.651367 0.341797 2.700195 1.660156 0.029297 
0.366211 2.65625 0.341797 2.695312 1.665039 0.029297 
0.356445 2.651367 0.322266 2.700195 1.782227 0.024414 
0.356445 2.65625 0.341797 2.700195 1.601562 0.019531 
0.341797 2.651367 0.351562 2.705078 1.806641 0.019531 
0.361328 2.69043 0.34668 2.700195 1.713867 0.014648 
0.336914 2.65625 0.341797 2.700195 1.660156 0.019531 
0.356445 2.651367 0.322266 2.700195 1.826172 0.019531 
0.361328 2.65625 0.341797 2.695312 1.655273 0.009766 
0.341797 2.651367 0.327148 2.700195 1.782227 0.014648 
0.361328 2.65625 0.327148 2.705078 1.772461 0.014648 
0.34668 2.651367 0.341797 2.695312 1.645508 0.014648 
0.34668 2.651367 0.327148 2.700195 1.831055 0.004883 
0.361328 2.65625 0.366211 2.700195 1.635742 0.014648 
0.327148 2.65625 0.34668 2.69043 1.68457 0.009766 
0.356445 2.65625 0.322266 2.705078 1.772461 0.009766 
0.34668 2.65625 0.375977 2.700195 1.577148 0.009766 
0.351562 2.65625 0.327148 2.700195 1.762695 0.014648 
0.375977 2.651367 0.332031 2.700195 1.674805 0.004883 
0.332031 2.651367 0.336914 2.700195 1.625977 0.009766 
0.375977 2.65625 0.322266 2.700195 1.826172 0.004883 
0.361328 2.651367 0.341797 2.700195 1.748047 0.009766 
0.336914 2.65625 0.327148 2.700195 2.314453 0.014648 
0.375977 2.651367 0.356445 2.700195 2.856445 0.009766 
0.34668 2.680664 0.341797 2.700195 2.055664 0.009766 
0.356445 2.651367 0.361328 2.700195 1.621094 0.009766 
0.361328 2.651367 0.327148 2.695312 1.464844 0.009766 
0.327148 2.651367 0.34668 2.700195 1.538086 0.024414 
0.366211 2.651367 0.327148 2.700195 1.640625 0.014648 
0.351562 2.680664 0.341797 2.700195 1.484375 0.019531 
0.34668 2.651367 0.327148 2.695312 1.694336 0.009766 
0.361328 2.661133 0.341797 2.695312 1.59668 0.004883 
0.361328 2.651367 0.336914 2.700195 1.586914 0.009766 
0.361328 2.651367 0.317383 2.729492 1.777344 0.004883 
0.366211 2.651367 0.351562 2.695312 1.625977 0.009766 
0.336914 2.666016 0.361328 2.700195 1.757812 0.004883 
0.361328 2.651367 0.34668 2.700195 1.757812 0.009766 
0.390625 2.65625 0.341797 2.700195 1.669922 0.004883 
0.356445 2.651367 0.322266 2.700195 1.875 0.004883 
0.361328 2.651367 0.34668 2.700195 1.723633 0.009766 
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0.336914 2.651367 0.327148 2.700195 1.811523 0.009766 
0.361328 2.651367 0.322266 2.700195 1.850586 0.004883 
0.351562 2.65625 0.341797 2.700195 1.699219 0.004883 
0.351562 2.65625 0.327148 2.700195 1.889648 0.009766 
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Appendix 6.1. Manchester Metropolitan University Ethics Approval for pre-
clinical study 
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Appendix 6.2. Calculation of intra-subject standard deviation from the 
reliability study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pooled standard deviation= 0.073 
 
 
 
 
 
 
skin conductance  
(trail 1) 
skin conductance  
(trail 2) 
skin conductance 
(trail 3) 
-0.053320004 -0.04467281 -0.061967198 
0.022751527 0.019996803 0.018878187 
0.00751345 0.007868697 0.008086099 
0.024250668 -0.032585701 -0.039228955 
-0.276431412 -0.235845303 -0.264078196 
-0.019269237 -0.02222825 -0.026558853 
-0.106401395 -0.101486957 -0.100205643 
-0.049508947 -0.03983114 -0.036051579 
-0.035504336 -0.030830301 -0.030207694 
-0.036498445 -0.025306178 -0.023510817 
0.102822581 0.07544566 0.056400969 
0.011356714 -0.004344958 -0.01280232 
-0.064255445 -0.061551413 -0.039649785 
-0.112785453 -0.14168008 -0.17820623 
0.041968811 0.033646869 0.040139802 
Mean trial 1= 
-0.036220728 
 
Standard deviation= 
0.08 
 
Mean trial 2= 
-0.040227004 
 
Standard deviation= 
0.07 
 
Mean trial 3= 
-0.045930814 
 
Standard deviation= 
0.07 
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Appendix 6.3. Participant Information Sheet (pre-clinical study) 
 
 
Participant Information Sheet 
Study Title: The neurophysiological responses of sympathetic nervous system to 
passive accessory mobilisations in asymptomatic population. 
The Principal Investigator:  
Mrs. Wafa AL Muslem, PhD student, Health Psychology and Social Care 
department, Manchester Metropolitan University. 
wafa_hashim@hotmail.com 
wafa-hashem.a.al-muslem@stu.mmu.ac.uk 
00447874107120 
The Director of Studies:  
Dr. Peter Goodwin, Health Psychology and Social Care department, Manchester 
Metropolitan University 
P.Goodwin@mmu.ac.uk 
01612472941 
I would like to invite you to take part in a research study. Before you decide you need 
to understand why the research is being done and what it would involve for you. 
Please take time to read the following information carefully. Ask questions if anything 
you read is not clear or would like more information. Take time to decide whether or 
not to take part.   
What is the purpose of the study? 
You are invited to participate in this study that aims to determine the nervous system 
responses of gentle pressure to the spine, by a physiotherapist, in a pain free 
population.  
Who can take part? 
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We are looking for healthy individuals aged 18-55 years, male and female gender, 
who able to provide informed consent for the study and asymptomatic of spinal pain. 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through the information 
sheet. You can take this information away with you to discuss with your friends and 
family. If you decide to take part we will ask you to sign a consent form to show you 
agreed to take part. You are free to withdraw at any time, without giving a reason.  
What will happen to me if I take part? 
If you are prepared to be involved in the study you will be required to attend room  
T0.18 of the John Dalton West building, (Manchester Metropolitan University, 
Chester Street, Manchester, M1 5GD) on three occasions. 
We will determine your suitability for inclusion to the study. You will be asked about 
your current and past health, any current medications any conditions that may affect 
the results of the study.  
It is important that prior to your visit, you try not exercise or eat any food for 3 hours 
or have any drinks that contain caffeine (tea, coffee, coca cola) and refrain from 
alcohol for up to 24 hours. This is essential as the measurements will be affected by 
food and certain drinks.      
What will I have to do? 
Visit 1, 2 and 3 
You will be required to partially undress your top half. We will have blankets and 
screens to protect your dignity at all times.  
First, we will measure your blood pressure which requires wearing a cuff round your 
arm which will be pumped up. After that in order to measure the levels of an enzyme 
which is linked to arousal of the sympathetic nervous system (alpha amylase) we 
would like to collect a sample of your saliva. To do this we will put a swab under your 
tongue and you will be asked to give a sign when the swab is full. Then, we will 
measure the pressure tolerance over your lower back, The Wagner algometer will 
be pressed perpendicularly and you will be instructed to inform the researcher when 
the algometer’s pressure changes to pain and a reading will be recorded.  
You will then be required to lie on your front, on a treatment couch. In order to 
measure your heart rate, skin temperature, respiratory rate and sweat levels 
responses, it is necessary to place small electrodes on your body.  
Airflow (breathing) will be measured by a set of two prongs, which are placed in the 
nostrils. Heart rate sensors will be connected to your chest. Body temperature 
sensor will be placed over the planter surface of the big toe. Sweat level sensors will 
be placed over the planter surface of the second and third toes.  
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The sites of the skin where the electrodes will be applied will be cleaned using an 
antiseptic swab (isopropyl alcohol) to remove any unwanted skin residue. To allow 
your body to acclimatise to the environment, you will have an initial 10-minute 
stabilisation period, and then we will begin to take recordings from the applied 
sensors over the next two minutes.  
Directly after that, a physiotherapist will apply gentle pressure (treatment) to one 
area in the middle of your spine; this will be interspersed with rest periods. 
Recordings will be taken from the applied sensors throughout this intervention. This 
treatment will last for 5 minutes.  
Following the treatment you will be asked to remain still for a further 10 minutes. 
During this period the researcher will remain in the room and will inform you when 
the period of the test has ended. 
After that we will measure the pressure tolerance over your lower back, The Wagner 
algometer will be pressed perpendicularly and you will be instructed to inform the 
researcher when the algometer’s pressure changes to pain and a reading will be 
recorded. 
Finally, we will measure your blood pressure using the sphygmomanometer. Then, 
in order to measure the level of alpha-amylase, we will put a swab under your tongue 
and you will be asked to give a sign when the swab is full. The whole session should 
not take more than 45-60 minutes and you will be informed when the period of the 
test has ended. 
Expenses and payments? 
Reasonable expenses will be made to volunteers for taking part in the study. 
What are the possible disadvantages and risks of taking part? 
It is not anticipated that you will experience any abnormal from any of the 
measurement procedures or the treatment technique. The technique is designed for 
treatment of patients with stiff and restricted joints. It is not physically demanding 
and so should not cause any undue tiredness. However, there is a chance that 
participant may experience discomfort in the lower back the day after the treatment. 
This should disappear within 24 hours. If you experience any undue discomfort 
during the test, it will be terminated immediately upon your request.  
What are the possible benefits of taking part? 
You will not get benefits of taking part but the information we get from the study will 
help to improve the treatment of people with low back pain.  
What if there is a problem? 
If you have any concerns about any aspect of this study, you should ask to speak to 
the primary researcher who will do the best to answer your questions (00447874 107 
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120). If you remain unhappy and wish to complain formally you can do this through 
contacting the primary supervisor, 
Dr Peter Goodwin 
Manchester Metropolitan University 
Birley Building 
Birley Fields Campus 
53 Bonsall Street 
Manchester 
M15 6GX 
Tel: 01612472941 
 
Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential, and any information about you which leaves the university 
will have your name and address removed so that you cannot be recognised. 
However, your involvement in the study may be revealed as others may see you 
entering or leaving the testing rooms. 
What will happen if I don’t carry on with the study? 
If you withdraw from the study all the information and data collected from you, to 
date, will be destroyed and your name removed from all the study files. 
What will happen to the results of the research study? 
Before presenting or publishing any data from this study, data will be anonymised. 
Who is organising or sponsoring the research? 
This study is organised by Manchester Metropolitan University and sponsored by 
Saudi Cultural Bureau.   
 
Thank you for taking the time to read the information and if you want any more 
information please do not hesitate to contact the primary researcher 
(00447874107120). 
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Appendix 6.4. Consent form (pre-clinical study) 
 
 
 
Participant Name:                                                                              Date of Birth: 
Contact Telephone Number: 
Study 2- CONSENT FORM 
Title of Project: The neurophysiological responses of sympathetic nervous system to passive 
accessory mobilisations in asymptomatic population. 
Name of Researcher: Mrs. Wafa AL Muslem, PhD student, Health Psychology and Social Care 
department, Manchester Metropolitan University. 
Please initial all boxes  
4. I confirm that I have read and understand the information sheet dated [23rd March 
2016] version [1.0] for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
   
5. I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected. 
 
6. I agree to take part in the above study.    
 
 
            
Name of Participant   Date    Signature 
                                
            
Name of Person   Date    Signature taking consent.  
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Appendix 7.1. Manchester Metropolitan University Ethics Approval for 
clinical study 
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Appendix 7.2. University of Dammam Ethics Approval for clinical study 
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Appendix 7.3. Letter from head of physiotherapy department 
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Appendix 7.4. Skin conductance mean difference from pre-clinical study 
 
Skin conductance 
(visit 1) 
Skin conductance  
(Visit 2) 
Mean difference 
-0.1389 -0.3703 -0.2314 
-0.2666 -0.2276 0.039 
-0.84415 0.0122 0.85635 
-0.34705 -0.17315 0.1739 
-0.34495 -0.34645 -0.0015 
-0.66245 -0.472 0.19045 
-0.9814 -0.31605 0.66535 
-0.17435 -0.1821 -0.00775 
-0.2178 -0.09585 0.12195 
-0.1985 -0.0403 0.1582 
-0.10845 -0.08975 0.0187 
-0.4856 -0.31785 0.16775 
-0.20675 -0.0424 0.16435 
-0.12055 -0.27365 -0.1531 
-0.2678 -0.40165 -0.13385 
-0.2293 -0.20855 0.02075 
-0.81485 -0.00045 0.8144 
-0.271 -0.1895 0.0815 
-0.42745 -0.4654 -0.03795 
-0.64875 -0.3931 0.25565 
-0.98375 -0.37505 0.6087 
-0.1635 -0.22455 -0.06105 
-0.11245 -0.0964 0.01605 
-0.2996 -0.07155 0.22805 
-0.1093 -0.0892 0.0201 
-0.4387 -0.30845 0.13025 
-0.2591 -0.0108 0.2483 
-0.1337 -0.2204 -0.0867 
-0.201 -0.3716 -0.1706 
-0.2094 -0.1876 0.0218 
-0.97845 0.00835 0.9868 
-0.26205 -0.2083 0.05375 
-0.51275 -0.5369 -0.02415 
-0.5435 -0.3473 0.1962 
-0.9695 -0.3915 0.578 
-0.16025 -0.1958 -0.03555 
-0.0773 -0.07495 0.00235 
-0.11305 -0.07965 0.0334 
-0.10685 -0.08425 0.0226 
-0.3924 -0.29695 0.09545 
-0.27255 -0.0389 0.23365 
-0.1393 -0.31075 -0.17145 
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Mean difference = 0.244144969048 
Pooled standard deviation= 0.212648 
𝑛 =
 2 × 𝑆𝐷2
(𝑚𝑑)2
× 7.8 (Rigby and Vail, 1998) 
𝑛 =
 2 × (0.21)2
(0.14)2
× 7.8 
𝑛 = 31.2 
Dropout rate= 31.2x20/100=6.2 
𝑛 =37 
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Appendix 7.5. Participant Information Sheet (clinical study) 
 
INFORMED CONSENT STATEMENT 
 
For children/minors participating in this study, the term 
 “You” addresses both the participant and the parents or legally 
authorized representative to consent. 
 
 
 ةقبسملا ةقفاوملا نايب ةرصبتملا    
 لافطألل و"تنأأ" حلطصم ن اف ،ةسارلدا هذه في ينكراشلما نيصراقلا 
  اينوناق هنع بوني نم وأأ نيلداولاو ينكراشلما نم كل بطايخ. 
 
PROJECT TITLE : The sympathetic nervous system effects 
of spinal mobilisations in those with and without low back pain 
(LBP) 
 Name of the Investigator/s--- Wafa Hashem AL Muslem / 
Dr Peter Goodwin /  Dr Emma Hodson-Tole /Mrs. Jackie 
Hindle  
 
In collaboration with (if applicable):------------------- 
(Names):------------------------------------------ 
(Affiliation) :--------------------------------------- 
1.You are being asked to participate in our study of Title  - 
The sympathetic nervous system effects of spinal 
mobilisations in those with and without low back pain 
(LBP) 
 for the  period/duration of 45 minutes/3 visits     You were 
particularly selected to participate in this study because you 
have been diagnosed with Low Back Pain. For the 
specific duration because we aim to determine the 
sympathetic nervous system responses to gentle 
pressure over the spine. 
For research purpose, the procedures to be followed are: 
- regular physical therapy assessment to assess your 
suitability for the treatment. 
- you will be required to partially undress your top 
half. We will have blankets and screens to protect 
your dignity at all times.  
- we will measure your blood pressure  
- we will measure the levels of an enzyme which is 
linked to arousal of the sympathetic nervous system 
(alpha amylase) by collecting a sample of your saliva.  
- we will measure the pressure tolerance over your 
lower back, The Wagner algometer will be pressed 
perpendicularly and you will be instructed to inform 
the researcher when the algometer’s pressure 
changes to pain and a reading will be recorded.  
عورشملا ناونع: زاهجلا ىلع يرقفلا دومعلل يوديلا جلاعلا ريثأت
رهظلا لفسا ملاا ىضرمل يواثابميسلا يبصعلا 
 :نيثحابلا ءامسأملسملا ءافو 
 
 (  عم نواعتلابدجو نإ) :-------------------- 
(ءماسألا): ------------------------------- 
ةييمدكاألا ةهلجا):  ---------------------------- 
1. بلطن نحن انتسارد يف كراشت نأ كنم  
عبناون :  يبصعلا زاهجلا ىلع يرقفلا دومعلل يوديلا جلاعلا ريثأت
رهظلا لفسا ملاا ىضرمل يواثابميسلا 
 :ةرتفلا/ ةدملا45 تاسلج ثلاث ةدلم ةقيقد 
 نم  يناعت: كنلأ ةساردلا هذه يف كراشتل ًايصخش كرايتخا مت
 ةددحملا ةرتفلا يف رهظلا لفسأ ةقطنم يف ملأ] ريثأت ةفرعمل
يواثابميسلا يبصعلا زاهجلا ىلع رهظلل يوديلا حلاعلا [ 
و انمهف ةدايز لجأ نم عوضوملا اذه يف ثحبن نحن     نع     
: يلاتلا للاخ نم فادهلأا 
-علما موقيس لوخدلل كتمئلام ىدم ةفرعلم كتلاح مييقتب )ثحابلا( يئايزيفلا لجا
.ثحبلا ةنيع نمض 
-خا متيس ثم مدلا طغض سايقب لجاعلما موقيس,ةيادبذ تسلا باعل ةنيع  اهمادخ
.يواثابميسلا  بيصعلا زاهلجا ةطساوب زرفي يمزنا ليلحتل اقحلا 
-ا ىدم سايق متيس و ريرسلا ىلع ءاقلتسلاا كنم بلطيسغضلل كلامتح في ط
.رهظلا  ةقطنم في ةنيعم طاقن 
-  .بلقلل طيطتخ لمعل ردصلا ةقطنم ىلع )باىطقأ( راعشتسا ةزهجأ عضو متيس
 ينمدقلا عباصأ ىلع باطقأو سفنتلا لدعم سايقل فنلاا تاحتف بنابج باطقاو
.مسلجا ةرارح ةجرد سايقل 
- لاعلا يئايزيفلا لجاعلما كل مدقيس, قئاقد رشع يضم دعبلم يوديلا ج  رهظلا ةقطن
 ,طغضلا نم لياخ تقو اهللختي ةطسوتم ةوقب تاترف ثلاث ىلع طغضلا قيرط نع
 للاخ .قئاقد سخم يوديلا ج لاعلا ةدم نوكتسذخأب باطقلاا موقتس كلذ 
.ةرمتسم ةروصب تاسايقلا 
 ىرخأ ةرم مدلا طغض لجاعلما كل سيقيس,ج لاعلا نم ءاهتنلاا نم قئاقد رشع دعب
كوذ كلخؤتسذ .ةيناث باعل ةنيع 
-  زواجتت نل ةسلجلل ةينمزلا ةدلما45  روف كرابخاب لجاعلما موقيسو ,ةقيقد
.تاسايقلا نم ءاهتنلاا 
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You will then be required to lie on your front, on a 
treatment couch. In order to measure your heart 
rate, skin temperature, respiratory rate and sweat 
levels responses, it is necessary to place small 
electrodes on your body.  
Airflow (breathing) will be measured by a set of two 
prongs, which are placed in the nostrils. Heart rate 
sensors will be connected to your back. Body 
temperature sensor will be placed over the planter 
surface of the big toe. Sweat level sensors will be 
placed over the planter surface of the second and 
third toes.  
The sites of the skin where the electrodes will be 
applied will be cleaned using an antiseptic swab 
(isopropyl alcohol) to remove any unwanted skin 
residue. To allow your body to acclimatise to the 
environment, you will have an initial 10-minute 
stabilisation period, and then we will begin to take 
recordings from the applied sensors over the next 
two minutes.  
- Directly after that, a physiotherapist will apply 
gentle pressure (treatment) to one area in the middle 
of your spine; this will be interspersed with rest 
periods. Recordings will be taken from the applied 
sensors throughout this intervention. This treatment 
will last for 5 minutes.  
Following the treatment you will be asked to remain 
still for a further 10 minutes. During this period the 
researcher will remain in the room and will inform 
you when the period of the test has ended. 
After that we will measure your blood pressure using 
the sphygmomanometer. Then, in order to measure 
the level of alpha-amylase, you will be asked to 
express saliva directly into cryotubes through a small 
straw. Finally, we will measure the pressure tolerance 
over your lower back, The Wagner algometer will be 
pressed perpendicularly and you will be instructed to 
inform the researcher when the algometer’s pressure 
changes to pain and a reading will be recorded. The 
 
  نأ ةظحلام ىجري يف كتكراشما هذهةيثحبلا ةساردل تعت رب
 ةيعوطتوةساردلا هذه نم اءزج نوكت نأ ىلع ةقفاوملا لبق 
 و ةءارق ىجري/ ملا ىلإ عامتسلاا وأةيانعب ةيلاتلا تامولع  ،
 اذإ ةلئسلأا حرط يف ددرتت لاهمهفت مل ءيش كانه ناك. 
2.  ةساردلا هذه يف ةكراشملاب تمق اذإدقف ربتلا كنم بلطي ع
 ةنيعب ] باعل  [ اهلاسرإ متيس يتلاو    [تدجو نإ  ]
نيثحابلاو ةرفشم نوكتس كتنيع .اهليلحتل 
لا  كتانايبو ةيصخشلا كتامولعم ىلإ لوصولا نوعيطتسي
 .ةيريرسلا 
 
كلذ ىلإ ةفاضلإاب  تانايبلا ىلع لصحيس ثحابلا نإف
.ىفشتسملا يف يبطلا كلجس نم ةيريرسلا 
 
3.  ةساردلا هذه ميمصت مت ىضرمللو كل ةدئافلا ةيلامتحلا
.كتلاحل نيهباشملا  لمتحي ةساردلا جئاتن نأ امكو
 ًلابقتسم اهمادختسا  ىضرمل[ ةليدب قرطب تاجلاع يف
.ةدئاف تاذ نوكت نأ نكمي يتلا ]  رهظلا لفسا ملاا 
4. نإ  تلاجسلا نم اهيلع لوصحلا مت يتلا تامولعملا عيمج
 ةيرس ةساردلا ءانثأ كب ةصاخلاو ةيامح متتس
تاقولأا عيمج يف كتيصوصخ و كيلع فرعتلا متي نل
 ًيصخشيف كتكراشمل ةجيتنك لاكشلأا نم لكش يأب ا هذه 
 ةساردلا. كلذ عمو  نإف نأ نكمي اهعمج مت يتلا تانايبلا
تاروشنملا نم ءزجك مدختست ةيثحبلا  قارولأاو
ب ةطبترملا ملاا ىضرمل يرقفلا دومعلل يوديلا جلاعلا [ ـ
.]       رهظلا لفسا 
5.  هذه للاخ ةعقوتم ريغ ضارمأ وأ ىذأ يأ ةلاح يف
عفديس يرورضلا يبطلا ضيوعتلا نإف ةساردلا سح ب
.ىفشتسملا يف ةمظنلأا 
6.  ًمامت ةيعوطت ةساردلا هذه يف كتكراشما  ضفرت نأ كلو
ه يف ةكراشملاثحبلا اذ  هل سيل ضفرلا اذهو يأ 
ةيبلس بقاوع تنك اذإ كل ةبسنلاب تأدب ف ةكراشملاي 
ثحبلا 
7. كنكمي  ببس يلأ و تقو يأ يف ةكراشملا نع فقوتلا
بقاوع يأ نود نمو بابسلأا نم. 
8. ةيرحلا ذخ لاو تت ودبي ءيش يأ نع لاؤس يأ حرط يف ددر
و كل حضاو ريغ كلذهل ةيانعب رظنت نأةساردلا ه  ثحبلا
.عيقوتلا لبق  ةقفاوملا جذومنو 
9.  وأ ثحبلا ىلع راسفتسا يأ كيدل ةلاح يف و ، كتكراشم دعب
  حاضيإ بلطلأ عم للاوتلا كنكميف  وضوم ي ( ءافو
ملسملا( مقر لاوجلا ىلع تقو يأ يف ).0509999707). 
وأ ..( ينورتكللإا ديربلا 
walmusallam@uod.edu.sa ،). 
 ىلع رثؤت تامولعم ةيأب كغلابإ متيس هنأ ىلإ ةفاضلإاب اذه
 ثحبلا ذيفنت ءانثأ كتكراشم 
10.  سيئرلا ثحابلا عقويىلع ريلبتلا دعب ةقفاوملا جذومن 
 كراشملل ىطعت عقوملا جذومنلا نم ةخسن و ، ةعقوم ةخسن.
 ثحابلا فلم يف اهب ظافتحلاا بجي ريلبتلا لبق ةقفاوملا نم
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whole session should not take more than 45 minutes 
and you will be informed when the period of the test 
has ended. 
 
 
We are investigating this topic in order to further our 
understandings of the objectives of our work that is to 
investigate one of the proposed underlying 
mechanisms behind the effectiveness of manual 
therapy in low back pain patients  
Your participation in the research study is voluntary. 
Before agreeing to be a part of this study please, read and/or 
listen to the following information carefully.  
Feel free to ask questions if you have any ambiguities. 
2. If you participate in this study, you may be asked to 
donate a sample of [saliva] which will be sent to [if 
applicable] for analysis.  Your sample will be coded 
however; investigators at [analysis center] will not have any 
access to your personal information and clinical data.   
 
3. In addition, the investigator will acquire clinical data 
from your medical record at the hospital.          
4. Risks are limited to the usual discomfort of donating 
specific samples.  
5. This study designed might benefit you and other 
similar patients, besides”, however, there is a possibility 
that the results of the study may contribute to future 
alternative treatments and procedures of spinal 
manual therapy that might also be beneficial. 
 
6. Any and all information obtained from your 
medical records during the study will be 
confidential. Your privacy will be protected at 
all times. You will not be identified 
individually in any way as a result of your 
participation in this research. The data 
collected however, may be used as part of 
publications and papers related to                    
low back pain. 
 ىلع ثحبلا تايقلاخلأ ةمئادلا ةنجللا فلمو سيئرلا
.ضيرملل يبطلا لجسلا فلمو ةَّيحلا تاقولخملا 
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7. “In case of any unexpected injury or illness 
during this study, the compensation or the 
necessary medical treatment will be given as 
per the rules and regulations of the hospital” 
8. Your participation in this study is entirely 
voluntary. You have rights to discontinue or refuse 
to participate even after initiation of study at any 
time for any reason. Such refusal will not have any 
negative consequences for you. 
9. Please feel free to talk to the researcher and ask 
questions. You may also want to talk to your 
family, friends, or your personal doctor or other 
health care provider about joining this study.  If 
you decide that you would like to participate in the 
study, you will be asked to sign this form and you 
will be given a copy of the signed form to keep. 
10. After your participation, in case you have any 
questions and/or concerns about  research, want 
clarification or report any matter related to your 
participation in the research you may contact 
Wafa Hashem AL Muslem any time on the 
number0509999707or via email 
walmusallam@uod.edu.sa 
11. In addition, if any new information is learnt, at any 
time during the research, which might affect your 
participation in the study, you shall be informed. 
12. Principal Investigator of the study will also sign the 
copy of Informed consent and the signed copy of 
the Informed Consent will be handed over to the 
Study Participant. Also, Signed copy of informed 
consent has to be kept in the PI file, SCRELC file, 
and patient’s medical record file. 
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Appendix 7.6. Consent form (clinical study) 
 
 
 
 
 I have read or listened to the above information and 
I have decided that I will participate in the project as 
described above. The researcher has explained me about the 
study, other beneficial treatments or procedures available 
and also clarified my doubts. I also understand what will be 
expected of me. I now understand that the purpose of the 
study is to further help the understanding of manual therapy 
as treatment for low back pain patients. If I do not participate, 
there will be no penalty or loss of rights. I can stop 
participating at any time, even after I have started.  
 
 
I agree to participate in the study and for my samples to be 
kept and used for future research on low back pain. 
 My signature below also indicates that I have 
received a copy of this English consent form together with 
an official translation of this document in Arabic.  
 
 
 
Participant’s signature ………………………………………..                
Principal Investigator signature ……………………… 
Witness - I ……………………………………………………..                  
 Witness –II …………………………………………………... 
 
تأرق دقل ىلإ تعمتسا وأ هلاعأ ةروكذملا تامولعملا  هيلعو دقفتررق 
يننأ كراشأ فوس عورشملا يف حضوأو .روكذملا بلااثح ةساردلا 
يل ةبسنلاب و باجأيتلئسأ ىلع .وانأ ب اًمامت ٍعاوام بلطيس  .ينمو انأ
نيقي ىلع ضرغلا نأ ةساردلا هذه نم زيزعت وه مهف                                                         [
و ]اذإ كراشأ مل فنل نوكت ةبوقع كانه نادقف وأ لقوقحل ويننكمي 
ةكراشملا نع فقوتلا قو يأ يف ت ىتحدق نوكأ نأ دعب تأدب  ًايلعف
.ةكراشملاب 
 
 
 
 
 
 
 يف ةكراشملا ىلع قفاوأ هذهو ةساردلا ظفحت نأ نم عنام لا
 ىلع لبقتسملا يف ثحبلل مدختستو يتانيع                                                             [
 .] 
 ةقفاوملا جذومن نم ةخسن تيقلت يننأب اضيأ هاندأ يعيقوت ريشي
ةيبرعلا ةغللاب  ةغللاب ةقيثولا هذهل ةيمسر ةمجرت بناج ىلإ
ةيزيلجنلاا. 
  
 عيقوتكراشلما ………………………………………………. 
 
 
 
